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ABSTRACT 
 
The present work aimed at providing additional knowledge about the application of wet treatments to 
healthcare waste (HCW), namely alkaline hydrolysis, through the study of transformations of some 
components usually present in HCW and characterization of effluents produced.  
Samples of components usually present in HCW were subjected to autoclaving or alkaline hydrolysis 
under the same conditions of temperature and time. Alkaline hydrolysis caused appreciable 
degradation of most of the components, particularly in adhesives and diapers. The autoclaving 
treatment degraded the components in a much lesser extent than alkaline hydrolysis. The effluents 
obtained showed an appreciable organic load. Nevertheless, the effluents produced by autoclaving 
showed a lower organic load and were less biodegradable than the ones resulting from the alkaline 
hydrolysis treatment. The minimum conditions of temperature, time and concentration of NaOH to 
achieve the total destruction of animal tissues (pork and beef) were studied. The bone and meat 
containing samples were completely destroyed when subjected to temperatures higher than 95 °C 
with 1 M NaOH solution in less than 60 minutes. The effluents generated, although with very high pH 
and organic load, were biodegradable after neutralization.  
Geobacillus stearothermophilus spores were used to assess the disinfection efficiency of alkaline 
hydrolysis. The survival curves and the D–values (decimal reduction time) were determined. The 
complete inactivation of spores (6 log10 reduction) was achieved at a temperature of 110 °C with 1 M 
NaOH in less than 5 minutes. 
Based on the conditions obtained for the total destruction of animal tissues as well as for the 
inactivation of Geobacillus stearothermophilus, i.e. temperature of 110 °C, time 35 minutes and 1 M 
NaOH, animal tissues and discarded medical components usually present in healthcare waste were 
hydrolyzed and the effluents were characterized according to Portuguese legislation laying down 
emission limit values for discharges of waste water, and their aerobic and anaerobic biodegradability 
was evaluated. The effluents showed values lower than the discharge limit values for almost all the 
parameters, except pH, total nitrogen, TOC, COD and BOD5. The effluents showed a coefficient of total 
aerobic biological degradation of 50.5 % and 52.9 % and an anaerobic biodegradability of 22.3 % and 
42.2 %, for discarded medical components and animal tissues, respectively.  
A real sample of infectious HCW was subjected to alkaline hydrolysis at a pilot scale, using the 
conditions of the treatment defined in the laboratorial study. The characteristics of the resultant 
effluent corroborate with studies carried out in the laboratory. 
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RESUMO 
 
O presente trabalho pretendeu acrescentar conhecimento adicional sobre a aplicação dos tratamentos 
de calor húmido, isto é, hidrólise alcalina, aos resíduos hospitalares, através do estudo das 
transformações de alguns componentes usualmente presentes nos resíduos hospitalares e da 
caracterização dos efluentes produzidos. 
Amostras de componentes normalmente presentes nos resíduos de hospitalares foram submetidas a 
autoclavagem e a hidrólise alcalina nas mesmas condições de temperatura e tempo usadas no actual 
processo de autoclavagem. A hidrólise alcalina causou uma degradação apreciável da maior parte dos 
componentes, sendo esta mais expressiva para o adesivo e a fralda. Embora na autoclavagem a 
degradação dos componentes tenha sido bastante inferior à hidrólise alcalina, os efluentes obtidos 
apresentaram uma carga orgânica elevada, mas menor biodegradabilidade do que os efluentes 
resultantes do tratamento por hidrólise alcalina. 
Nos ensaios de hidrólise alcalina realizados com tecidos de origem animal (carne de porco e carne de 
boi) foram avaliadas as condições mínimas de temperatura, tempo e concentração de NaOH necessárias 
para a destruição total dos tecidos animais. Estes foram completamente destruídos, quando sujeitos a 
temperaturas superiores a 95 °C e NaOH 1 M em menos de 60 minutos. Os efluentes gerados embora 
com elevados valores de pH e carga orgânica são biodegradáveis após neutralização. 
Nos ensaios efectuados para avaliar a eficiência de desinfecção da hidrólise alcalina foi usada a estirpe 
do microrganismo Geobacillus stearothermophilus. A eficiência do tratamento alcalino foi determinada 
pelas curvas de sobrevivência e pelos valores D (tempo de redução decimal). A completa inactivação dos 
esporos (redução 6 log10) foi conseguida à temperatura de 110 °C e a uma concentração de NaOH 1 M 
em menos de 5 minutos. 
Com base nas condições obtidas para a destruição total dos tecidos de origem animal bem como para 
inactivação do Geobacillus stearothermophilus, isto é temperatura de 110 °C, tempo de 35 minutos e 
concentração de NaOH 1 M, as amostras foram hidrolisadas e os efluentes produzidos foram 
caracterizados de acordo com a legislação portuguesa que estabelece os valores limites de emissão de 
descarga de águas residuais. A biodegradabilidade aeróbia e anaeróbia dos efluentes também foi 
avaliada. Os efluentes, na maioria dos parâmetros excepção para o pH, azoto total, COT, CQO e CBO5, 
apresentaram valores inferiores aos valores limites de emissão. Os efluentes apresentaram um 
coeficiente de degradação biológica aeróbia total entre 50,5 % e 52,9 %, e uma biodegradabilidade 
anaeróbica entre 22,3 % e 42,2 %  
Uma amostra de resíduos hospitalares do grupo III foi submetida ao tratamento por hidrólise alcalina, à 
escala piloto, nas condições de tratamento definidas nos ensaios laboratoriais. As características do 
efluente resultante do tratamento corroboraram os resultados obtidos nos ensaios laboratoriais. 
 
PALAVRAS-CHAVE: Resíduos Hospitalares; Hidrólise alcalina; Autoclavagem 
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CHAPTER 1 – INTRODUCTION 
 
 
1.1  FRAMEWORK 
 
1.1.1 RELEVANCE OF THE STUDY 
 
Waste management is a matter of concern in developed countries due to environmental 
consequences, public health and valuable resources waste, many of them strategic. In the 
European Union, 2.5 billion tonnes of waste are produced annually out of which 100 million 
tonnes are hazardous waste (Eurostat, 2010). 
Healthcare waste (HCW) is a small fraction of solid waste produced, since it represents only  
0.3 % of total generated in Europe (Eurostat, 2010), but it requires special attention due to the 
danger it represents to public health and environment. Nevertheless, the amount of HCW is 
increasing compared to other types of waste, mainly due to the use of medical disposable 
products, higher number of healthcare facilities and medical services.  
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HCW includes all the waste generated by healthcare establishments, research facilities and 
laboratories (Prüss et al., 1999). It is a heterogeneous mixture of waste with different 
components produced in variable amounts, differing among countries according to their 
particular medical management practices (Prüss et al., 1999).  
Characterisation, composition and quantities of HCW generated per year and per country or 
region can be found in the literature (Lee and Huffman, 1996; Diaz et al., 2008). The majority 
of HCW, of about 75 – 90 % is not infectious, thus can be treated as municipal waste posing no 
additional risk to health or the environment. The remaining 10 – 25 % is classified as hazardous 
waste, and it represents the fraction that requires special attention and specific treatments 
(WHO, 2005). In Portugal, in recent years, the quantity of hazardous HCW generated was 
about 30 000 ton (Figure 1.1). 
 
 
Figure 1.1 – Hazardous healthcare waste generated in Portugal (source: INE, 2014). 
 
The implementation of efficient and environmentally friendly technologies for HCW waste 
treatment requires considerable technical and funding resources and a legal framework, all 
which are mostly lacking in developing countries. For these reasons, in these countries, is 
common to watch an inappropriate treatment and uncontrolled deposition of HCW that, due 
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to the infectious nature of the waste, may contaminate surface and groundwater, exposing the 
population to diseases and parasites and increasing the epidemics risk (Hossain et al., 2011). 
There are several HCW treatment processes, including incineration, pyrolysis, autoclaving, 
chemical disinfection, encapsulation, microwave disinfection, irradiation and gasification. 
Autoclaving and incineration are the main processes used for treating HCW (Sukandar et al., 
2006), the last being the oldest and, until now, the most used (Lee and Huffman, 1996). 
However, the incineration process presents a drawback, and may emit a wide range of 
hazardous pollutants including dioxins, furans, heavy metals, fine dust particles and other 
pollutants resultant of incomplete combustion (Alvim-Ferraz and Afonso, 2005; Sukandar et 
al., 2006; Singh and Prakash, 2007). 
In 2004, the Stockholm Convention on Persistent Organic Pollutants put a focus on eliminating 
or reducing releases of 12 persistent organic pollutants (POPs) including dioxins and furans. 
Accordingly, stricter emissions limits for incinerators were introduced in the European Union 
(EU). Additionally, World Health Organization (WHO) has been promoting the use of non-
incineration technologies to treat medical waste, eliminating the risk of dioxins and furans 
emissions that may be generated by uncontrolled medical incinerators.  
Also, the small producers of HCW, due to issues of current technique as the storage areas 
needed for the HCW and the high transportation costs of untreated waste to the treatment 
unit, are seeking for viable alternatives technologies.  
Some of the treatments applied to HCW, as autoclaving and microwave, require a mechanical 
process to reduce the waste volume, which increases the operating costs. Additionally, due to 
the low mass reduction achieved in these treatments, there is a considerable mass of waste 
that is disposed of in landfills; and, in some countries as Korea, there was reluctance to accept 
the disposal of the sterilized products in their landfills (Jang et al., 2006). 
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Under such guidelines, alkaline hydrolysis may be an alternative treatment process for HCW in 
some countries (Health Care Without Harm, 2004). This treatment has been shown to have 
significant advantages compared to other HCW treatments, because it sterilizes and destroys 
at once, and it also reduces the total waste volume. Also, alkaline hydrolysis may have a range 
of application larger than autoclaving, since it can also accept organic tissues.  
 
However, the effects of various materials present in HCW during the autoclaving process as 
well as the final effluent composition and its treatability are not well known. This lack of 
knowledge makes authorities to have some reluctance in licensing autoclaving plants and in 
permitting their effluents to be discharged into domestic sewage treatment systems. 
Thus, once the consequences of application of alkaline hydrolysis are well known, it may 
advantageously substitute autoclaving and incineration to treat some types of HCW and offer 
an interesting basis of decentralised treatment for reducing the risks of infection from handling 
and transporting HCW. 
 
1.1.2 OBJECTIVES OF THE WORK 
 
The present work aimed at providing some additional light on the application of wet 
treatments to HCW, namely autoclaving and alkaline hydrolysis. It intends to help waste 
treatment operators, regulatory authorities, general public concerned with wastes and as well 
as researchers to clarify some particularities of those two processes through carefully obtained 
experimental data. Some of these aspects include answers to questions as the following: how 
common materials in HCW behave under these treatments, and, in particular, which are the 
minimum conditions of alkaline hydrolysis to destroy animal tissues? Which conditions 
guarantee disinfection when HCW contain very resilient infectious microorganisms? What kind 
of effluents is produced and are they compatible with discharge in public sewage network?   
Thus, this work established some objectives and tasks as follows: 
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1 – Study the transformations of some components generally present in HCW and characterize 
the effluents produced, at laboratory scale using similar conditions to autoclaving. 
2 – Study the transformations of some components generally present in HCW and characterize 
the effluents produced by alkaline hydrolysis, i.e. using similar conditions of temperature and 
time to those used in autoclaving but with different NaOH solution concentrations, at 
laboratory scale. 
3 – Make the alkaline hydrolysis process an alternative treatment for animal tissues and 
discarded medical components present on HCW by determining in laboratory:  
i. milder conditions than those described in the literature for destroying animal tissues 
with bones and make them unrecognizable. 
ii. effective minimum sterilization conditions using a very resilient biological indicator. 
iii. the characteristics of the effluents from the treatment. 
iv. the aerobic and anaerobic biodegradability of the effluents obtained. 
4 – Test the alkaline hydrolysis process with a real HCW sample under pilot scale conditions:  
i. design and build a reactor to scale up the laboratorial process to the range of tenths of 
liters not far from 100 L. 
ii.  make at least one test with a real sample of hazardous HCW using the conditions of 
treatment defined in the laboratorial study and determine the characteristics of the 
effluent and waste obtained. 
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1.1.3 OUTLINE  
 
The outline of the work is shown in Table 1.1, including the synthetic description of the 
content approached in each chapter. 
 
Table 1.1 – Outline of the work 
CHAPTERS  CONTENT 
CHAPTER 1  
INTRODUCTION 
 
Introduces the subject relevance, objectives and outline of 
the work. 
Presents an overview of HCW as: definition; classification; 
generation; composition and management. 
 
CHAPTER 2  
HEALTHCARE WASTE TREATMENT 
TECHNOLOGIES 
 
 
Presents and describes the technologies used on the 
treatment of HCW. 
CHAPTER 3  
ALKALINE HYDROLYSIS 
 
 
Describes the alkaline hydrolysis process. 
CHAPTER 4  
EFFECTS OF ALKALINE HYDROLYSIS AND 
AUTOCLAVING ON DISCARDED MEDICAL 
COMPONENTS PRESENT IN HEALTHCARE 
WASTES 
 
Studies the behaviour of some discarded medical 
components usually present in healthcare waste when 
subjected to treatments of alkaline hydrolysis or autoclaving. 
CHAPTER 5 
APPLICABILITY OF ALKALINE HYDROLYSIS TO 
DESTROY ANIMAL TISSUES PRESENT IN 
HEALTHCARE WASTES 
 
 
Studies the behaviour of animal tissues usually present in 
HCW when subjected to alkaline hydrolysis treatment. 
CHAPTER 6 
INACTIVATION OF Geobacillus 
stearothermophilus SPORES BY ALKALINE 
TREATMENT   
 
 
Studies the effects of NaOH concentration and temperature 
on the inactivation of Geobacillus stearothermophilus spores. 
CHAPTER 7 
CHARACTERIZATION OF EFFLUENTS 
RESULTANT FROM ALKALINE HYDROLYSIS 
TREATMENT 
 
 
Characterize the effluents produced when alkaline hydrolysis 
is applied to animal tissues and discarded medical 
components common in HCW and assess their aerobic and 
anaerobic biodegradability. 
 
CHAPTER 8 
SCALE-UP EXPERIMENTS 
 
Alkaline hydrolysis tests with a real infectious HCW sample 
using a designed reactor with 70 L of capacity. 
CHAPTER 9  
CONCLUSIONS AND FUTURE WORK  
 
 
Presents the main conclusion and suggests future work. 
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1.2 HEALTHCARE WASTE CHARACTERISTICS  
 
1.2.1 DEFINITION AND CLASSIFICATION 
 
The definition of healthcare waste is not universal and is relatively variable worldwide. Many 
terms as “medical waste”, “clinical waste”, “hospital waste”, “biomedical waste” and 
“infectious waste” have often been used in the literature. These terms can have different 
meanings according to its designation; the severe differences between them often depend on 
which legal or regulatory authority is defining the term. Indeed, in some countries the 
definition of medical waste is often different due to the existing regional legislation. In Spain, 
most of regional laws use the common term “medical waste” and only one region, of 
Cantabria, uses the term “hospital waste”.  
 
Medical waste is defined, according to the WHO, as “all the waste generated within healthcare 
facilities, research centers and laboratories related to medical procedures. In addition, it 
includes the same types of waste originating from minor and scattered sources, including 
waste produced in the course of healthcare undertaken in the home (e.g. home dialysis, self-
administration of insulin, recuperative care)”. In the United States of America (USA), the 
Medical Waste Tracking Act of 1988 (MWTA, 1988) defines medical waste as "any solid waste 
that is generated in the diagnosis, treatment, or immunization of human beings or animals, in 
research pertaining thereto, or in the production or testing of biologicals”. This definition is 
commonly used in some countries, such as Greece, (Hellenic legislation, Ministerial Decision 
37591/2031) or India, although in the later the term used is “biomedical waste” (Biomedical 
Waste Rules, 1998). According to the Chinese legislation the medical waste is defined “as 
waste characterized by infectious, toxic and other hazardous properties deriving directly or 
indirectly from medical treatment, prevention, health protection, and other related activities 
in healthcare institutions” (PR China State Council, 2003). The current legal definition of clinical 
CHAPTER 1 – INTRODUCTION 
8 
 
 
 
waste in the United Kingdom (UK) is taken from The Controlled Waste Regulations 1992, 
issued under the Environmental Protection Act 1990. It has remained unchanged since it was 
first issued under the Collection and Disposal of Waste Regulations 1988, issued pursuant to 
the Control of Pollution Act 1974. Clinical waste is defined as: (a)“...any waste which consists 
wholly or partly of human or animal tissue, blood or other bodily fluids, excretions, drugs or 
other pharmaceutical products, swabs or dressings, syringes, needles or other sharp 
instruments, being waste which unless rendered safe may prove hazardous to any person 
coming into contact with it; and (b)“…any other waste arising from medical, nursing, dental, 
veterinary, pharmaceutical or similar practice, investigation, treatment, care, teaching or 
research, or the collection of blood for transfusion, being waste which may cause infection to 
any person coming into contact with it.” 
 
The Portuguese legislation defines hospital waste as “waste resultant from healthcare 
activities to humans or animals, in the areas of prevention, diagnosis, treatment, rehabilitation 
or research and education, as well as other activities involving invasive procedures such as 
acupuncture, piercings and tattoos” (Decree Law No 73/2011). 
Medical waste is often considered as a subcategory of healthcare waste or hospital waste 
which contains the waste with infectious character. WHO defined infectious waste as “the 
waste type suspected to contain pathogens (viruses, bacteria, parasites or fungi) in enough 
concentration or quantities to cause disease in susceptible hosts” (Prüss et al., 1999). 
 
The classification of healthcare waste is not uniform worldwide and brings some confusion 
and disagreement between countries, regions and institutions. Several classifications have 
been used in legislation and in the literature. Healthcare waste may be classified into different 
types according to the source of production, chemical and physical composition, type and risk 
factors associated with their handling, storage and ultimate disposal. In the early 1980s, WHO 
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suggested a simple classification of HCW into eight categories; currently there are seven 
categories as shown in Table 1.2 (Chartier et al., 2014).  
 
Table 1.2 – Healthcare waste classification according to WHO. 
Waste type  Description 
General Waste 
 
Infectious to potentially 
infectious waste 
Wastes that have similar properties to the household solid waste. 
 
Waste contaminated with blood and its by-products, cultures and stocks 
of infectious agents, waste from patients in isolation wards, discarded 
diagnostic samples containing blood and body fluids, infected animals 
from laboratories, and contaminated materials (swabs, bandages) and 
equipment (such as disposable medical devices). 
 
Pathological waste Human tissues or fluids, e.g. body parts, blood and other body fluids, 
fetuses.  
Sharps waste Syringes, needles, disposable scalpels and blades, etc. 
 
Chemicals waste Waste containing chemical substances, e.g. laboratory reagents, film 
developer, disinfectants that are expired or no longer needed, solvents. 
  
Pharmaceuticals waste Expired, unused and contaminated drugs; vaccines and sera. 
 
Radioactive waste  Such as glassware contaminated with radioactive diagnostic material or 
radiotherapeutic materials. 
  
 
According to United States Environmental Protection Agency (EPA 40 CFR Part 60.51c), the 
wastes are divided into six categories (Table 1.3). In Greece, according to the Hellenic 
legislation (HMWC, 2003), the wastes are classified into three categories; in Turkey, the 
Medical Waste Control Regulation (MWCR, 2005) categorized wastes in four categories; 
Chinese national legislation (PR China MOH, SEPA, 2003) and the federal resolutions of Brazil 
(ANVISA, 2004 and CONAMA, 2005) classify wastes in five categories; in Korea, under Waste 
Management Act in 1999, exist six categories, and India define ten categories in accordance 
with Biomedical Waste Rules, 1998 (Table 1.4 to Table 1.9). In the case of Spain, wastes 
classification varies from region to region in the range of three to seven categories, according 
to the regional laws of the Autonomous Communities (Table 1.10).  
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Table 1.3 – Healthcare waste classification according U. S. Environmental Protection Agency. 
Waste type  Description 
Cultures and stocks Cultures and stocks of infectious agents and associated biologicals, 
including cultures from medical and pathological laboratories; 
cultures and stocks of infectious agents from research and industrial 
laboratories; wastes from the production of biologicals; discarded 
live and attenuated vaccines; and culture dishes and devices used to 
transfer, inoculate, and mix cultures. 
 
Pathological and chemo 
wastes 
 
Human pathological wastes, including tissues, organs, and body 
parts and body fluids that are removed during surgery or autopsy or 
other medical procedures and specimens of body fluids and their 
containers. 
 
Human blood and blood 
product 
Liquid waste human blood; products of blood; items saturated 
and/or ripping with human blood; or items that were saturated 
and/or dripping with human blood including serum, plasma, and 
other blood components. 
 
Sharps Sharps that have been used in animal or human patient care or 
treatment or in medical, research, or industrial laboratories, 
including hypodermic needles, syringes (with or without the 
attached needle), Pasteur pipettes, scalpel blades, blood vials, 
needles with attached tubing, and culture dishes (regardless of 
presence of infectious agents).  
 
Animal wastes Contaminated animal carcasses, body parts, and bedding of animals 
that were known to have been exposed to infectious agents during 
research (including research in veterinary hospitals), production of 
biologicals, or testing of pharmaceuticals. 
 
Isolation wastes Biological waste and discarded materials contaminated with blood, 
excretion, exudates, or secretions from humans who are isolated to 
protect others from certain highly communicable diseases or from 
isolated animals known to be infected with highly communicable 
diseases. 
 
Table 1.4 – Healthcare waste classification in Greece according to the Hellenic legislation 
(HMWC, 2003). 
Waste type Description 
Household type medical wastes  Wastes that have similar properties to the household solid 
waste.  
 
Hazardous medical wastes Waste with solely infectious properties, such as body tissues, 
blood, fecal and urine samples from patients with an infectious 
disease, needles etc. 
Waste with both infectious and toxic properties, such as 
chemotherapy related waste, waste from bio-pathology and 
histology laboratories, etc. 
Waste with solely toxic properties, such as waste that contains 
mercury, hazardous organic waste, expired drugs, filters, etc. 
 
Other types of medical waste Radioactive waste, batteries, pressurized cans, etc.  
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Table 1.5 – Healthcare waste classification in Turkey according to the Medical Waste Control 
Regulation (MWCR, 2005). 
Waste type Subgroup Description 
Municipal Wastes General wastes  
 
 
Packaging wastes 
Wastes generated from offices, warehouse, 
kitchen, etc.  
  
Recyclable materials such as paper, cardboard, 
plastics, glass, metals, etc. 
 
Medical wastes Infectious wastes 
 
 
 
 
 
Pathological wastes  
 
 
Sharps objects 
Microbiological laboratory wastes, blood, 
objects and products contaminated with blood, 
used surgical gloves, dialysis wastes, quarantine 
wastes, air filters that contain bacterium and 
viruses, infectious organ pieces.  
 
Tissues, organs, placenta, blood, wastes 
produced from surgical operations. 
 
Needles, syringes, broken glass, blades and 
other objects that could cause a cut or 
puncture. 
 
Hazardous wastes  Hazardous chemicals, cytotoxic, amalgam 
wastes, gynotoxic and cytotoxic wastes, 
pharmaceutics wastes, heavy metal containing 
wastes, pressurized vessels. 
 
Radioactive wastes  Collected and removed according to Turkey 
atomic energy council act. 
 
 
Table 1.6 – Healthcare waste classification according to the China Ministry of healthcare, 2003. 
Waste type  Description 
Infectious waste  Hazardous medical wastes carrying pathogenic microorganisms 
which can cause the infectious disease transmission. 
 
Pathological waste  
 
Medical waste generated in the human body and medical laboratory 
animal carcasses during the diagnosis and treatment, including 
tissues, organs, blood and body parts and fluids. 
 
Sharp objects Needles, syringes, broken glass, blades and other items that could 
cause a cut or puncture. 
 
Pharmaceutical waste Overdue, eliminated or contaminated waste drugs. 
 
Chemical waste Hazardous chemicals, heavy metal containing wastes, toxic, 
corrosive, flammable and explosive waste drugs. 
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Table 1.7 – Healthcare waste classification in Brazil according to federal resolutions (ANVISA, 
2004 and CONAMA, 2005).  
Waste type  Description 
A Waste representing risk to public health and the environment due to presence of 
biological agents such as: blood, bodily fluids, drainage fluids or excreta (ex. surgical 
gloves, gauze, cotton, bandages; laboratory plates and blades; microorganism 
cultures; vaccines discarded and devices used for transference, inoculation or stir 
cultures). 
 
B Substances representing risk to public health and the environment, depending on 
their characteristics of inflammability, corrosiveness, reactivity and toxicity (ex. some 
chemical products and pharmacological substances). 
 
C Radioactive waste. 
 
D General waste represented by recyclable materials (e.g. paper, cardboard, plastic, 
metals, and glass) and non-recyclable (e.g. organic substances, food leftover, and 
toilet paper). 
 
E Sharp devices (ex. needles, syringes, lancets and similar tools). 
 
 
 
Table 1.8 – Healthcare waste classification in Korea according to Waste Management Act in 
1999. 
Waste type Description 
Tissue Human or animal pathological wastes, including tissues, 
organs, blood, pus, and body parts and fluids that are 
removed during autopsy or surgery. 
 
Absorbent cotton Items (e.g. cotton pads, bandages, disposable diapers, 
or bedding) saturated or stained with human or animal 
blood, pus, discharge, or secretion. 
 
Discarded medical plastics Disposable syringe, blood bag or waste from blood 
dialysis. 
 
Pathological waste Culture and stocks of infectious agents from test or 
examination, culture dishes, discarded blood fluids and 
containers; items that were in contact with infectious 
agents, such as used slides and cover glass. 
 
Waste sharps Discarded sharps, hypodermic needles, syringes, surgical 
blades and blood lancets. 
 
Waste mixed with infectious waste Wastes that are not classified into the above categories 
but mixed or in contact with waste tissue and waste 
sharps. 
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Table 1.9 – Healthcare waste classification in India according to the Biomedical Waste Rules, 1998. 
Waste type  Description 
Human anatomical waste Human tissues, organs and body parts. 
 
Animal waste 
 
Microbiology and biotechnology waste  
Animal tissues, organs, body parts, carcasses, bleeding 
parts, blood and experimental animals used in research. 
 
Waste from lab culture, specimens from microorganisms, 
vaccines, cell cultures, toxins, dishes, devices used to 
transfer cultures.  
 
Waste sharps  Syringes, needles, disposable scalpels and blades, glass. 
 
Discarded medicines and cytotoxic drugs Contaminated, expired, discarded drugs. 
 
Soiled waste  Waste contaminated with blood and body fluids including 
cotton, dressings, and soiled plasters. 
 
Solid  waste  Tubes and catheters. 
 
Liquid waste  
 
 
Incineration waste 
 
Chemical waste 
Waste generated from laboratory and washing, cleaning, 
disinfection. 
 
Ash from incineration of any medical wastes 
 
Chemicals used in production of biologicals, disinfection 
 
Table 1.10 – Healthcare waste classification in Spanish Autonomous Community of Madrid. 
Groups Waste type  Description 
I Municipal waste  Waste comes from no polluted and infectious risk areas 
of the hospital (ex. papers, glass, plastic, metals, wood 
or food remains). 
 
II Non-specific waste Includes waste from medical activities without 
infectious or toxic risk, such as dialysis filters, gloves, 
probes, and bandages, which have not been in contact 
with patients. 
 
III Anatomical substances These substances belong to category 1 of the hazardous 
waste listed by Directive 91/689/EEC and Royal Decree 
833/1988. 
IV Large pieces of human remains  
V Chemical products Includes chemical substances, pharmaceuticals, 
medicines and veterinary compounds, biocides and 
phyto-pharmaceutical substances. 
 
VI Cytostatic waste Waste is only generated by medical activities related to 
cancer treatment as carcinogenic, mutagenic and 
teratogenic drugs. 
 
VII Radioactive waste This waste refers to radioactive chemical elements that 
do not have a practical purpose, as well as those 
products that have come in contact with them, including 
solid and liquid substances. 
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Portuguese legislation classifies HCW in four categories (Table 1.11), the two first are 
considered non-hazardous waste and the third and fourth ones are hazardous waste (Order No 
242/96).  
 
Table 1.11 – Healthcare waste classification according Portuguese legislation (Order No 
242/96). 
Groups Waste type  Description 
I Wastes similar to municipal ones Wastes that do not present special requirements in 
their treatment such as: wastes from general 
services, support services, kitchen and packaging 
(paper, cardboard, etc). 
 
II Non-hazardous hospital wastes Wastes that do not require specific treatment and 
can be considered similar to municipal wastes. 
Orthopedic supplies, diapers and disposable guards, 
personal protective equipment from general and 
support services without contamination and no 
traces of blood. Serum bottles without 
contamination except those from group IV. Empty 
containers of drugs except those included in group 
III and group IV. 
 
III Hospital wastes with biological risk  Waste contaminated or suspected of contamination 
susceptible of incineration or other effective pre-
treatment before elimination as municipal wastes, 
such as waste from rooms and wards for infectious 
patients or suspected of infectious, materials 
contaminated with blood or traces of blood, 
anatomical not identified pieces, materials used in 
dialysis, etc. 
  
IV Specific hospital wastes Wastes with compulsory incineration, such as 
animal tissues, organs, body parts, carcasses of 
animals used in research, sharps materials, chemical 
substances, pharmaceuticals and cytostatic waste. 
 
 
 
In some countries of European Union, as United Kingdom, the healthcare classification is based 
in the European Waste List (EWL). In order to standardize the waste classification, in December 
1993, the European Union publishes the EWL adopted by Commission Decision 2000/532/EC, 
as amended by Commission Decisions 2001/118/EC, 2001/119/EC and 2001/573/EC. In the 
EWL, wastes are referred to using 6 digit numerical codes, the first two digits of the code relate 
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to the EWL chapter, the second two digits relate to sub-grouping within the chapter, and the 
final two digits are specific to the waste (Table 1.12). HCW are identified with code 18 in the 
EWL, which includes various categories. Wherein, the first sub-grouping corresponds to the 
waste generated in diagnosis, treatment or prevention of disease in humans and the second 
sub-grouping corresponds to the waste generated from research, diagnosis, treatment or 
prevention of disease involving animals. In general, the healthcare wastes are categorized in 
two types: general waste and special waste or non-infectious and infectious waste, thus 
defined as non-hazardous and hazardous wastes. Therefore, the EWL considers both types of 
waste and defines a separate category for cytotoxic agents and chemicals. Indeed, the HCW 
can be further characterized to a more universal form as shown in Figure 1.2 (Chartier et al., 
2014).  
 
 
 
 
 
 
 
 
Figure 1.2 – Healthcare waste classification. 
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Table 1.12 – Healthcare waste classification according to the European Waste List. 
18 01 Wastes from natal care, diagnosis, treatment or prevention of disease in humans 
18 01 01  Sharps (except 18 01 03) 
18 01 02 Body parts and organs including blood bags and blood preserves (except 18 01 03)  
18 01 03* Wastes whose collection and disposal is subject to special requirements in order to 
prevent infection  
18 01 04 Wastes whose collection and disposal is not subject to special requirements in order 
to prevent infection (e.g. dressings, plaster casts, linen, disposable clothing, diapers, 
'Controlled Waste' as defined in NZS 4304:2002 Management of Healthcare Waste)  
18 01 06* Chemicals consisting of or containing hazardous substances  
18 01 07 Chemicals other than those mentioned in 18 01 06  
18 01 08* Cytotoxic and cytostatic medicines  
18 01 09 Medicines other than those mentioned in 18 01 08  
18 01 10* Amalgam waste from dental care  
18 02 Wastes from research, diagnosis, treatment or prevention of disease involving 
animals 
18 02 01 Sharps (except 18 02 02)  
18 02 02* Wastes whose collection and disposal is subject to special requirements in order to 
prevent infection  
18 02 03 Wastes whose collection and disposal is not subject to special requirements in order 
to prevent infection  
18 02 05* Chemicals consisting of or containing hazardous substances  
18 02 06 Chemicals other than those mentioned in 18 02 05  
18 02 07* Cytotoxic and cytostatic medicines  
18 02 08 Medicines other than those mentioned in 18 02 07  
 
 
 
1.2.2 GENERATION 
 
There has been an increase in the quantities of HCW compared to municipal waste mainly due 
to changes in healthcare policies, higher number of healthcare facilities, medical services and 
to the use of medical disposable products. In USA more than 3.5 million tons of HCW are 
produced each year (Lee et al., 2004); India generates about 3 million ton/year (Mohankumar 
and Kottaiveeran, 2011), while China produces 650 000 ton/year (Yang et al., 2009). In 
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Portugal, near 90 000 ton are generated every year (DGS, 2006). Thus, the quantities of HCW 
generated do not depend only on the population but also on several factors such as the 
medical situation of each country and its waste management systems.  
The major sources of HCW are hospitals, but other sources as clinics, healthcare 
establishments, laboratories and research facilities, mortuary and autopsy centers, animal 
research, blood banks, veterinary surgeons, dentists, nursing homes are also generating 
extensive quantities of HCW (Prüss et al., 1999). In Portugal, about 94 % of the total HCW 
production has been generated by hospitals (DGS, 2006).  
In recent years, there have been an increasing number of patients receiving a home healthcare 
and medical services. The home-based healthcare services also produce substantial quantities 
of HCW with a variety of waste materials. Some researchers (Ojeda-Benítez et al., 2013; 
Yasuda and Tanaka, 2006) have studied the characteristics, generation and composition of 
household hazardous waste (HHW). Gu et al. (2014) found that approximately 17.7 % of the 
HHW stream was medicines in Suzhou, China. These wastes are still included in general 
household waste even though they are infectious (Blenkharn, 2008). Nevertheless, there is no 
management guideline and legislation for this type of waste even in developed countries as 
Japan (Miyazaki et al., 2007).  
 
The quantities of HCW generation differ among countries by their waste medical management 
practices allied on the level of economic development. The developing countries generate 
lower quantities of HCW than the developed countries (Prüss et al., 1999). The quantities of 
HCW generated are usually depicted as a function of the bed capacity of healthcare services 
(kg/bed/day); however, in healthcare facilities where the beds are not available the production 
is expressed as kg/patient/day. For the low-income countries, WHO estimated a HCW 
generation range of 0.5 – 3 kg/bed/day and for the high income countries a HCW generation 
range of 1.1 – 12 kg/bed/day (Prüss et al., 1999). The high-income countries generate on 
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average up to 0.5 kg/bed/day of hazardous waste, while low-income countries generate on 
average 0.2 kg/bed/day of hazardous waste. However, the real quantity of hazardous waste 
can be much higher in low-income countries because the HCW are often not separated into 
hazardous or non-hazardous wastes (WHO, 2014). According to WHO, the North America 
generates 7 – 10 kg/bed/day of HCW, while South America produces just 3 kg/bed/day. In Asia, 
richer countries generate 2.5 – 4.0 kg/bed/day and poorer countries produce  
1.8 – 2.0 kg/bed/day of HCW. The same happens in Europe, on Western the production rate is 
about 3 – 6 kg/bed/day while on Eastern the production rate is 1.4 – 2.0 kg/bed/day of HCW 
(Prüss et al., 1999). Diaz et al. (2008) reported that the quantities of HCW in various types of 
facilities located in developing countries are lower than in some industrialized countries. They 
described that the range of HCW and infectious wastes in developing countries varies from 
0.016 to 3.23 kg/bed/day and 0.01 to 0.65 kg/bed/day, respectively. This wide variation is due 
to the fact that some facilities, used in their study, provide very basic services and thus 
quantities of the waste generated are relatively small. In fact, the quantities of HCW generated 
depend on the level of economic development, and the developed countries generate more 
quantities of HCW mainly due to the the use of medical disposable products, higher number of 
healthcare facilities and medical services and greater consumption of disposable instruments 
and packing materials. Moreover, in developing countries the HCW are still handled, stored 
and disposed together with municipal wastes for which reason the amount of HCW is smaller 
than really produced (Rudraswamy et al., 2013; Hossain et al., 2011; Bendjoudi et al., 2009; 
Sawalem et al., 2009). 
The quantities of HCW generated per country in kg/bed/day can be found in the literature and 
Table 1.13 shows the values found in some references.  
 
The quantity of HCW generated varies not only from country to country, but also within the 
same country mainly due to the type of healthcare establishment, the collection and disposal 
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methods adopted by healthcare services managers, hospitals departments or services, and the 
use of medical disposable products as a result of developing healthcare technology. Prüss et al. 
(1999) estimated HCW generation according to source size of healthcare establishment, 
namely university hospital, general hospital, district hospital and primary healthcare center. 
 
Table 1.13 – Healthcare waste generation in different countries.  
Country/city Waste generation 
(kg/bed/day) 
Reference 
Algeria 0.7 – 1.22 Bendjoudi et al. (2009) 
Bangladesh/Dhaka and Khulna 0.55 – 1.10 Akter and Tankler (2003) 
China 0.5 – 3.0 Changping et al. (2012) 
Croatia  1.2 Marinkovic et al. (2008) 
El Salvador/San Salvador 0.37 Johnson et al. (2013) 
Greece/Attica 0.24 – 0.27 Komilis et al. (2011) 
Iran/Tabriz 3.48 Taghipour and Mosaferi (2009) 
Italy 1.3 – 2.87 Giacchetta and Marchetti (2013) 
Jordan (northern) 
Jordan (southern) 
0.83 
0.73 
Abdulla et al. (2008) 
Fraiwan et al. (2013) 
Korea 0.48 Jang et al. (2006) 
Kuwait 3.87 – 7.44 Alhumoud and Alhumoud (2007) 
Mongolia/Ulaanbaatar 0.78 Shinee et al. (2008) 
Nigeria/Lagos 0.43 – 0.67 Longe and Williams (2006) 
Portugal 3.3 Botelho and Pinto (2010) 
Sudan/Khartoun 0.80 – 1.71 Saad (2013) 
Taiwan 2.41 – 3.26 Cheng et al. (2009) 
Tanzania 0.75 Manyele and Anicetus (2006) 
Turkey/Istambul 
USA 
2.11 
5 – 7 
Eker and Bilgili (2011) 
Medical Waste Committee (1994)* 
*Taken from Lee et al. (2004). 
 
The highest generation rate was in university hospital with 4.1 – 8.7 kg/bed/day followed by 
general hospital, 2.1 – 4.2 kg/bed/day, district hospital and primary healthcare center with a 
generation rate about 0.5 – 1.8 kg/bed/day and 0.05 – 0.2 kg/bed/day, respectively. Shinee et 
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al. (2008) reported medical waste generation rate (kg/patient/day) in the inpatient services of 
public healthcare facilities was 1.4 to 3.0 times higher than in the outpatient services a sample 
of 56 healthcare facilities at Ulaanbaatar, capital of Mongolia. Sawalem et al. (2009) studied 
the amounts of HCW generated in fourteen different healthcare facilities, in three cities with 
different size and population, in Libya. These cities were: Tripoli a large city, Misurata a 
medium-sized city and Sirt a small city. They have showed that the highest generation rate was 
found in Tripoli and the lowest rate was found in the clinics and rural health centers. This fact 
was due to the medical centers in Tripoli were more developed general public facilities and 
serve a higher number of patients. Abdulla et al. (2008) and Fraiwan et al. (2013) studied the 
medical waste management practices in northern and southern Jordan. The average amount 
of medical waste generated in both regions is not the same, the northern produced  
0.83 kg/bed/day and southern produced 0.73 kg/bed/day.  
 
In the Portuguese hospitals, according to DGS (2006), the region of Lisbon and Tejo Valley 
produced the highest generation rate of 3.8 kg/bed/day followed by the northern region with 
2.6 kg/bed/day. Those two regions are the ones with higher population density. Coker et al. 
(2009) characterized and quantified the medical wastes generated in Ibadan, Nigeria. They 
selected 52 healthcare facilities based in size and function. Their results indicated that large 
hospitals and clinics generated the greatest amounts of medical wastes followed by the small 
healthcare units, which have facilities to treat only outpatients, and diagnostic service 
laboratories. Different results were obtained by Cheng et al. (2010) when investigated the 
quantities of medical waste generated in small clinical facilities (private clinics, medical 
laboratories, blood centers and public clinics) in Taiwan. They reported that the production 
rate of medical wastes was higher at the small clinics (3.97 kg/bed/day) than at the large 
hospitals (2.41 – 3.26 kg/bed/day). The highest quantities of infectious wastes generated were 
from blood centers (3.14 kg/bed/day) and the lowest were from public clinics  
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(0.053 kg/bed/day). Graikos et al. (2010) evaluated the production rate of HCW generated in 
two laboratories and in two departments of the healthcare facility of social insurance institute 
of Xanthi, Greece. The injection therapy showed the highest HCW production rate of  
0.145 kg/patient/day while the surgery department had a production rate of  
0.041 kg/patient/day. The clinical pathology laboratory showed higher HCW production rate 
(0.071 kg/patient/day) than X-ray laboratory (0.023 kg/patient/day). Taghipour and Mosaferi 
(2009) determined the quantity and generation rate of medical waste generated in 10 
hospitals at the city of Tabriz, Iran. The maximum quantities produced of medical waste and 
hazardous–infectious waste were associated with non-governmental organization and private 
hospitals. A similar conclusion was reported by Eker and Bilgili (2011) when studied the 
amounts of HCW generated in 375 healthcare services in Istanbul, Turkey. Their study 
indicates that the major producers of medical waste were the private hospitals, while the 
amount of hazardous waste generation is much higher at state hospitals. Komilis et al. (2011), 
in the study conducted in 95 public and private medical facilities in the Attica region, Greece, 
concluded that no correlation among the number of beds and the unit medical waste 
generation rate could be established. Each hospital should be studied separately due to the 
differences in the type of hospitals, the number of occupied beds, number of external patients 
and the types of departments or laboratories. 
 
The implementation of standardized and optimized management practices leads to the 
reduction of HCW quantities, mainly a decrease of generation rate of hazardous waste. 
According to Chartier et al. (2014), 75 – 90 % of HCW is classified as general waste and  
10 – 25 % is classified as hazardous waste, of which 1 % is made of cutting and perforating 
materials, 3 % are discarded chemicals and pharmaceuticals and less than 1 % is radioactive 
and genotoxic matter and heavy metal content. However, some authors reported different 
CHAPTER 1 – INTRODUCTION 
22 
 
 
 
fractions of hazardous waste on the total HCW generated in several countries Table 1.14 
summarize their results. 
 
Table 1.14 – Hazardous and non-hazardous wastes in different countries. 
Country/city Hazardous Waste  
(%) 
Non-Hazardous Waste 
(%) 
Reference 
USA 15 85 Lee and Hufman (1996) 
Bangladesh/Dhaka 
and Khulna 
20 80 Akter and Tankler (2003) 
Croatia  14 86 Marinkovic et al. (2008) 
Mauritius 10 90 Mohee (2005) 
Brazil, São Paulo 25 75 Moreira and Gunther 
(2013) 
Iran/Tabriz 29.9 70.1 Taghipour and Mosaferi 
(2009) 
Libya  28 72 Sawalem et al. (2009) 
Kuwait 10 – 15 85 – 90 Alhumoud and Alhumoud 
(2007) 
Nigeria/Lagos 26 – 37 63 – 74 Longe and Williams (2006) 
Turkey/Istambul 28.8 71.2 Eker and Bilgili (2011) 
 
1.2.3 COMPOSITION  
 
HCW is a heterogeneous mixture of wastes, with different components in different countries, 
depending on their medical situation (Zhao et al., 2009). A sample of HCW can contain plastics, 
food waste, paper, pathological waste, animal carcasses, blood soaked-bandages and many 
other types of materials (Lee and Huffman, 1996).  
In order to develop appropriate waste management policies, it is essential to characterize the 
composition of the waste stream. With this purpose, several authors have studied the 
composition of HCW generated in several types of healthcare establishments or hospitals 
worldwide (Prüss et al., 1999; Lee et al., 2004; Shinee et al., 2008; Diaz et al., 2008; Graikos et 
al., 2010). Some studies, where HCW were not differentiated into hazardous and non-
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hazardous waste, showed that plastics have the highest contribution in total HCW with 35 % to 
20.1 %, (Fraiwan et al., 2013; Coker et al., 2009) followed by paper with about 12.6 – 38 % 
(Taghipour and Mosaferi, 2008; Abdulla et al., 2008;). Others indicated that the major 
component present in HCW was organic waste/food waste, with about 31 % (Dehghani et al., 
2008; Taghipour and Mosaferi, 2008. Metals constitute the minor component in HCW with a 
percentage of 1.1 – 6.7 % (Figure 1.3). Coker et al. (2009) reported the composition of medical 
waste into eleven fractions, specifying the various components in each fraction, including 
animal infected anatomical fraction (Figure 1.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 – The HCW composition reported by four studies: a) Abdulla et al. (2008); b) 
Dehghani et al. (2008); c) Taghipour and Mosaferi (2008); d) Fraiwan et al. (2013); e) Coker et 
al. (2009). 
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The knowledge of the waste stream contents, essentially the composition of non-hazardous 
fraction of the waste, is advantageous in the development of reduction and recycling programs 
(Diaz et al., 2008). Therefore, the composition of non-hazardous waste in different countries 
have been examined in various studies (Mohee, 2005; Alhumoud and Alhumoud, 2007; 
Taghipour and Mosaferi, 2008; Sawalem et al., 2009). Again, these studies indicated that 
organic waste or food waste, plastics and paper have the highest contribution for non-
hazardous HCW (Figure 1.4). The high plastic content found is due to the widespread use of 
disposables rather than reusable for various purposes such as bottles, packing materials and 
bags. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 – The non-hazardous waste composition reported by: a) Sawalem et al. (2009); b) 
Taghipour and Mosaferi (2008); c) Alhumoud and Alhumoud (2007); d) Mohee (2005). 
 
Taghipour and Mosaferi (2008), in their study of the composition of hazardous waste (Figure 
1.5), reported plastics as having the highest contributions in hazardous waste with 35.7 % 
followed by the textiles with 20.8 %. Sharps represent about 1 % within hazardous waste. 
Other study (Marinkovic et al., 2008) reported that sharps represented 8 % of the hazardous 
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waste generated in Croatia. The sharps fraction is inserted into the metals component in the 
HCW composition.  
 
 
 
 
 
 
Figure 1.5 – The hazardous waste composition reported by Taghipour and Mosaferi (2008). 
 
These studies permit to conclude that waste composition varies among different countries. 
This variability can be explained by different HCW management systems mainly by preventing 
or minimizing production, appropriate segregation and recycling programs. 
 
1.2.4 OTHER CHARACTERISTICS 
 
Waste specific weight is defined as the weight of uncompacted material relative to its volume. 
Waste specific weight is expressed as mass per unit of volume, e.g., kg/m3. The knowledge of 
this parameter is fundamental in waste management, such as for determination of storing 
space; definition of size for the collection vehicle and estimation of requirements for 
compaction, size reduction, disinfection, and other equipment to treat this type of waste. 
Table 1.15 shows the waste specific weight of HCW reported in some studies. The data show 
that the average specific weight for total waste varies from 99.6 to 218 kg/m3 while for general 
waste ranges from 101.3 to 211 kg/m3 and for hazardous–infectious waste the values 
fluctuated from 96.2 to 262 kg/m3. The reason for such variation is mainly due to different 
amounts of plastics and paper/cardboard in the composition of generated HCW. 
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Table 1.15 – Specific weight of healthcare waste in different studies. 
Country /Reference  Average specific weight (kg/m
3
) 
 Total waste General waste Hazardous–infectious 
waste 
Iran/Taghipour and Mosaferi (2008) 99.6 101.3 96.2 
Peru/Diaz et al. (2008) 218 211 226 
Philippines/Diaz et al. (2008) - 151 262 
 
 
The specific weight of various components present into HCW was also reported in literature 
(Lee and Huffman, 1996; Diaz et al., 2008).  
Table 1.16 shows the specific weight for several components of HCW generated in Guayaquil, 
Ecuador and in USA. The specific weight vary from 56 to 960 kg/m3 in the first study ( Diaz et., 
2008) and in the second study (Lee and Huffman, 1996) the data show the wide range of values 
for some of materials present into HCW, the sharps and needles having the highest value. 
Other two important variables, in the case of incineration of the HCW, are the moisture 
content, i.e., the quantity of water contained in a material, and the heating value, the amount 
of heat produced by combustion of a unit quantity of a fuel. Table 1.16 lists typical moisture 
contents and heating value of several components of HCW. The reported values show a wide 
variety allied to the high heterogeneity of healthcare waste. 
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Table 1.16 – Specific weight, moisture content and heating value of various components of 
healthcare waste in Ecuador, India and USA. 
Component Specific 
weight 
(kg/m
3
) 
Moisture 
content 
(%) 
Heating value 
(kcal/kg) 
Country/Reference 
 
General waste 
 
56.22 
 
– 
 
– 
Ecuador/Diaz et al. 
(2008) 
 
Kitchen waste 322.19 47.07 2087  
Yard waste 126.25 – –  
Paper/cardboard 65.14 16.20 2899  
Plastic/rubber 85.35 14.87 7076  
Textiles 120.27 30.41 1985  
Sharps 429.11 – –  
Food waste 580.19 44.95 3269  
Medicines 959.71 64.18 3340  
Garden waste  – 40.24 1863  
 
Human anatomical 
 
– 
 
70–90 
 
50–800 
India/Gupta and Boojh 
(2006) 
Kitchen – 70 1400  
Clinical – 0–30 3600–4500  
Paper – 0–10 4700  
Cotton – 0–10 4700  
Plastics  – 0–1 9000–11100  
 
Human anatomical 
 
810–1215 
 
70–90 
 
444–2000 
United States/Lee and 
Huffman (1996) 
Plastics 80–2330 0–1 7700–11100  
Swabs, absorbents 80–1000 0–30 3100–6700  
Alcohol, disinfectants 780–1000 0–0.2 6100–7800  
Infected animals 490–1300 60–90 500–3600  
Glass 2840–3650 0 0  
Bedding, shavings, 
paper, fecal matter 
320–750 10–50 2200–4500  
Gauze, pads, 
garments, paper, 
cellulose 
80–1000 0–30 3100–6700  
Sharps, needles 7300–8100 0–1 0–33  
Fluids, residuals 1000–1020 80–100 0–1100  
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1.3 HEALTHCARE WASTE MANAGEMENT 
 
The management of HCW is a challenge, principally in most healthcare facilities of the 
developing world. Poor practices, inappropriate handling and HCW disposal methods as well as 
inappropriate treatments can expose the population to parasites and diseases, like typhoid 
fever, tuberculosis, diarrhoea and skin infections, thus increasing the epidemics risk (Diaz et 
al., 2005; Coker et al., 2009). The development of upgraded waste management practices in 
middle- or low-income countries are hampered, essentially, by insufficient financing and 
management commitment to develop improved treatment and disposal facilities (Rushbrook, 
1999; Ananth et al., 2010). In countries as Nigeria, Ethiopia, Indonesia and Sudan, where the 
HCW has not received sufficient attention, there is no HCW waste legislation at the national 
level, existing only some federal general environmental regulations. The HCW is still handled 
and disposed together with domestic waste causing high health risks to all health 
professionals, patients, community and the environment (Coker et al., 2009; Anagaw et al., 
2012; Kühling and Pieper, 2012; Saad, 2013). An inadequate healthcare handling operation is a 
potential contamination source principally for health professionals because a poor handling 
can originate infections inside hospitals (Park et al., 2009). This type of infection originated in 
hospitals is called a nosocomial infection. Studies conducted in some developing countries 
have reported hospital-wide nosocomial infection rates mostly higher than 15 % with a range 
from 6 % to 27 % (Mayon-White et al., 1988; Pittet et al., 2008). The hands are the main route 
of transmission, and approximately 21 % of nosocomial infections are caused by 
microorganisms present in the medical personnel hands. These infections explain around 25 % 
of the extra hospitalization days (Silva, 2001).  
In 2002, the results of a study made by the WHO in 22 developing countries showed that the 
possibility of contracting an infection, promoted by improper handling and disposal HCW 
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methods, varies from 18 % to 64 %, in these countries the risk is two to twenty times higher 
than in developed countries (WHO, 2004; Pittet et al., 2008). 
Several authors have studied the risk of exposure to serious infection, such as Mycobacterium 
tuberculosis (Johnson et al., 2000), pathogenic viruses and bacteria, including Pseudomonas 
spp., Lactobacillus spp., Staphylococcus spp. (Park et al., 2009), hepatitis B and hepatitis C 
(Franka et al., 2009; Anagaw et al., 2012) in medical waste. Health professionals, as nurses and 
waste workers, are especially at risk of acquiring infections caused by injury with syringe 
needles contaminated with human blood, or laboratory specimens containing 
immunodeficiency virus (HIV), hepatitis viruses B (HBV) and hepatitis viruses C (HCV) (Anagaw 
et al., 2012). Epidemiological studies indicate that the percentage of an individual contracting 
an infection when in contact with an infected syringe being with HBV, HCV and HIV is 30 %,  
1.8 % and 0.3 %, respectively (WHO, 2014). In 2000, the WHO estimated the population that 
was infected with contaminated syringes: 21 million infected with the hepatitis B virus (HBV),  
2 million with the hepatitis C virus (HCV) and 260 thousand with HIV (Chartier et al., 
2014).There is strong evidence that these infections can occur when sharps waste is poorly 
managed (Chartier et al., 2014). In Africa, this fact is more patent due to high cost of safety 
boxes for proper disposal of sharps that limits their use (Rudraswamy et al., 2013). For 
healthcare workers, the fractions of infections that are due to percutaneous occupational 
exposure to HBV, HCV and HIV are 37 %, 39 % and 4 %, respectively. It is estimated that more 
than two million healthcare workers are exposed to percutaneous injuries with infected sharps 
every year (Prüss-Üstün et al., 2005). The annual number of HBV infections in the USA resulting 
from exposure to healthcare waste was between 162 and 321 (Chartier et al., 2014).  
The production of disposable syringes was assumed as a solution to minimize the risk of 
infections. However, in developing countries, there has been an opposite effect with the re-
use and recycling of disposable syringes, thereby increasing healthcare risks. Tamplin et al. 
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(2005) studied the issues and options for the safe destruction and disposal of syringes reused 
in developing countries.  
Developed countries, and organizations like WHO and USEPA, due to the high risk of 
contracting diseases by contaminated needles and syringes, promote a public awareness and 
solutions for safe disposal of self-injections, such as home needle destruction device, 
household hazardous waste collection and drop-off collection sites. 
Many studies have focused on HCW management practices in developing countries. The 
studies were carried out in countries such as Bangladesh (Akter and Tränkler, 2003), Mauritius 
(Mohee, 2005), Nigeria (Longe and Williams, 2006 and Coker et al., 2009), Tanzania (Manyele 
and Anicetus, 2006), Mongolia (Shinee et al., 2008), Algeria (Bendjoudi et al., 2009), Iran 
(Taghipour and Mosaferi, 2009), China (Yong et al., 2009), Libya (Sawalem et al., 2009), India 
(Mohankumar and Kottaiveeran, 2011), Ethiopia (Debere et al., 2013) and Sudan (Saad, 2013).  
Several developing countries are faced with a serious problem that is poor scavengers; women 
and children collect some of the HCW for reselling, despite the health risks to which they are 
subjected (Diaz et al., 2005; Blenkharn, 2006; Coker et al., 2009; Patwary et al., 2011). The 
scavengers, involved with waste collecting, scavenging, recycling and resale to the community, 
have access to potentially hazardous medical waste due to poor waste segregation and 
inadequate disposal of HCW (Blenkharn, 2006; Coker et al., 2009). Patwary et al. (2011) 
studied the illicit economy associated with scavenging and recycling of HCW in Dhaka, 
Bangladesh. They reported that in some cases the scavengers’ motivation for being involved in 
the collection of HCW is often related to drug use, but exist other motivations, including 
service to the community. Outside the scavengers and cling operators, other groups are 
involved in scavenging and recycling HCW as healthcare facilities employees that sell 
hazardous items directly to scavengers. According to Patwary et al. (2011), many people 
benefit from the Bangladesh unregulated and informally managed HCW system. More 
recently, Patwary et al. (2012) reported that HCW scavengers in Bangladesh who were 
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involved in unauthorised scavenging and reselling of HCW are essentially young people with 
problems as homelessness sexual abuse and drug use. 
 
The need to develop a healthcare waste management in order to reduce the environmental 
risks caused by an inadequate treatment or disposal of wastes brings together various 
organizations such as WHO, UNICEF, USEPA and national governments. National governments 
have an important role in this intervention through implementation of HCW management 
guideline and a strict legislation, as well as defining responsibilities and training requirements 
for agreement with the resources of each country. 
The WHO defines some guidelines to be adopted through legislation to this waste, namely: a) a 
clear definition of hospital waste and their categories; b) a precise indication of the legal 
obligations regarding the production, handling and safe disposal; c) specifications regarding 
the maintenance of records and reports; d) specification for implementing a control system in 
order to ensure law enforcement and appropriate penalties to be imposed for violation of 
these; e) name of the judge responsible for the handling of disputes arising from the 
application or non-compliance with the law. 
WHO also suggests the establishment of a document to state the reasons for enforcement and 
to mention the national targets and key steps to achieve these targets, based on the following 
items: a) description of the health and safety risks arising of poor management of HCW; b) list 
of treatment and disposal methods adopted for each waste category, c) warning against 
incorrect practices for disposal of hazardous waste such as disposal of this type of waste in 
landfills for municipal waste; d) the producer responsibility within the management and 
outside the health establishments; e) assessment of costs associated with the management of 
HCW; f) key steps for waste management, technical specifications and guidelines for 
implementation of each stage, i.e., minimization, separation, storage, transport, treatment and 
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final disposal; g) record keeping and documentation; h) training requirements standard safety 
and security applied to individuals who directly handle the HCW.  
Several countries adopt the WHO recommendations and guidelines; however, the directives of 
USEPA are used, too. In many developed countries, specific guidelines and regulations have 
been implemented for HCW management systems that are more effective than those in many 
developing countries (Yong et al., 2009). The major reasons of HCW poor management are the 
lack of appropriate legislation, lack of specialized healthcare professionals, lack of awareness 
and effective control (Hossain et al., 2011). Some studies reported that healthcare workers do 
not have education enough and most of them do not have any special training on the 
management of HCW, often performing most activities without correct guidance and 
insufficient protection (Shinee et al., 2008; Diaz et al., 2008; Coker et al., 2009; Ananth et al., 
2010; Nema et al., 2011; Anagaw et al., 2012). 
Although some developed countries already implemented guidelines for HCW management 
there are still some flaws in hospitals of UK (Blenkharn, 2007), Croatia (Marinkovic et al., 2008) 
and Italy (Giacchetta and Marchetti, 2013). The Jordan healthcare facilities represents one of 
the most advanced and comprehensive healthcare systems in the Middle East. Nevertheless, 
the practices of medical waste management in major hospitals in southern Jordan were 
suffering from serious defects, namely the segregation that is performed inaccurately due to 
the lack of both training and proper education (Fraiwan et al., 2013). 
 
Fundamental principles of HCW management include preventing or minimizing production, 
appropriate segregation of general HCW from hazardous-infectious waste, aggregation of 
general HCW to the municipal waste stream for final disposal and using effective treatments 
for hazardous-infectious HCW. Preventing the formation of HCW contributes significantly to 
the reduction of waste management costs in healthcare. The cost to handle and dispose of 
hazardous HCW is indeed substantially higher than municipal waste handling (Tudor et al., 
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2005). When domestic waste is mixed with HCW it must be treated as part of the HCW stream 
which handling costs about 20 times more than municipal waste (Giacchetta and Marchetti, 
2013). The implementation of sustainable decision making regarding resource use, including 
methods of waste minimisation at the source and recycling, lead to the reduction of waste. 
Healthcare professionals training and awareness underpin several of the short and 
medium/long term solutions suggested to reduce the waste at the source and recover value 
from that produced, could potentially reduce disposal quantities by as much as 20 – 30 % (wt.) 
and costs by around 25 – 35 % (Tudor et al., 2005). 
 
As HCW contains high amounts of reusable and recyclable materials (Marinkovic et al., 2008), 
developing of reusing and recycling programs for non–hazardous wastes can serve as a means 
of reducing rising quantities of waste generation and treatment costs (Lee et al., 2004; 
Blenkharn, 2005). Presently, many healthcare facilities in developed countries as USA and UK 
have recycling programs for non–hazardous wastes materials as paper, cardboard, metal and 
glass (Hossain et al., 2011). 
 
1.3.1 SEGREGATION, COLLECTION AND STORAGE  
 
The most important step in waste management of medical waste is the appropriate 
segregation of hazardous-infectious waste from the general waste. Segregation and sending of 
general HCW to municipal waste disposal can reduce at least 70 % of the total quantity of 
generated waste (Taghipour et al., 2014). The hazardous waste portion is usually separated 
into two portions: used sharps and potentially infectious items. Since sharps may cause 
injuries, both contaminated and uncontaminated sharps should be collected in a puncture-
proof and impermeable container that is difficult to break or open after closure. 
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One of the practical ways for segregation is colour coded method. Many countries have 
national legislation that prescribes the waste segregation categories to be used, and where 
there is no national legislation WHO has available an easy color coding (Table 1.17) for 
healthcare professionals to put waste items into the correct container. The segregation of 
infectious waste is made in yellow bags, despite some countries, such as Greece, Korea and 
Turkey, use red bags. In Spain, non-specific wastes are collected in green bags and, in some 
Autonomous Communities, are used color blue containers for cytostatic waste. In Portugal the 
segregation is made according the Order No 242/96, the two first groups are collected in black 
bags, the third group in white bags and fourth in red bags, exception for the sharps which are 
collected in impermeable container. The colour bags and containers (Figure 1.6) for 
segregation of HCW should be available to staff in each medical and other waste-producing 
area in a healthcare facility. This system allows to segregate and dispose waste at the point of 
generation, as well as reduces the need for healthcare professionals to carry waste through a 
medical area. In USA, the segregation of HCW is usually made considering three types: red bag; 
pathological and general waste.  
 
Table 1.17 – WHO – Recommended segregation scheme (Chartier et al., 2014).  
Type of waste  Colour of container and markings  
Highly infectious waste  Yellow, marked “HIGHLY INFECTIOUS”, with  
biohazard symbol  
Other infectious waste, pathological and 
anatomical waste  
Yellow with biohazard symbol  
Sharps  Yellow, marked “SHARPS”, with biohazard 
symbol  
Chemical and pharmaceutical waste  Brown, labelled with appropriate hazard 
symbol  
Radioactive waste  Labelled with radiation symbol  
General healthcare waste  Black  
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Figure 1.6 – a) Colour plastics bags for waste collection; b) Container for sharps collection;  
c) Waste containers. 
The collection stage includes the process of packaging and labelling. The bags are collected 
only after being filled up to three-fourths of its volume to avoid overloading and prevent 
possible spills. Once this level is reached, they should be sealed and are ready for collection. 
Collection times should be fixed and adequate to the quantity of waste produced in each area 
of the healthcare facility. General waste should not be collected at the same time or in the 
same trolley as infectious or other hazardous wastes (Chartier et al., 2014). 
According to WHO, the collection should be daily for most wastes, with collection timed to 
match the pattern of waste generation during the day. The hazardous waste generated in 
medical areas should be stored in utility rooms, to avoid the contact between HCW and 
patients before removal, then collected and transported to a central storage facility. 
 
After segregation and collection of the HCW, the wastes are temporary stored in a large 
container, properly labelled and packed. These containers can be of varied shapes and sizes 
and be made from diverse materials. Many modern waste containers are designed for 
automated systems that empty their contents into the waste disposal system and wash and 
disinfect them mechanically. Additionally, waste containers may also be made of reused plastic 
and metal. Moreover, they should be sturdy and leak-proof, and lined with a sturdy plastic 
bag. The container and the bag should have the same color for the waste they are intended to 
receive, to avoid potential confusion and poor segregation (Chartier et al., 2014).  
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1.3.2 TRANSPORT, TREATMENT AND DISPOSAL  
 
Onside transport of HCW is carried out through pre-established routes, which include specific 
corridors and elevators, and deposited in an adequate area designated for that purpose before 
treatment and final disposal. Despite the fact that most of the hospitals have not any special 
place for waste storage, the infectious waste should be kept in a refrigerator at a temperature 
preferably no higher than 3 °C to 8 °C if stored for more than a week to avoid biodegradation, 
odours, insects and rodents. 
Offsite transport of hazardous HCW should comply with national regulation and with 
international agreements if wastes are shipped across an international frontier for treatment. 
In Portugal, the transport of waste within the national territory is established by ordinance No. 
335/97. If there is no national regulation, responsible authorities may refer to 
recommendations on the transport of dangerous goods published by the United Nations.  
The international agreement which regulates the transboundary movements of hazardous 
waste produced worldwide is the Basel Convention. Composed by 181 parties, specifically 
refers to transportation of clinical wastes from medical care in hospitals, medical centers and 
clinics and waste pharmaceuticals, drugs and medicines. 
Drivers of vehicles carrying hazardous HCW should have appropriate training about risks and 
handling of hazardous waste. Vehicles or containers used for transporting HCW should be 
exclusively used on transport of this type of wastes. Vehicles should be kept locked at all times, 
except when loading and unloading, and kept properly maintained. Vehicles and transporting 
containers used for the transportation of waste should be cleaned and disinfected daily after 
use (Chartier et al., 2014). 
 
There are several processes that can be used to treat hazardous HCW, including chemical 
disinfection, encapsulation, microwave disinfection, irradiation, gas sterilization, pyrolysis and 
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oxidation. However, autoclaving and incineration are the most used to treat this type of waste 
(Sukandar S., 2006). According to some studies, about 40 – 60 % of wastes are incinerated, and 
14.5 – 37 % are treated by autoclaving (Lee et al., 2004; Moreira and Günther, 2013). Some 
countries, such as Poland (Gielar and Helios-Rybicka, 2013), Croatia (Marinkovic et al., 2008) 
and Korea (Jang et al., 2006) used both methods to treat the HCW. Nevertheless, incineration 
has been the most used process to treat HCW all around the world until now (Lee, 1996; 
Changping et al., 2012). In developing countries, the major hazardous HCW fraction is 
incinerated and is disposed on the land (i.e. open dump). The remaining waste, mainly 
domestic waste, generated by the healthcare facilities is disposed of as municipal waste.  
 
1.4 HEALTHCARE MANAGEMENT IN PORTUGAL 
 
Until mid-eighties of the XX century, the management of HCW was incipient, and generally 
these wastes were deposited in dumps or landfilled together with the municipal waste, despite 
being considered specific waste. In 1985, the Decree Law No 488/85 determined the 
requirements for institutions that generated HCW to set up an inventory updated with the 
quantity, nature, origin and destination of wastes; and those institutions were still responsible 
for the collection, transport and disposal of these wastes. Later, in 1990, the Order No 16/90 
classified the HCW in two groups: contaminated waste (group A) and non-contaminated waste 
(Group B), and also defined the type of treatment to which they must be subjected. The waste 
of group A should be incinerated, while the wastes of group B were considered general waste 
and thus did not require any special treatment. In the nineties, all hazardous HCW were 
incinerated in more than 40 on-site incinerators without any environmental monitoring, 
causing serious environmental problems. In the last two decades, due to the increase of HCW 
production and the impossibility of compliance with the air emissions limits it was considered 
essential to implement new rules for HCW management. 
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In 1996, through Order No. 242/96, the HCW was classified in four groups (see Table 1.11), 
with the main objective of reducing the amount of waste to be treated and of introducing 
alternative processes to incineration. This legislation follows the main guidelines 
recommended by the WHO with concern to HCW management, including the steps for 
segregation, collection, storage, transport, treatment and disposal. As a result of a better 
screening, taking into account the classification of the HCW, the quantities of hazardous waste 
decreased from 25 000 tons in 1995 to 16 000 tons in 2004 (DGS, 2006). 
According to WHO recommendation, in 1999 it was approved, through Joint Order No 761/99, 
the Strategic Plan for Healthcare Waste 1999-2005. It was the first national legislation for 
HCW, prepared by both Ministries of Health and Environment. This plan defines these 
important guidelines: accentuate the responsibility, supervision and control of administrators 
of the HCW units; encourage the development of management plans; improve the safety of 
segregation and packaging at production; reduce and environmentally adapt the existing 
treatment units; rationalize the collection circuits and storage units; concentrate the 
treatment by incineration in a small number of units, with responsiveness to current and 
future production; reinforce the use of new technologies to treat the waste of Group III; 
promote training and/or information of stakeholders in the process, professionals, users and 
the general public; create a permanent Commission to monitor the implementation of the 
Plan.  
In 2005, 75 – 90 % of HCW were treated as municipal waste (groups I and II), out of which 20 % 
were recycled and the remaining were disposed of in landfills or incinerated by municipal 
waste incinerators. Concerning waste of Group III, it was incinerated or subjected to an 
effective treatment that allowed its disposal in a municipal landfill. During 2005, approximately 
12 000 tons were produced, 92 % of which were autoclaved, 8 % incinerated and only a small 
fraction was treated by chemical disinfection (DGS, 2006). Currently, the HCW of group III are 
treated in five units of autoclaving throughout the country. More recently (April 10th, 2013) 
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opened a new unit to treat HCW of group III by microwave technology, located in Eco Parque 
do Relvão, Chamusca. All wastes from group IV are incinerated in continental Portuguese 
territory in an incineration plant, licensed since 2007, located in the park of Health in Lisbon 
and another incinerator is located in Madeira Island.  
In 2010, the Strategic Plan for Healthcare Waste 1999-2005 was revised and in 2011 was 
approved through Order No. 43/2011 the second Strategic Plan for Healthcare Waste 2011-
2016. This Plan aims at emphasizing prevention measures, introducing the approach to 
lifecycle of product and materials, highlighting the reduction of environmental impacts from 
the production and management of HCW, and strengthening the notion of economic value 
associated with them. Also, it emphasizes the incentive to waste recovery and the use of the 
materials resulting from the recovery, considering elimination the last management option.  
Thus, the latter plan included the following categories of waste for recovery: paper and 
cardboard; organic matter; packaging and packaging waste; waste electrical and electronic 
equipment; batteries and accumulators; used cooking oil; bulky waste; computer 
consumables, dental amalgam; chemicals rejected and other waste resulting from radiology 
activities. Thereby increasing the amount of waste collected, in 2006 the selective collection 
already represented over 20 % of HCW of group I and group II. 
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CHAPTER 2 – HEALTHCARE WASTE TREATMENT TECHNOLOGIES  
 
 
2.1 INTRODUCTION 
 
The essential purpose of HCW treatment is to reduce the potential health and environmental 
hazard (Chartier et al., 2014). Indeed, the treatment should inactivate pathogens using 
different disinfection methods for potentially infectious waste. The State and Territorial 
Association on Alternate Treatment Technologies (STAATT) define the following microbial 
inactivation levels, shown in Table 2.1 (Health Care Without Harm, 2004). 
The recommended minimum criterion for HCW disinfection, based on the STAATT, is the level 
III although, the microbial inactivation achieved in some processes is the level IV. 
 
A large number of processes are available to treat HCW. Most of them use the same 
fundamental principle of heat, chemicals, irradiation, biological and mechanical.  
The thermal processes use heat to destroy pathogens present on HCW and can be subdivided 
into low-heat and high-heat processes. In these two processes, occur different 
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thermochemical reactions and physical changes on the waste as well as different atmospheric 
emissions depending on the diverse types of equipment. Generally, low-heat thermal 
technologies operate between 95 °C and 250 °C (Salkin et al., 2000), and take place in either 
moist or dry-heat environments. The low-heat technologies are autoclaving, dry heat and 
microwave. The high temperatures thermal technologies operate from approximately 500 °C 
to greater than 6 000 °C (Salkin et al., 2000). Incineration, pyrolysis, gasification and plasma are 
considered to be high-heat technologies. 
 
            Table 2.1 – Levels of microbial inactivation. 
Level I Inactivation of vegetative bacteria, fungi and lipophilic 
viruses at a 6 log10 reduction or greater. 
 
Level II Inactivation of vegetative bacteria, fungi, 
lipophilic/hydrophilic viruses, parasites and 
mycobacteria at a 6 log10 reduction or greater. 
 
Level III Inactivation of vegetative bacteria, fungi, 
lipophilic/hydrophilic viruses, parasites and 
mycobacteria at a 6 log10 reduction or greater; and 
inactivation of G. stearothermophilus spores and B. 
subtilis spores at a 4 log10 reduction or greater. 
 
Level IV Inactivation of vegetative bacteria, fungi, 
lipophilic/hydrophilic viruses, parasites and 
mycobacteria, and inactivation of G. 
stearothermophilus spores and B. subtilis spores at a 6 
log10 reduction or greater. 
 
 
Chemical processes use disinfectants such as dissolved chlorine dioxide, sodium hypochlorite, 
or other chemicals to eliminate pathogens.  
Irradiation processes employs electron beams irradiation, cobalt-60 or ultraviolet sources to 
treat HCW. 
The biological processes consist on the degradation of organic matter by natural living 
organisms when applied to HCW treatment. Enzymes are sometimes used to accelerate the 
destruction of organic waste containing pathogens. 
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Mechanical processes, although they cannot destroy pathogens, these methos reduce 
substantially waste volume using technologies as shredding, grinding, mixing and compaction. 
Normally these processes are supplement of other treatment methods as microwave or steam 
sterilization.  
 
Incineration is the oldest method, and until now, the most used in the world (Lee and 
Huffman, 1996). According to Lee et al. (2004), about 59 – 60 % of hazardous waste are 
incinerated, 20 – 37% are steam sterilized, and 4 – 5 % are treated by other methods. In 
developed countries the most used processes are incineration and autoclaving, these two 
technologies are considered mature technologies (Salkin et al., 2000; Sukandar et al., 2006). In 
developing countries, due to low costly compared to other methods, the most common 
methods for treating or disposing of HCW are open dumping and landfilling (Soares et al., 
2013; Bendjoudi et al., 2009; Coker et al., 2009; Sawalem et al., 2009; Shinee et al., 2008; 
Rogers and Brent, 2006). The production of degraded waste, leachate and gas generated by 
landfilling are, also, the highest source of public health infection and environmental pollution. 
In these countries, incineration is also used, however the full combustion is not always 
completely achieved creating further negatives environmental impacts (Bendjoudi et al., 2009; 
Coker et al., 2009). Figure 2.1 shows a simple incinerator used to treat HCW in a developing 
country.  
 
 
 
 
 
Figure 2.1 – Incinerator used to treat HCW in a developing country (source: Diaz et al., 2005). 
  
CHAPTER 2 – HEALTHCARE WASTE TREATMENT TECHNOLOGIES 
 
48 
 
 
 
Table 2.2 shows the most usual processes to treat and dispose of HCW in different countries.  
 
Table 2.2 – Treatment and disposal processes of HCW in different countries. 
Country  Treatment or disposal processes Reference  
Algeria Open dumping 
Incineration 
 
Bendjoudi et al. (2009) 
Brazil 
 
 
 
 
Croatia  
Open burning  
Incineration 
Autoclaving 
Microwave 
 
Incineration  
Sterilization  
 
Soares et al. (2013) 
 
 
 
 
Marinkovic et al. (2008) 
India  Chemical Disinfection 
Autoclaving 
Hydroclaving 
Microwave 
Incineration 
Compacting and shredding 
 
Gupta et al. (2009) 
Korea Autoclaving 
Incineration 
 
Jang et al. (2006) 
Lybia Dumping 
Incineration 
 
Sawalem et al. (2009) 
Mauritius  Incineration 
 
Landfill  
 
Mohee (2005) 
Mongolia  Open dumping or open burning 
Incineration 
 
Shinee et al. (2008) 
Nigeria Dumping  
Burning 
Incineration 
 
Coker et al. (2009) 
Portugal  
 
 
 
Spain 
Autoclaving 
Microwave 
Incineration 
 
Steam sterilization 
Autoclaving  
Incineration  
 
 
 
 
 
Insa et al. (2010) 
Tanzania  Open burning  
Incineration 
Autoclaving 
Manyele and Anicetus (2006) 
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According WHO, the selection of HCW treatment processes must be cost effective, easily 
implemented and environmental friendly. The selection of treatment involves also 
consideration of waste characteristics, quantity of waste, types of waste as well as reduction of 
their volume.  
Incineration requires high financial start-up costs and occupational capital to implement 
incineration facilities (Hossain et al., 2012; Coker et al., 2009; Sawalem et al., 2009; Blenkharn, 
2005). The capital costs needed for autoclaving are lower, followed by microwave 
technologies. Karagiannidis et al. (2010) reported that costs of HCW sterilization in Greek 
hospitals ranged from 0.52 to 1.76 € kg-1. Soares et al. (2013) based on the life cycle 
assessment, reported that costs for microwaves treatment of HCW were US$ 0.12 kg-1 and 
costs for the HCW treated by autoclaving were US$ 1.10 kg-1. Tudor et al. (2009) showed that 
the costs of HCW sterilization varied from US$ 470 to US$ 627 ton-1 and for incineration ranged 
US$ 783–1253 ton-1. 
The treatment can be carried out on-site or off-site of healthcare facilities. Normally, the 
middle-sized and large healthcare facilities treated their HCW on-site while the small-sized 
healthcare facilities use off-site systems. Still, the selection of each system is a controversial 
subject. Some studies compared both methods and determined their advantages and 
disadvantages for hazardous HCW treatment (Taguipour et al., 2014). 
 
The off-site systems have the disadvantages of having to transport infectious waste through 
public roads and the added cost of transport, such as fuel costs. However, it has the advantage 
of the economy of scale and it is the preferred approach in many developed countries (Health 
Care Without Harm, 2004). Currently, the quantities of off-site incineration systems have been 
increasing due to several regulations concerning on-site incineration (Lee et al., 2004). The on-
site systems have the advantage of disinfecting infectious waste close to the source of 
generation. By avoiding the problem of transporting infectious waste through public roads, the 
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potential for accidental release of infectious materials is reduced (Health Care Without Harm, 
2004). More recently appeared a new system – mobile treatment – that is mounted on trucks 
and is brought to different health facilities to treat their waste. This treatment unit has the 
disadvantage of high capital and operating costs. 
Another important factor is the public acceptability. Due to risk of pollution, the public 
acceptance for incineration process is quite low, and for this reason many countries, such as 
USA, Greece and Canada, decreased the number of units used to treat hazardous HCW (Soares 
et al., 2013; Karagiannidis et al., 2010). Due to problem of pollution caused by HCW 
incineration through the production of dioxins and furans, and considerable amounts of heavy 
metals (Gielar and Rybicka, 2013; Singh and Prakash, 2007; Sukandar et al., 2006), many 
government and state regulatory agencies, namely European Union, introduced more 
stringent emission standards for HCW incinerators. To meet these enhanced requirements, 
many incinerators units should be provided with air pollution control devices that represented 
an important additional cost, for which reason several units were simply deactivated. In USA, 
since 1997, over 2 000 incinerators were shut down and in some states, such as California 
(Walton et al., 2008), the incineration of infected waste was effectively prohibited. In Portugal 
more than 40 on-site HCW incinerators were closed in the nineties of the last century. 
In order to meet the Stockholm Convention on Persistent Organic Pollutants and to protect 
public health, the WHO promotes the use of non-incineration technologies (also called 
alternatives technologies to incineration) to treat hazardous HCW. Consequently, the Global 
Environment Facility (GEF) in partnership with WHO and Health Care Without Harm funded the 
Global Healthcare Waste Project with the objective to protect public health and the global 
environment from the impacts of dioxin and mercury releases by incinerators. The project also 
involves a number of other partners at a global, regional and national level. This project 
convers seven countries: Argentina, India, Latvia, Lebanon, Philippines, Senegal and Vietnam 
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and focuses primarily on activities, such as promoting the use of non-burn waste treatment 
technologies, improved waste segregation practices and the use of appropriate alternatives to 
mercury-containing devices. 
In recent years, new non-incineration technologies being considered for the treatment of HCW 
include autoclaving, microwaving, irradiation, alkaline hydrolysis and biological treatment. 
However, no single technology can treat all types of HCW, i.e., more than one treatment 
technology may be needed to treat all types of the stream waste. Each technology has its 
advantages and disadvantages, so it is still necessary to determine the most appropriate type 
of waste technology to be used to minimize the consequences for environment, protect the 
public health and improve the occupational safety (Health Care Without Harm, 2004). 
 
2.2 THERMAL PROCESSES 
 
2.2.1 AUTOCLAVING  
 
Autoclaving or steam sterilization have been used, since 1876, when Charles Chamberland 
built the first pressure steam sterilizer for the sterilization of surgical instruments, medical 
devices, heat stabile liquids, as well as numerous applications in medical laboratories and 
private industry (Salkin et al., 2000).  
In autoclaving the waste is loaded into the unit and saturated steam (steam holding water as a 
vapor) is introduced, forcing the air out of the chamber. The removal of the air from the 
chamber is done in three ways: gravity-displacement; pre-vacuum (or high-vacuum) and pulse 
or multi-vacuum cycle. The high vacuum method is the most effective and fastest. With steam 
accumulation, the pressure and temperature within vessel increases until the minimum 
temperature and pressure are sufficient for the wastes treatment and these conditions are 
maintained during a determined time, referred to as the exposure period. Generally, the 
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minimum time and temperature for waste treatment are 30 minutes at 121 °C to achieve level 
III disinfection (Table 2.1). However, these parameters should be established by each facility 
based on the typical waste composition, type of containers used and method of stacking the 
waste in the autoclave. At the end, the steam is slowly released through a condenser until the 
pressure reaches the atmosphere pressure. The sterilized HCW is removed and taken to the 
disposal landfill, treated mechanically or it can also be incinerated in municipal waste 
incinerators as happen in some countries like Germany (Karagiannidis et al., 2010). Mechanical 
treatment generally involves size reduction, compaction or both. Some autoclaves are 
designed to shred waste during the treatment cycle; other systems rely on the use of a pre-
treatment process to macerate the waste before the waste is heated. Wastes that are treated 
in an autoclave do not change considerably from their original state and the waste mass may 
even increase, due to the addition of water depending upon the type of unit. 
Disinfection in an autoclave is carried out by batches: the unit is loaded, the disinfection is 
carried out, and then the contents are removed from the unit. The entire process, from loading 
to unloading, is called a cycle.  
 
The major concern associated with the use of autoclaving is that standard autoclaves cannot 
be used to treat a wide variety of waste including: wastes from chemotherapy treatment, 
mercury, volatile and semi-volatile organic compounds, and radioactive wastes (Lee et al., 
2004; Diaz et al., 2005). It is also not suitable to treat large body parts, animal carcasses, or 
other large items, due to their mass and other characteristics, makes it difficult or time 
consuming for the entire material to reach the prescribed temperatures (Diaz et al., 2005). A 
typical autoclave would release liquid and gaseous discharges that must be properly managed 
prior to release into the environment. A poorly segregated hazardous HCW may release toxic 
contaminants into the air. Since pressurized steam is an excellent method of volatilizing 
organic compounds and many organic reactions are accelerated at elevated temperatures, 
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possible volatile organic compounds (VOCs) and others maybe emitted into the air, depending 
upon the quantity and composition of the waste (Salkin et al., 2000). The odors can also be 
another problem with autoclaves if these are not equipped with proper ventilation for odors 
removal, such as enzyme-based deodorants (Health Care Without Harm, 2004). Table 2.3 
summarizes the main advantages and disadvantages of autoclaving process. 
 
Table 2.3 – Advantages and disadvantages of autoclaving process (Yang et al., 2009; Salkin et 
al., 2000). 
Factors Advantages Disadvantages 
o Waste characterization 
o Temperature and pressure 
o Steam penetration 
o Size of waste load  
o Length and number of 
treatment cycles 
o Degree of vacuum in the 
chamber 
 Low investment cost 
 Low operation cost  
 Ease of biological tests 
 Low hazard residue 
 PCDD/PCDFs emission 
free 
 Appearance, volume 
unchanged 
 Not suitable for all waste  types  
 Possible air emissions 
 Ergonomic concerns 
 Possible incomplete 
disinfection 
 
The inactivation of pathogens is achieved by the combination of three variables: temperature, 
pressure and time. The degree of bacteria inactivation depends on contact time and 
temperature, so, for a higher temperature less contact time is required (Hossain et al., 2012).  
 
The steam sterilization can be carried out in a retort, this unit is similar to autoclaves (Figure 
2.2). The major difference between them is that the retort does not incorporate a steam 
jacket, resulting in inefficient heat transfer and, consequently, higher temperatures are 
required for a retort than are required for an autoclave (Diaz et al., 2005). 
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Figure 2.2 – Typical autoclave (adapted from Chartier et al., 2014). 
 
Even with the numerous alternatives available, autoclaves continue to be one of the most 
popular methods to HCW treatment because of their history of use and track record within 
healthcare. If followed by shredding it can reduce volume by 60 – 80 % (Gupta et al., 2009; 
Diaz et al., 2005).  
 
Example – Autoclaving unit in city of Vila Nova de Gaia, Portugal 
The unit treats HCW of group III using 2 sterilizers with capacity of 6 200 L.  
These sterilizers treat daily 5 796 kg and perform 7 cycles at each 8 hours. 
Operation conditions:  Temperature – 135 °C 
   Saturated steam pressure – 3 bar 
   Cycle time > 60 min. 
After sterilization the HCW is shredded and compressed in a crusher with capacity of 1 ton/h 
and in a compactor with a volume of 20 m
3
. The compression cycle is 30 seconds. 
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A new generation of more efficient autoclaves has been developed to improve the heat 
transfer, decreasing the processing time, achieving more uniform heating of the waste and 
eliminating cold spots, rendering the waste unrecognizable, reducing waste volume 
significantly (up to 85 %) making most of the operation automatic, and/or making the 
treatment system a continuous process. These technologies now incorporate maceration or 
shredding during the treatment process to ensure better penetration of steam. Additionally, 
these systems combine post-treatment drying and compaction, and some also have odors 
elimination using activated carbon or high efficiency particulate air filters. However, these 
autoclaves have higher capital costs than standard autoclaves for the same capacity (Health 
Care Without Harm, 2014; Emmanuel, 2007). 
 
To test the effectiveness of the disinfection process, either biological (for example, Geobacillus 
stearothermophilus or Bacillus subtilis spore strips) or chemical indicators are inserted in waste 
loads, introduced into the autoclave and removed after the process is finished. Although, a few 
studies have documented that autoclaving inactive pathogenic microorganisms, Hossain et al. 
(2012) observed in their study a re-growth of bacteria as Bacillus subtilis, Staphylococcus 
aureus, Streptococcus pyogenes, Acinetobacter baumannii, Escherichia coli and Pseudomonas 
aeruginosa after some days of sterilization. 
 
2.2.2 DRY HEAT 
 
The dry heat process uses the electrically generated heated air, oil or molten plastic to 
inactivate potentially pathogenic microorganisms present in the wastes. The waste is heated 
by conduction, natural or forced convection and thermal radiation. This technology operates at 
temperatures between 100 °C to 180 °C, though without the intervention of steam. Dry heat 
technology generally operates at higher temperatures than steam technology and requires 
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longer exposure times to meet minimum disinfection levels. Above 180 °C, chemical alteration 
and, ultimately, combustion can occur, creating hazardous by-products (Health Care Without 
Harm, 2014). 
In radiation process, the shredded HCW is introduced in a heart, an air-tight stainless steel 
chamber, which operates under a negative pressure. After, the waste is exposed to high 
velocity heated air pumped into the bottom of the chamber through a ring of vanes or slots 
similar in design to turbine blades. The hot air is directed in a way that causes the waste 
particles to rotate turbulently around a vertical axis in a toroidal mixing action. Under these 
conditions, high rates of heat transfer take place. Within four to six minutes, dry 
unrecognizable waste is ejected into a compactor and put in sealed containers to be disposed 
at a landfill. With shredding and compaction, the waste volume is reduced by about 80 %. 
The types of waste treated are similar to those treated in autoclaving: cultures and stocks, 
sharps, materials contaminated with blood and body fluids, isolation and surgery wastes, 
laboratory wastes (excluding chemical waste), liquids such as blood and body fluids. The waste 
that should not be treated by a dry heat process are: volatile and semi-volatile organic 
compounds, chemotherapeutic wastes, mercury, other hazardous chemical wastes, and 
radiological wastes. Table 2.4 summarizes the main advantages and disadvantages of dry heat 
process. 
 
Table 2.4 – Advantages and disadvantages of dry heat process (Yang et al., 2009; Salkin et al., 
2000). 
Advantages Disadvantages 
 Dry and unrecognizable waste 
 Significant volume reduction 
 Absence of liquid effluents 
 Air emission free 
 Automated and easy 
 Decrease moisture content of waste 
 Not suitable for all waste types 
 Possible air emissions 
 Any large or hard metal objects 
may interfere with the shredder 
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2.2.3 MICROWAVE AND MACROWAVE  
 
  
The microwave process has been an alternative to incineration for certain categories of 
hazardous HCW (Hoffman and Hanley, 1994). 
Microwaves are defined as those with a frequency between radio and infrared waves in the 
electromagnetic spectrum. When used in the treatment of medical waste, they stimulate the 
pre-shredded and moistened waste to generate heat (95 °C or greater) and release steam. The 
combination of the two – microwaves and moisture – creates the thermal process, which is 
required to generate the thermal energy to effectively treat the medical waste. The 
disinfection by microwave units is not a result of exposure of waste to the microwaves, reason 
why it is important that the waste be wet. Some treatment processes use microwaves to heat 
water to form steam, which is then applied to the infectious waste stream. “Dry” microwave 
systems are also available. These use direct microwave energy in a nitrogen atmosphere to 
treat the waste and produce higher treatment temperatures than those used by “wet” 
microwave technologies.  
 
In microwave process, the waste is placed in carts and transported to the treatment facility. 
The carts are lifted by a hydraulic mechanism, the waste is discharged into the hopper and the 
steam is injected into the hopper and the air is extracted from the unit. All extracted air is 
passed through a high efficiency particulate air filter. The waste in the hopper is forced into a 
shredder. The shredded waste is then transported via a rotating conveyor screw, exposed to 
steam, and then heated to between 95 °C and 100 °C by means of microwaves, during a 
minimum of 30 min to ensure proper disinfection. Still, microwaving is not sufficient for 
sterilization temperature above 120 °C (Lee et al., 2004). In some units, the treated waste may 
be passed through a secondary shredder to achieve a higher degree of size reduction which is 
mainly important in the event that sharps are part of the waste stream. The treated waste is 
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conveyed using a second conveyor screw or auger, after it is discharged into a bin or roll-off 
container and sent to a landfill. 
 
The classic microwave units consist of three types of apparatus: material handling equipment; 
disinfection equipment itself; and environmental control equipment (Figure 2.3). 
This process can operate as a batch process or in semi-continuous mode and can be of various 
sizes, ranging from a few kg/h to more than 400 kg/h.  
The microwave technology is not suitable for large scale treatment and the cost is also 
expensive. Moreover, some offensive odors around the microwave units may occur. This 
process is usually not applicable for laboratory and chemotherapy wastes, pathological waste 
and radioactive wastes (Lee et al., 2004). Table 2.5 shows the advantages and disadvantages of 
microwave process. 
 
 
 
 
 
 
 
 
 
Figure 2.3 – Diagram of a mobile microwave unit: 1. Feeding hopper, 2. Feeding crank, 
3.Shredder, 4. Connecting hopper, 5. Level sensors, 7. Microwave generators, 8. Temperature 
holding section, 9. Discharge conveyor auger, 10. Temperature sensors, 11. Filter system, 12. 
Water tank with pump and spraying connection, 13. Steam generator, 14. Steam connection, 
15. Hydraulic aggregate, 16. Room heater, 17. Container (source: Diaz et al., 2005). 
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Table 2.5 – Advantages and disadvantages of microwave process (Yang et al., 2009; Salkin et 
al., 2000). 
Factors Advantages Disadvantages 
o Moisture content of 
waste 
o Microwave strength 
o Duration of exposure 
o Extent of waste 
mixture 
 Unrecognizable waste 
 Significant volume 
reduction 
 Absence of liquid discharge 
 PCDD/PCDFs emission free 
 Moderate-High investment 
 Not suitable for all waste types 
 Possible air emissions 
 Possible incomplete disinfection 
 
Some macrowaves systems apply low-frequency radio waves to heat shredded, moistened, 
compacted medical waste to 90 °C for an extended period of time, thereby inactivating 
microbes contained within the waste. The macrowaves heat the waste from the inside of the 
materials to their external surfaces.  
 
2.2.4 INCINERATION  
  
Incineration is a high-temperature dry oxidation process that converts organic and 
combustible waste to inorganic and incombustible matter. The process involves the chemical 
and physical breakdown of organic material through the processes of combustion. HCW is 
burned in incineration units under controlled conditions to yield ash and combustion gases. It 
is carried out at a temperature from 800 °C to more than 1 000 °C, resulting in significant 
reduction of waste volume , of about 85 – 90 % (Rushbrook, 1999; Alvim-Ferraz and Afonso, 
2003; Gielar and Rybicka, 2013) and weight, of about 70 % (Singh and Prakash, 2007). HCW 
usually requires long incineration times to ensure thorough waste burnout and that the 
residue quality is good (BREF, 2006). The correct practices of operation, such as controlling the 
mixing of solids, gas turbulence, the residence time and the incineration temperature as well 
the air emission limit values are conceded out in accordance with European legislation, 
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Directive 2010/75/EC and Directive 2000/76/EC. In Portugal, the legislation concerning to 
incineration of waste are Decree Law No 127/2013 and Decree Law No 85/2005. 
The best available techniques (BAT) and best environmental practices (BEP) guideline describes 
and recommends the proper design and operation parameters for different of incinerators.  
Two types of hazardous HCW incinerators are currently used: modular and rotary kilns.  
 
Modular incinerators  
The modular incinerators work on starved air or excess air conditions and usually consist in 
two furnace chambers. In the starved air incinerators, the most used to treat hazardous HCW, 
the waste is burned in the primary chamber, usually at temperatures between 800 °C and  
900 °C with less than the stoichiometric air requirement. Depending on the size of the 
installation, the residence time can vary from 1 to 4 hours. Airborne contaminants, such as 
volatile organics, that are released from the primary chamber, are combusted in the secondary 
chamber at temperatures from 1 100 °C to 1 600 °C, with 100 – 140 % of stoichiometric air 
needs. This second combustion reduces the smoke, carbon monoxide and odors. Figure 2.4 
shows a modular controlled air incinerator. 
 
 
 
 
 
 
´ 
 
 
Figure 2.4 – Controlled air incinerator (source: Diaz et al., 2004) 
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In the excess air incinerators, the waste is burned out in the primary chamber and in the 
secondary chamber is provided the residence time, temperature and supplementary fuel to 
burn off VOCs in the flue gas. The incinerator contains multiple internal baffles to guide the 
combustion gases through 90° turns in both lateral and vertical directions. At each turn, ash 
drops from the gas stream. The air is injected into the primary and secondary combustion 
chambers through the supplementary fuel burners to reach temperatures of around  
800 – 1000 °C.  
 
Rotary kiln 
The rotary kiln consists in a rotating oven (in a horizontal refractory lined cylinder that rotates 
on horizontal axis) that rotates 2 – 5 times per minute and a post-combustion chamber. The 
waste is charged directly into the kiln with excess of the air to burn. The off-gas from the kiln 
contains volatiles that have not burnt out on the initial stage and their burning is completed in 
a secondary chamber that usually has a long residence time of two or more seconds. The 
incineration temperatures are between 900 °C and 1 200 °C. Figure 2.5 shows a rotary kiln 
incinerator, which is commonly used for hazardous HCW. 
 
Figure 2.5 – Rotary kiln incinerator (adapted of BREF, 2006). 
Several modern large-sized incinerator units can recover the heat energy generated from the 
combustion of waste, offering an attractive advantage. For an effective incineration is essential 
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that waste has the following characteristics: heating value above 2 000 kcal/kg; calorific values 
within the regulatory and design requirements (e.g. the desired residence time, system 
operating temperature and excess air levels); content of combustible matter above 60 %; 
content of non-combustible solids below 5 %; content of non-combustible fines below 20 %; 
moisture content below 30 %. The heating value for HCW containing high levels of plastics can 
exceed 4 000 kcal/kg, but some of these may contain a high moisture content and 
consequently, much lower calorific values. A simple schematic of the incineration process is 
shown in Figure 2.6. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 – Simplified flow scheme of the incineration process (adapted of Chartier et al., 
2014). 
The advantages of incineration process shown in Table 2.6 easily explain the success of this 
technology.  
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Table 2.6 – Advantages and disadvantages of incineration process (Yang et al., 2009; Salkin et 
al., 2000). 
 Factors Advantages Disadvantages 
o Turbulence and mixing 
o Moisture content of waste 
o Filling combustion chamber 
o Temperature and residence  
time 
o Maintenance and repair 
 Volume and weigh 
reduction 
 Heat recovery for large 
systems 
 Large scale system waste 
 Unrecognizable waste 
 Mature and widely used 
technology  
 Complete disinfection  
 Acceptable for all waste 
types  
 High investment and 
operation costs 
 High maintenance costs 
 Bottom and fly ash may be 
hazardous 
 Public opposition 
 Polluting emissions in case of 
inadequate operation 
 Skilled operators needed 
 
However, one of the disadvantages of these technologies is the release of combustion by-
products into the atmosphere and the generation of residual ash. The HCW combustion 
produces mainly gaseous emissions containing: fly ash (particulates); inorganic acidic gases 
such as hydrogen chloride, hydrogen bromide, hydrogen fluoride; nitrogen oxides; sulfur 
oxides; heavy metals; polycyclic aromatic hydrocarbons (PAHs), dioxins; furans and particulate 
matter, plus solid residues in the form of ashes, as bottom ash. In addition, the gaseous 
emissions may contain carbon monoxide as a result of incomplete combustion. Several studies 
reported some of these pollution emissions from medical waste incinerators (Gielar and 
Rybicka, 2013; Sukandar et al., 2006; Chen et al., 2003; Lee et al., 2002). Inorganic acidic gases, 
nitrogen oxides and sulfur oxides are generated due to the presence of elements such as 
chloride, bromide, fluorine, sulfur and nitrogen in HCW and are emitted during incineration. 
The direct combustion of nitrogen and oxygen produces also nitrogen oxide, this reaction is 
accelerated at high temperatures. The presence and forms of heavy metals in fly ash, be 
contingent operation conditions of the incinerator such as temperature, residence time, gas 
composition and the presence of reactive compounds. Those conditions influence the final 
heavy metal speciation and particle size of the residue (Sukandar et al., 2006). Normally the 
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heavy metals associated with HCW incineration are cadmium, chromium, lead, arsenic and 
mercury (Singh and Prakash, 2007). The highest amount is usually present on fly ash and 
bottom ash with the exception of mercury where the greater amount is vented via the flue 
stack (Singh and Prakash, 2007). Several heavy metals are toxic at low concentrations, 
persistent and bio-accumulative. PAHs are formed mainly by incomplete combustion and their 
emissions are directly affected by temperature and excess air during incineration as well as the 
HCW composition (Singh and Prakash, 2007). Chen et al. (2003) reported in their study that 
PAHs concentrations of the stack flue gas for two animal carcass incinerators were about 1.5 
times higher than for medical waste incinerator. Many of PAHs have been shown to be 
carcinogenic and mutagenic in experimental animal studies (Chen et al., 2003). 
The main sources of dioxin emissions are the incineration of plastics (widely used as disposable 
materials) and chlorinated materials as paper and inks present in HCW. The dioxins consist of 
75 chlorinated dibenzodioxins (PCDDs) and 135 chlorinated dibenzofurans (PCDFs) (Alvim-
Ferraz and Afonso, 2003). The dioxins and furans are carcinogenic and toxic at extremely low 
concentration, producing effects in humans and animals. These chemicals are persistent in the 
environment due to accumulation in the food chain and to distribution globally (Singh and 
Prakash, 2007). In modern hospitals, more than 40 % of plastic wastes are chlorinated plastics 
(Chartier et al., 2014). Because of this and because the plastic content in HCW is significantly 
higher than in municipal waste, it have been implemented recycling programs. Decreasing of 
percentage of HCW halogenated plastics reduces the amount of hydrogen chloride and other 
halogenated pollutants. Thereby, reduces the treatment and disposal costs of HCW that are 
much more expensive than of municipal waste (Lee et al., 2004). 
On the other hand, incinerator emissions should comply with national standards and in 
accordance with the Stockholm Convention’s guidelines for BAT and BEP limit, the levels of 
dioxins and furans in air emissions should not exceed 0.1 ng I-TEQ/Nm3 at 11 % O2. All 
countries that have signed the convention are required to use the BAT for new incinerators.  
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Incinerators require emission controls equipment to meet modern emission standards. Alvim-
Ferraz and Afonso (2005) determined that without emission controls, dioxin concentrations in 
combustion gases were 93 to 710 times higher than the European Union legal limit  
(0.1 ngTEQ/m3), depending on variations in the waste composition. The atmospheric emissions 
released by hazardous HCW incineration are strongly influenced by the segregation methods, 
incineration conditions and waste type classification (Alvim-Ferraz and Afonso, 2005). 
Moreover, the hazardous HCW products from incineration – fly ash – is disposed of in 
hazardous waste landfill, whose costs are several times higher than disposal of 
decontaminated hazardous HCW at landfills for the municipal waste. The bottom ash is 
characterized by a leaching test to determine the appropriate ultimate disposal landfill. Some 
researchers have studied the stabilization/solidification of medical waste incineration ash. 
Tzanakos et al. (2014) studied the use of both ashes (fly and bottom) as a raw material for the 
production of geopolymers. They proved that solidified matrices by geopolymerization were 
able to reduce the leachability of the heavy metals which existed at the medical waste ash. The 
stabilization of fly ash with colloidal silica solution, suitable for chloride–rich fly ash as it is the 
fly ash derived from incineration of hospital wastes, could be another treatment method 
(Karagiannidis et al., 2010). 
However, incineration had been the preferred option for the treatment of infectious waste in 
countries such as Japan, mainly because the area for landfill is limited, only 10 % of the land is 
suitable for residential purposes this technology is extremely advantageous due to production 
of minor amount of waste. In Croatia, for ethical reasons, the pathological waste, namely the 
recognizable body parts is incinerated in crematoria or buried in cemeteries (Marinkovic et al., 
2008). Zhao et al. (2009) compared the environmental performances of hazardous HCW 
incineration and autoclaving with sanitary landfill using life cycle. Their results showed that 
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from a life cycle perspective the conventional waste hierarchy implying incineration with 
energy recovery is better than landfilling. 
In some cases a distinction is made between the incineration routes for pathological 
(potentially infectious waste) and non-pathological waste. The incineration of pathological 
waste is sometimes restricted to dedicated incinerators, while non-pathological waste is, in 
some cases, treated in other installations, for example with mixed municipal or hazardous 
wastes (BREF, 2006). In some countries exist national regulations that limit the ratio of HCW 
that may be incinerated in combined incinerators, as France where ratio is <10 % thermal load 
(BREF, 2006). Some countries also practice the co-incineration, high-temperature incineration 
of hazardous HCW, namely chemical and pharmaceutical waste, in industrial cement kilns or 
steel furnaces (Chartier et al., 2014). 
 
 
Example – Incineration unit in city of Lisbon, Portugal 
 
The unit treats HCW of group IV using a pyrolytic incinerator with capacity of 7 200 kg/day.  
HCW is loaded to the incinerator by a hydraulic lifting and tipping of containers. 
The incineration is carried out in 2 stages: primary chamber and post-combustion chamber. 
The primary chamber is a static horizontal chamber with 3 combustion uneven levels and it 
works at 850 °C in oxygen absence. 
The post-combustion chamber is a horizontal chamber, on the primary chamber, and it 
operates at 1 100 °C, with an oxygen concentration of 6 % and residence time of 2 seconds. 
The post–combustion chamber is equipped with 2 natural gas burners, it is connected to a 
heat exchanger to cooling the gases and energy recovery.  
Gaseous emissions treatment 
The gases are cooled to 180 °C and neutralized by injection of powdered sodium 
bicarbonate. Then the gases pass through a ceramic filter to remove particulate matter. 
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2.2.5 PYROLYSIS  
 
Pyrolysis process is a novel technology to treat hazardous HCW; it operates at high 
temperatures, between 550 °C and 1 000 °C, in absence of oxygen (Salkin et al., 2000). It 
makes the waste into innocuous and converts it into fuel (Na et al., 2008).  
At these temperatures the systems treat, destroy and reduce the volume of HCW. Na et al. 
(2008) studied the thermal decomposition of several usual HCW. Their results showed a weight 
loss up to 95 % at 800 °C for most of the test samples, thus proving that the pyrolysis can 
reduce the mass of waste. Table 2.7 shows the main advantages and disadvantages of pyrolysis 
process. 
 
Table 2.7 – Advantages and disadvantages of pyrolysis process (Yang et al., 2009; Salkin et al., 
2000). 
Advantages Disadvantages 
 Almost no waste remains 
 Heat recovery for large systems 
 Unrecognizable waste 
 Novel technology 
 Air emissions must be treated 
 Skilled operator needs 
 
The products generated during the process are directly affected by temperature: gases; ash 
and coke (in solid phase) pyrolysis oil and water (in liquid phase). The combustible gases are 
obtained by high temperature pyrolysis (above 1 000 °C); a medium temperature pyrolysis 
(600 °C – 700 °C) produces mainly oils, and materials such as scrap tires, waste plastics are 
transformed into a kind of heavy oil materials; and the product obtained by low temperature 
pyrolysis (under 600 °C) is principally coke (Wei et al., 2012). The gases remaining after 
pyrolysis can also be used as energy resources. The pyrolysis oil can be further used as a 
furnace fuel or a fuel for diesel generators.  
There are many types of pyrolysis reactors, including muffle furnace, tube furnace, fixed bed, 
fluidized bed, and entrained flow reactors. Typical pyrolysis reactors employ energy input from 
conventional sources of heat.  
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2.2.6 GASIFICATION  
 
Gasification is not a new technology; it was implemented during the nineteenth century in 
factories to produce town gas (Tchobanoglous et al., 1993). Nowadays, gasification is the main 
technology for biomass conversion to energy and an attractive alternative for the thermal 
treatment of solid waste (Fabry et al., 2013). 
 
Gasification differs from incineration because incineration combusts completely the waste is 
burned with the purpose to produce carbon dioxide and water. In gasification, the objective is 
to produce carbon monoxide and hydrogen which are intermediate products of combustion; 
during the process the following exothermic and endothermic reactions occur (Tchobanoglous 
et al., 1993): 
 
 + 	 					→       [2.1] 
 + 			 →  +      [2.2] 
 + 	 			→ 2     [2.3] 
 + 2	 			→ 	      [2.4] 
														 + 	 →  +     [2.5] 
 
To achieve that, the operating conditions in gasification must be appropriately maintained in 
order to avoid complete combustion. 
 
In the gasification process the wastes are thermally decomposed in an oxygen starved (sub 
stoichiometric) atmosphere. The gasification operates at high temperatures, between 500 °C 
to 1 600 °C, at a pressure ranging between 1 bar and 45 bar with gasification agent O2 or H2O 
(Chartier et al., 2014). When gasification occurs in the presence of an oxidant gasification 
agent, that is used to partially oxidize the feedstock and produce heat, it is called direct 
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gasification. If the process does occur with an oxidizing agent, and needs an external energy 
source, it is called indirect gasification. Steam is the most commonly used indirect gasification 
agent, because it is easily produced and increases the hydrogen content of the combustible 
gas (Belgiorno et al., 2003).  
In gasification, the wastes are ignited and reduced in a self-sustaining process. The products 
generated during gasification of wastes are “syngas”, so called “producer gas”, and, this 
depending on the waste content, various vaporised tar oil fractions. The syngas is mainly 
composed of carbon monoxide (CO) and hydrogen (H2) with low quantities of carbon dioxide 
(CO2), water (H2O), methane (CH4), hydrogen sulfide (H2S), ammonia (NH3), and under certain 
conditions, solid carbon (C), nitrogen (N2), argon (Ar) and some tar traces (Fabry et al., 2013). 
The syngas is cleaned through its passage by a series of scrubbers/filters and cyclonic 
separators. Syngas is a desirable product because of its versatility, carbon monoxide and 
hydrogen can be used in a number of ways to produce heat and electricity and can also be 
compressed for later use. Additionally, syngas can be used to produce methanol using a 
Fischer-Tropsch process (Fabry et al., 2013). 
 
There are three fundamentally types of reactors, namely: fixed bed, fluidized bed and indirect 
gasifier.  
Vertical fixed bed reactors are the most competitive fixed bed gasifiers, and can be updraft 
and downdraft gasifiers. Updraft is a counter-current gasifier, where the feedstock is loaded 
from the top while air is introduced from the bottom of the reactor. In a downdraft reactor, 
co-current, the carbonaceous material is fed in from the top, the air is introduced at the sides 
above the grate while the combustible gas is withdrawn under the grate.  
Fluidized bed has a fixed bed of fine solids, typically silica sand, which is transformed into a 
liquid-like state by contact with a gasification agent. Fluidized bed gasification arises to resolve 
problems related to feed stocks with a high ash content in the fixed bed and, principally, to 
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increase the efficiency of the process. The efficiency of a fluidized bed gasifier is about five 
times higher than a fixed bed (Belgiorno et al., 2003). 
Indirect gasifiers are the reactors used for the steam indirect gasification and are grouped as 
char indirect gasifiers and gas indirect gasifiers, depending on the type of internal energy 
source. Gas indirect gasifiers use a steam fluidized bed gasifier within bed heat exchange 
tubes. A fraction of combustible gas is burned with air in a pulse combustor and the hot 
combustion products provide heat to gasify the feed (Belgiorno et al., 2003). 
The main advantage of indirect gasification is the high quality of the combustible gas produced 
in contrast with greater investment and maintenance cost of the reactor (Belgiorno et al., 
2003).  
 
2.2.7 PLASMA  
 
In a plasma system, an electric current is used to ionize an inert gas (e.g., argon) causing the 
formation of an electric arc to create temperatures as high as 6 000 °C. The waste within the 
system is brought to temperatures between 1 300 °C to 1 700 °C, destroying potentially 
pathogenic microbes and converting the waste into a glassy rock or slag, ferrous metal, and 
inert gases (Gomez et al., 2009; Rezaiyan and Cheremisinoff, 2005). 
A plasma-arc employing carbon electrode was first used in 1960s as a source of intense heat 
(Nema and Ganeshprasad, 2002). 
The plasma technology was applied to destroy highly toxic compounds and to modify 
refractory compounds in an environment-friendly way. The abundant ultraviolet radiation in 
thermal plasma can dehydrogenate organic chlorine. The reactors can process gaseous, liquid 
and solid materials (Nema and Ganeshprasad, 2002). 
It is an environment friendly technology, which converts organic waste into commercially 
useful by-products. Plasma-arc technology is a well proven, well-demonstrated, commercially 
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viable technology, which is utilized in industrial plants to treat different waste materials, 
worldwide. Medical waste is pyrolyzed into CO, H2 and hydrocarbons when it comes in contact 
with the plasma-arc (Gomez et al., 2009). These gases are burned and produce a high 
temperature (around 1 200 °C). 
 
Plasma pyrolysis integrates the thermo-chemical properties of plasma with the pyrolysis 
process. This technology makes use of an ionized gas in the plasma state to convert electrical 
energy to temperatures of several thousand degrees using plasma arc torches or electrodes. 
The high temperatures are used to pyrolyse waste in an atmosphere with little or no air. Hot 
plasmas are particularly appropriate for treatment of solid waste and can also be employed for 
destruction of toxic molecules by thermal decomposition. 
This technology provides an efficient treatment of hazardous HCW, and it does not require 
segregation of chlorinated hydrocarbons. The quantity of dioxins and furans was found to be 
well below the accepted emissions standards. Another advantage of plasma pyrolysis is the 
reduction in volume of organic matter, which is more than 99 %.  
 
2.3 CHEMICAL PROCESSES 
 
Chemicals have an extensive and well-documented history in the clinical setting in disinfecting 
environmental surfaces and medical devices. Table 2.8 summarizes the advantages and 
disadvantage of chemical processes. 
Inherent to the operation of such systems is the fact that the waste must first be shredded 
prior to exposure to such agents as sodium hypochlorite, chlorine dioxide, peracetic acid, 
formaldehyde, glutaraldehyde, quaternary ammonium compounds, calcium oxide, ozone, etc., 
in order to bring all surfaces of the waste into direct contact with the chemicals. The process 
appears to be able to treat: cultures and stocks, sharps, liquid human and animal wastes 
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including blood and body fluids (in some technologies this may be limited to a certain 
percentage of the waste), isolation and surgery wastes, laboratory waste (excluding chemical 
waste). Chemical sterilization may be considered as an alternative to autoclaving mainly in 
disinfection of scalpels, syringes with needles and other recyclable sharps (Prüss et al., 1999). 
However, this process may be problematic due to production of toxic effluents by the used 
chemical disinfectants. Recently, some controversy arises regarding the use of chlorine-based 
chemicals, namely hypochlorite and its by-products in wastewater, which may be cause long-
term environmental effects (Health Care Without Harm, 2014). There may be some offensive 
odors around some chemical treatment units.  
Table 2.8 – Advantages and disadvantages of chemical process (Yang et al., 2009; Salkin et al., 
2000). 
Factors Advantages Disadvantages 
o Concerns for chemicals and 
temperature 
o pH 
o Chemical contact time 
o Waste and chemical mixing 
o Recirculation vs flow-
through 
 Unrecognizable waste 
 Significant volume 
reduction 
 Rapid processing 
 PCDD/PCDFs emission free 
 Waste deodorization 
 Not suitable for all waste 
types  
 Need for chemical storage 
 Possible incomplete 
disinfection  
 Moderate-high 
investment  
 
Some systems combine heat with the chemicals to reduce the treatment cycle. An example of 
these systems is alkaline hydrolysis, which requires an aqueous solution with sodium 
hydroxide or potassium hydroxide at temperatures around 150 °C. This HCW treatment will be 
addressed in more detail in Chapter 3. 
For an efficient disinfection is essential that: the disinfectant has the ability to act on all the 
key pathogen groups; the disinfectant is maintained in the waste at sufficient concentration or 
it is given enough time to achieve the required level of treatment for each of the key pathogen 
groups; and the treated waste (which may be highly absorbent) should not be rendered 
chemically hazardous due to the presence of residual disinfectant.  
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2.4 IRRADIATION PROCESSES 
 
Gama irradiation, Cobalt-60, has been used for many years as a means of inactivating potential 
pathogens on the surfaces of many different products. Since the appropriate dose of radiation 
can be precisely calculated, it has been found to be an extremely reliable treatment system. A 
newer form of irradiation systems employs an electron beam generated by an accelerator to 
sterilize hazardous HCW. Electron beam irradiation uses a shower of high-energy electrons to 
destroy microorganisms by causing chemical dissociation and rupture of cell walls. Irradiation 
systems require extensive shielding to protect the workers. These processes can only treat 
relatively small quantities of waste. It does not alter the physical appearance of the material 
and would require a grinder or shredder to render the waste unrecognisable. 
The types of waste that can be, or not, treated by irradiation are similar to those treated by 
autoclaving, dry heat and microwave. Table 2.9 summarizes the main advantages and 
disadvantages of irradiation process. 
 
Table 2.9 – Advantages and disadvantages of irradiation process (Health Care Without Harm, 
2004). 
Advantages Disadvantages 
 Air emissions free 
 Absence of liquid effluents 
 Low operating costs 
 Well automated  and requires little 
operator time  
 Noiseless 
 Not reduce waste volume 
 Personnel must be protected from 
radiation exposure 
 Skilled operator needs 
 
2.5 BIOLOGICAL PROCESSES 
 
Biological processes are categorized as either aerobic or anaerobic treatments. Aerobic 
treatment requires oxygen and the microorganisms convert the organic components of the 
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hazardous waste into carbon dioxide and water. Anaerobic treatment occurs in absence of 
oxygen and the microorganisms convert the waste into methane and carbon dioxide. 
In the biological processes, composting and vermiculture (digestion of organic wastes through 
the action of worms) have been used successfully to decompose hospital kitchen waste, as 
well as other organic digestible waste and placenta waste (Chartier et al., 2014). In the 
biological processes that use an enzyme mixture to decontaminate HCW, the resulting sludge 
is put through an extruder to remove water for sewage disposal. This process is also being 
used in the agricultural sector to break down animal waste. The natural decomposition of 
pathological waste through burial is another example of a biological process. 
 
2.6 MECHANICAL PROCESSES 
 
This technology is used with other types of equipment for the following reasons: 1) reduces 
the volume of waste; 2) removes or reduces physical hazards; and 3) renders the waste 
unrecognizable.  
These technologies are commonly used for compaction and shredding/grinding HCW, due to 
their capability to reduce waste volume by about 60 – 80 % (Gupta et al., 2009; Diaz et al., 
2005). The compaction process involves compressing the waste into containers to reduce its 
volume. The compaction is used in conjunction with other treatment methods, but it is 
normally less efficient than shredding or grinding and might generate infectious aerosols 
(Salkin et al., 2000). The purpose of shredding is to covert HCW into a more homogenous form 
that can be easily handled and efficiently sterilized. The shredding process includes 
granulation, grinding, pulping, etc. In these processes, HCW are physically broken into smaller 
particles in a container. The container is usually maintained at a negative pressure to ensure 
that no waste escapes from the device. The more advanced shredders are usually low-speed, 
high-torque, single-pass shredders with easily replaceable cutters and with discharge screens 
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to control the size of shredded waste. Nevertheless, shredding or grinding waste in a stand-
alone unit, before disinfection, is not recommended because, although it increases the surface 
area of the waste and can make treatment easier, it can create an aerosol of infectious 
particles (Health Care Without Harm, 2014). 
 
2.7 OTHER PROCESSES 
 
Encapsulation is recommended as the easiest technology for the safe disposal of sharps. 
Sharps are collected in puncture-proof and leak-proof containers, such as high-density 
polyethylene boxes, metallic drums or barrels. When a container is three-quarters full, a 
material such as cement mortar, bituminous sand, plastic foam or clay is poured in until the 
container is completely filled. After this material has dried, the container is sealed and may be 
landfilled, stored, or buried inside the hospital premises. It is also possible to encapsulate 
chemical or pharmaceutical residues together with sharps. In Figure 2.7 is shown a schematic 
diagram of cement encapsulation. Several systems currently available provide waste 
containers which already contain chemical packets which, when activated through the addition 
of liquids, encapsulate the waste into solid clear or opaque blocks or cylinders. It is possible 
that the chemicals also treat the waste, but support documentation is limited. 
 
 
 
 
 
 
 
Figure 2.7 – Schematic diagram of cement encapsulation (source: Diaz et al., 2005). 
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The main advantages of the process are: simple and safe; low cost and also applicable to 
chemicals pharmaceuticals. Additionally, is effective to reduce the risk of scavengers gaining 
access to the hazardous HCW. Not recommended for non-sharp infectious waste. 
Table 2.10 shows the main advantages and disadvantages of encapsulation process. 
 
Table 2.10 – Advantages and disadvantages of encapsulation process  
Advantages Disadvantages 
 Simple, inexpensive and safe 
 A solution that can be envisaged for 
sharps and pharmaceutical wastes 
 The risks for scavengers are reduced 
 
 To be regarded as a temporary solution  
 The quantities of waste treated are small  
 The weight and volume of the waste is 
increased 
 
Another treatment process, especially for pharmaceuticals waste, is the inertization. This 
involves mixing waste with cement and other substances before disposal to minimize the risk 
of toxic substances contained in the waste migrating into surface water or groundwater. 
The typical proportions (by weight) for the mixture are: 65 % waste; 15 % lime; 15 % cement;  
5 % water. The process is reasonably inexpensive and can be performed using relatively 
unsophisticated mixing equipment (Chartier et al., 2014). 
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CHAPTER 3 – ALKALINE HYDROLYSIS   
 
3.1 INTRODUCTION 
 
Alkaline hydrolysis is not a recent chemical process, given that it was patented in 1888 by 
Amos Herbert Hobson in the United States Patent Office, England. The main objective of this 
patent was the removal of nitrogenous materials from the bones to make a suitable fertilizer, 
and byproducts. In this work alkaline hydrolysis could have other benefits, such as a process to 
treat animal carcass materials. Only in the nineties this process was used to destroy tissue 
wastes, including anatomical parts, organs, placenta, blood, body fluids, specimens, human 
cadavers and animal carcasses (BREF, 2005). This technology is reported in full scale in the USA 
and Canada for disposal of transmissible spongiform encephalopathy (TSE) wastes. It is 
currently used in many institutions, laboratories, and animal disease diagnostic facilities to 
treat carcasses dispose and other forms of biological waste (BREF, 2005). Until 2009 no units 
were in operation in EU, due to the lack of approval of the technique, as required by 
Regulation (EC) No 1774/2002. Nevertheless, alkaline hydrolysis was considered an alternative 
method for the treatment of animal by-products when the Regulation (EC) No 1069/2009, 
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which defines the basic outline regulation covering the import of animal derived material not 
used on human or animal consumption, and the Regulation (EU) No 142/2011, that provides 
the implementing rules, were implemented. Together, these two documents address, both, 
animal by-products and animal derived products and cover all aspects for collection, 
processing and transport of these materials into and within the European Community.  
 
Alkaline hydrolysis combines steam sterilization with tissue digestion using sodium hydroxide 
(NaOH) or potassium hydroxide (KOH). The process converts animal carcasses, human body 
parts and tissues in a sterile alkaline “soap” with a brownish coloration and high biochemical 
oxygen demand (BOD). The by-products generated by alkaline process are mineral 
constituents of the bones and teeth (which can be crushed and recovered as sterile bone meal) 
and a decontaminated aqueous solution of peptide chains, amino acids, sugars, soaps and 
salts. 
In addition, the alkaline hydrolysis destroys fixatives in tissues and various hazardous 
chemicals, including formaldehyde, glutaraldehyde and many chemotherapeutic agents or 
cytotoxic agents (Health Care Without Harm, 2004). This process can also destroy pathogens 
including prion and, is effective in eliminating radioactively contaminated tissues (Thacker, 
2004). Therefore, alkaline hydrolysis emerges, in some countries, as an alternative process for 
HCW treating, reported in USA and in UK (Health Care Without Harm, 2004).  
This treatment has been shown to have significant advantages compared to other HCW 
treatments, because it sterilizes and destroys at once, and also reduces the total waste 
volume. It has also other important benefits, such as the absence of emissions releases into 
the atmosphere resulting in a minor odour production. For this reason, it is considered a green 
process. And, so, the treatment of infectious wastes and hazardous wastes by alkaline 
hydrolysis has been patented (US 5384092, US 20010053869, US 7910788, etc.). Table 3.1 
shows the advantages and disadvantage of alkaline hydrolysis. 
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Table 3.1 – Advantages and disadvantages of alkaline hydrolysis (Thacker, 2004; USEPA, 2014). 
Advantages Disadvantages 
 Combination of sterilization and digestion 
into one operation 
 Reduction of waste volume and weight (> 
97 %) 
 Complete destruction of pathogens, 
including prions 
 Elimination of radioactively contaminated 
tissues 
 Production of limited odor or public 
nuisances 
 Potential issues regarding disposal of 
effluent 
 Limited capacity for destruction of 
large volumes  
 Not widely available 
 Transportation concerns/costs  
 Residues require proper handling and 
management 
 Public perception 
 
 
Another attractive factor for this technology is the cost, which is smaller than for others 
technologies used to treat hazardous HCW. Thacker (2004) reported the estimated costs of 
$320 ton-1, including costs with steam, water, electricity, chemicals, labor, sanitary sewer and 
maintenance and repair. A similar value was obtained by Murphy et al. (2009) that calculated 
the cost of approximately $260–$310 ton-1 using alkaline hydrolysis to dispose of animal 
tissues and carcasses during their study of prion inactivation. However, these costs do not 
include the initial capital investment. Still, these authors considered as acceptable the financial 
costs of this technology and indicated alkaline hydrolysis as a valid alternative to incineration, 
landfill burial, and rendering for disposing of biological material potentially infected or 
contaminated with prion disease.  
Alkaline hydrolysis technology can be of various sizes, from small to very large, with the 
installation of multiple units being appropriate for large scale operations. In addition, it can be 
used for on-site treatment, thereby saving on transport costs and decreasing environmental 
damage (BREF, 2005). 
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3.2 CHEMICAL FUNDAMENTALS 
 
Hydrolysis is defined as a chemical transformation in which a molecule, RX, reacts with water, 
resulting the formation of a new covalent bond with OH and cleavage of the covalent bond 
with X in the original molecule (equation 3.1). 
 
																																													
 +  → 
	 + 

	+ 

	     [3.1] 
 
If occurs in the presence of acid or base it is called acid catalysis or base catalysis. Both 
catalysis can significantly accelerate hydrolysis kinetics, due the hydronium ion and hydroxide 
ion provide an alternative mechanism for hydrolysis that is energetically more favourable. In 
acid catalysis, hydronium ion provides a reaction pathway of lower energy by withdrawing 
electron density from the atom bearing the leaving group, X, thus making it more susceptible 
to nucleophilic attack by H2O. Base catalysis occurs because OH
- is a much more reactive 
nucleophile than H2O. Bases are usually aqueous solutions of alkali metal hydroxides, such as 
NaOH or KOH. The heat is used to accelerate the hydrolysis reactions. 
Alkaline hydrolysis degrades the proteins, the major solid component of all animal cells and 
tissues, into salts of free amino acids. Proteins are linear polymers which consist of one or 
more long chains of amino acids. Amino acids are linked to each other by a peptide bond in 
which the carboxyl group of one amino acid is condensed to the amino group of another 
amino acid with elimination of water. Alkaline hydrolysis reverses the condensation of amino 
acids into proteins of the peptide bonds and the addition of water at the break. Moreover, 
under alkaline hydrolysis some amino acids such as arginine, asparagine, serine and glutamine 
are completely destroyed while others modify its configuration to structures of lower 
molecular weight (Fountoulakis and Lahm, 1998).  
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Due to its effectiveness in degrading the proteins, the alkaline hydrolysis of proteins recovered 
from slaughterhouse blood is used to obtain profitable peptides and free amino acids for 
animal feed. For this purpose, Álvarez et al. (2013) studied the use of NaOH to obtain useful 
peptides from porcine haemoglobin. They obtained an 80 % peptide recovery using 6 M NaOH 
at 50 °C during 24 hours. Lóki et al. (2010) examined the changes in D-amino acid content of 
slaughterhouse waste, and reported that alkaline hydrolysis at 135 °C for 2 hours with NaOH or 
KOH is sufficient for the entire destruction of the protein structure. The obtained product was 
unfit for being used as animal feed; however, the product resultant of the hydrolysis with KOH, 
after neutralization, may be used as nitrogen fertilizer in the soil. 
 
Alkaline hydrolysis with the purpose to separate and recover chromium from tanned leather 
and collagen hydrolysate has also been investigated (Ferreira et al., 2008). Ferreira et al. (2014) 
investigated leather treatment at 150 °C for 1.5 hours with 4 M solution and found that under 
these conditions the quantity of leather and chromium dissolved was more than 98 % and  
85 % respectively. The alkaline treatment (with lime) of chicken feather keratin to obtain a 
liquid product rich in amino acids and polypeptides, that can be used as an animal feed 
supplement, has also been studied (Coward-Kelly et al., 2006). They reported that at 150 °C,  
80 % of feather keratin was solubilized within 25 min, whereas at 100 °C, a relatively longer 
reaction time (300 min) was needed to solubilize 80 % of keratin. 
The alkaline hydrolysis is also used to quantify liberation of all amino acids of the substrate and 
the quantitative recovery of them in the hydrolyzate. This method is often applied in the 
quantification of phospho-amino acids, is applied in nucleic acid research and for the digestion 
of a wide variety of substrates in order to release products such as carbohydrate moieties, 
lipids, etc. (Fountoulakis and Lahm, 1998). 
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The animal fats, triglycerides, are esters composed of three fatty acids chains bound connected 
to a glycerol molecule. The triglycerides react with strong bases, as NaOH and KOH to form the 
carboxylate salts of fatty acids. Also, the phosphodiester bonds of nucleic acids are hydrolysed 
by alkaline hydrolysis into their constituent bases, sugars and phosphate. The carbohydrates 
are the most resistant compounds to alkaline hydrolysis. The glycogen, the most common 
large polymer of glucose in animals, requires much longer treatment time than it is required 
for other polymers. When broken down, the constituent monosaccharides are rapidly 
destroyed by the hot aqueous alkaline solution. Nevertheless, the alkaline hydrolysis is 
insufficient to destroy long hydrocarbon molecules, such as cellulose. Knill and Kennedy (2003) 
studied the cellulose degradation under alkaline hydrolysis. Their study reported that the 
production of acids with low molecular weight and the composition of the degradation 
products are influenced by some reaction parameters, such as temperature, type of the 
alkaline solution and concentration. The cellulose degradation products of low molecular 
weight, formic acid, acetic acid, glycolic acid, and lactic acid were detected at higher 
temperatures (approximately 280 °C). At lower temperatures the major alkaline degradation 
products observed were the glucoisosaccharinic acids and their lactones. 
 
Some authors have been studying the degradation of some polymers by alkaline hydrolysis. Gu 
et al. (2001) evaluated the changes on polyester films using 3 M NaOH solutions at room 
temperature measuring both mass and total organic carbon losses, among other parameters. 
Their results showed an increase of mass and organic carbon losses with the increase of the 
exposure time; this fact was attributed to the hydrolysis of ester groups and the subsequent 
leaching of low molecular mass and water soluble fragments of the polyester material into the 
solution. Shin et al. (1998) studied the effect of NaOH concentration on the degree of polyvinyl 
chloride dehydrochlorination at high temperatures (between 150 °C and 250 °C) using 0 – 7 M 
NaOH solutions during 12 hours. They observed that the degree of dehydrochlorination 
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increased with increasing temperature, and reached about 100 % at 250 °C. The maximum rate 
of the dehydrochlorination was obtained using 3 M NaOH. Blazevska-Gilev and Spaseska 
(2007) described the alkaline dechlorination of polyvinyl chloride (PVC) in organic solvents at 
30°C – 80 °C for 1 – 5 hours. The final products were polyvinyl alcohol with small chloride 
content and NaCl. Studies on the degradation of polyethylene terephthalate (PET) using 
alkaline solutions showed the depolymerizing of PET into small molecules as ethylene glycol 
and terephthalic salts (Kao et al., 1998; Karayannidis et al., 2002; Kumar and Guria, 2005). 
 
3.3 DESTRUCTION/INACTIVATION OF DISEASE AGENTS 
 
The successful inactivation of a Creutzfeldt–Jajob disease (CDJ) agent by a sequential process 
involving exposure to 1 M NaOH for 60 min, followed by autoclaving at 121 °C for 30 min 
(Taguchi et al., 1991), and the inactivation of 22A strain of scrapie agent by autoclaving at   
121 °C for 30 min in the presence of 2 M NaOH (Taylor et al., 1997) has been proven. Taylor 
(2000) addressed the inactivation conditions of agents that cause TSE by some sterilization 
methods described in various studies. He reported that the hot solutions of NaOH appear to be 
completely effective in inactivation of these agents.  
Bauman et al. (2006) studied the inactivation of prions by 0.1 M NaOH after pre-treatment 
with detergent. In the presence of detergent, prions become more accessible to NaOH, which 
can then inactivate prions by altering its structure.  
Murphy et al. (2009) reported the inactivation of Prion–Positive Material by alkaline hydrolysis 
at 150 °C. More recently, the prion decontamination using 0.15 M NaOH at 25 °C for 1 h was 
shown to be partly effective with a prion reduction of 4 log10 (McDonnell at al., 2013). 
The alkaline hydrolysis destroys all pathogens listed as index organisms by the STAATT (Table 
2.1) which require a 6 log10 (99.9999 %) reduction in vegetative agents and a 4 log10 (99.99 %) 
reduction in spore forming agents (Thacker, 2004).  
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Kaye et al. (1998) evaluated the efficacy of alkaline hydrolysis by testing the destruction of the 
following microorganism cultures: Staphylococcus aureus, Mycobacterium fortuitum, Candida 
albicans, Bacillus subtilis, Pseudomonas aeruginosa, Aspergillus fumigatus, Mycobacterium 
bovis BCG, MS-2 bacteriophage, and Giardia muris. The tests were carried out during digestion 
of animal carcasses in a digester at 110 – 120 °C and for 18 hours. The results showed the 
complete destruction of these cultures by alkaline hydrolysis.  
Dixon et al. (2012) reported the use of alkaline hydrolysis at ambient temperature for the 
inactivation of the fish pathogens infectious salmon anaemia virus and Lactococcus garvieae. 
 
3.4 PRINCIPLE OF OPERATION  
 
According to the Commission Regulation (EU) No 142/2011, the alkaline hydrolysis must be 
carried out in a batch system and the material in the vessel must be constantly mixed in order 
to facilitate the digestion process until the tissues are dissolved and bones and teeth are 
softened. It requires either a NaOH or KOH solution (or a combination thereof), which must be 
used in an amount that assures approximate molar equivalency to the weight, type and 
composition of the animal by-products to be digested. The mixture must be heated to a core 
temperature of at least 150 °C and at a pressure of at least 4 bars. 
The process is carried out in a tissue digester, which consists in a steam-jacketed, stainless-
steel tank and a basket. After loading the waste in the basket (for the retention of bone 
remnants) and into the hermetically sealed tank, the alkali (sodium or potassium hydroxide) is 
added in amounts proportional to the quantity of waste in the tank, along with water. The 
contents are heated and stirred. Depending on the amount of alkali and temperature used, the 
time required is between three and eight hours. However, another important factor to 
consider in the processing time is the disease agents of concern present in waste. To treat 
bacterial and viral contaminated waste, the time required is three hours; nevertheless 
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according European Commission Scientific Steering Committee (2002), for material infected 
with TSE or potentially TSE-infected, the time recommended is six hours.  
 
 
 
 
 
 
 
Figure 3.1 – Alkaline hydrolysis digester (source: Thacker, 2004). 
 
The byproducts of the process consist in a solid and a liquid (effluent). The residue, 
correspondent to approximately 2 % of the initial weight and volume, the waste rich in mineral 
components of the bones and teeth is sterile and easily crushed into a power, which may be 
used as a soil additive. Some studies have been conducted to evaluate the recycling of by-
products into animal feed supplement or fertilizer in soils for by alkaline hydrolysis (Kim and 
Patterson, 2003; Gousterona et al., 2003; Kalambura et al., 2011). 
The effluent is characterized by the brownish color, high pH, normally around 10.3 to 11.5, 
high BOD (approximately 70 000 mg/L) and high COD (up to 100 000 mg/L) and can be 
discharged to the sewer after neutralization, however, subjected to the local or federal 
guidelines. The estimate quantity of effluent generated on the treatment of 907 kg of material 
is 2196 L of hydrolyzate and 4392 L of total effluent including hydrolyzate, cooling water, rinse 
water and coflush water. The sterile effluent resultant from the alkaline hydrolysis process can 
be a source of sustainable energy, in the form of the fertilizer generation, biodiesel fuels, and 
biogas from large-scale tissue digester units which generated large volumes of effluents. 
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DISCARDED MEDICAL COMPONENTS PRESENT IN HEALTHCARE WASTE 
 
This chapter is based on Pinho S. C.; Almeida M. F.; Nunes O. C. Effects of alkaline hydrolysis  
and autoclaving on inorganic components present in healthcare waste. 
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ABSTRACT 
In this work, samples of components usually present in healthcare waste, such as cotton, diapers, 
transfusion tubes, surgical gloves, examination gloves, adhesives, surgical masks, urine bag 
collectors, serum bottles and syringes, were subjected to alkaline hydrolysis or autoclaving and 
effects of these treatments were assessed. Both treatments were carried out at 135 °C and the 
weight loss and the carbon loss of the components as well as the total organic carbon and the 
chemical oxygen demand in the effluents were determined. The biodegradability of effluents was 
assessed by measuring the biochemical oxygen demand after 5 days.  
Alkaline hydrolysis caused appreciable degradation in most of the components, with the 
adhesives and the diapers having the highest weight losses and carbon losses. Components made 
with low-density polyethylene, high-density polyethylene and polypropylene showed good 
chemical resistance with 2 M NaOH solution. The effluents obtained after alkaline treatment of 
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healthcare waste are hazardous due to their very high alkalinity. The effluent obtained after 
treatment of a mixture of all components using a 2 M NaOH solution was biodegradable with the 
following parameters: 6.5 g C/L of total organic carbon, 29.8 g O2/L of chemical oxygen demand 
and 14.9 g O2/L of biochemical oxygen demand after 5 days. 
Although the autoclaving treatment degraded the components much less than alkaline 
hydrolysis, the effluents obtained from some components showed an appreciable organic load. 
 
 
4.1 INTRODUCTION  
 
The HCW is a heterogeneous mixture of wastes, consisting of paper products, textiles in the 
form of cotton and gauze and plastics. Plastics are the major fraction, around 30 % of initial 
weight. 
The behaviour of some polymers such as PET (Kao et al., 1998; Karayannidis et al., 2002; Kumar 
and Guria, 2005), polyester (Gu et al., 2001), PVC (Blazevska-Gilev and Spaseska, 2007; Shin et 
al., 1998) and cellulose (Knill and Kennedy, 2003) have been studied when exposed to alkaline 
hydrolysis. Despite some achievements in degradation of materials with alkaline solutions, 
little is known about the interaction of materials under alkaline hydrolysis when digested 
together and the emissions resulting from this treatment. Also, the effects in common 
discarded medical components present in HCW during the autoclaving process as well as the 
final effluent composition and its treatability are not well known. This lack of knowledge 
makes authorities to have some reluctance in licensing autoclaving plants and in permitting 
their effluents to be discharged into domestic sewage. 
In this work, the effect of a treatment similar to autoclaving in some discarded medical 
components present in HCW was studied as well as when they were treated with NaOH 
alkaline solutions. The effect on components was assessed by measuring weight loss (WL) and 
carbon loss (CL). In addition, thermogravimetric (TG) and differential scanning calorimetric 
(DSC) analyses were performed on samples before and after the treatments. The effluent 
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obtained after treating each component alone was characterised with respect to total organic 
carbon (TOC) and chemical oxygen demand (COD). Also, Principal Components Analysis (PCA) 
was used to establish differences the results obtained and to establish differences among the 
components and consequences of the two types of treatments. 
Additionally, biochemical oxygen demand after five days (BOD5) was determined in the 
effluents resulting from testing a mixture of all analysed components in order to assess its 
biodegradability and the possibility of being discharged in a domestic wastewater treatment 
plant.  
 
4.2 MATERIALS AND METHODS 
 
4.2.1 MATERIALS  
 
HCW materials include textiles, glass, metals, anatomical waste and others, but mostly plastics 
and paper (Prüss et al., 1999). These materials are present in diapers, tubes for transfusion, 
surgical gloves, examination gloves, adhesives, surgical masks, bag collectors for urine, serum 
bottles and syringes, but also in some minor components, such as sensors for analysing 
characteristics from biological fluids (Gupta et al., 2003). Due to their clinical application, 
materials of these components are subjected to additional treatments during the 
manufacturing process, such as disinfection, application of anti-allergic substances, additives, 
and others. Samples of most of those HCW components, including cotton, were considered in 
this study.  
Table 4.1 shows qualitative data on the HCW components used in the trials, according to the 
respective suppliers, as well as their total carbon (TC) determined in several samples.  
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Table 4.1 – Components of the HCW used in the experimental work, their materials and carbon 
content.  
Material Composition C, %
(1) 
Serum bottle 
Syringe 
Low-density polyethylene (LDPE) 
Polypropylene (PP) and high-density  
polyethylene (HDPE) 
84.76 ± 1.11 
89.01 ± 0.74 
Transfusion tube Polyvinyl chloride (PVC) 47.76 ± 1.38 
Bag collector for urine PVC  50.76 ± 1.34 
Examination glove 
Surgical glove  
PVC 
> 90 % natural rubber  
53.27 ± 0.15 
75.22 ± 1.63 
Cotton  94 % cellulose 45.16 ± 0.53 
Surgical mask PP (outer and middle layer); polyester and  
pressed PE (inner layer); polyurethane (tapes)  
84.54 ± 0.72 
Diaper Cellulose fibre and PP (70 – 80 %); PE film;  
thermoplastics adhesives; elastic threads; flocgel  
(5 –10 % of sodium polyacrylate) 
43.27 ± 1.35 
Adhesive Non-woven polyester; synthetic adhesive from 
rubber 
77.67 ± 0.05 
(1) Mean of three determinations ± standard deviation (SD)  
 
4.2.2 METHODS 
 
Alkaline hydrolysis and autoclaving-like treatments 
 
The treatments were performed in a Parr batch reactor with a titanium vessel of 450 ml 
capacity under temperature control and with a pressure gauge. The reactor operated at  
135 °C, with a heating rate of 10 °C/min up to 135 °C and holding time of 30 minutes. A 
liquid/solid ratio of 10:1 (w/w) was used in all the tests. The alkaline solutions tested consisted 
of 0.1 M, 1 M and 2 M, the last two being also studied by other authors (Taguchi et al., 1991; 
Taylor et al., 1997). The autoclave-like treatment was performed under the same conditions in 
the absence of NaOH; therefore, the solids were usually immersed in water and not only in a 
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water vapour saturated atmosphere. Despite that, it is believed that the consequences of this 
treatment are not much different than from those obtained from classic autoclaving. For 
simplicity, the autoclave-like treatment is herein referred to as autoclaving. 
All the tests were made using samples with 2 g of each component; 5 g were used when a 
mixture was studied (0.5 g of each component). Since syringes were composed of two distinct 
materials, a sample with equal weight of each was taken. Except for cotton, the components 
were cut in fragments of approximately 1 cm
2
 before the tests. 
After cooling to ambient temperature, the resulting product was filtered, and, in the case of 
alkaline hydrolysis, the solid fraction was washed with distilled water in order to remove all of 
the sodium hydroxide. Subsequently, it was dried, held for 48 h in a desiccator at room 
temperature and finally weighted. Figure 4.1 shows a diagram of the process.  
 
 
Figure 4.1 – Diagram of the alkaline process. 
 
The pH, TC, TOC and COD, as well as chlorides in case of the medical materials composed by 
PVC, were determined in the solutions resultant from the treatments. All the experiments 
were repeated three times and the results showed in the tables are the mean values of the 3 
tests under the same conditions. 
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TC and TOC in solutions were determined with a Shimadzu TC analyser model TOC-VCSH, 
according to EN 1484 (1997). TC in the materials was determined with the same equipment 
using its solids module, according to EN 13137 (2001). Measurements of pH were made with a 
pH-meter model 632 of Metrohm. Chlorides were determined following 4500 B: Argentometric 
method. COD was determined following 5220 D: Closed reflux – colorimetric method; and 
BOD5 following 5210 B: 5-Day BOD method as described by the Standard Methods for 
Examination of Water and Wastewater (APHA, 1998). 
 
TG and DSC analyses 
 
TG and DSC analyses on the selected components were performed using two equipments 
(Setaram, model 92-16.18 and model Labsys, respectively). Samples with almost the same 
volume, ranging from 9 to 40 mg due to their different densities, were placed in a platinum 
crucible (TG), or aluminium crucible (DSC), heated at a rate of 10 °C/min up to 135 °C and held 
3600 s at that temperature; for syringes and surgical masks, composed by polyethylene (PE) 
and polypropylene (PP), the DSC analyses were prolonged by heating up to 200 °C at the same 
rate, in order to reach the end of melting peaks of both materials. 
Blank tests were carried out for both TG and DSC analyses with unloaded crucibles using the 
same conditions. Thermal analysis was carried out on original components samples, in those 
from autoclaving and in those from alkaline hydrolysis with 1 M NaOH solutions. All the TG 
analyses were carried out in triplicate. The profiles shown are a mean of the 3 values of WL at 
the same temperature, corrected with the values obtained in the blank test.  
 
Statistical analysis 
 
The effect of autoclave-like and alkaline hydrolysis treatments on the tested components, 
based on WL, CL, TOC and COD parameters, was assessed through PCA using the software 
package CANOCO, version 4.5.  
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4.3 RESULTS AND DISCUSSION  
 
4.3.1 HCW COMPONENTS TRANSFORMATIONS AND EFFLUENTS PRODUCED 
 
Table 4.2 reports the WL values of the tested components after alkaline hydrolysis and 
autoclaving treatments, computed as the percentage of their initial weight. The low-density 
polyethylene (LDPE) serum bottle and the high-density polyethylene (HDPE) plus PP syringe 
samples had the smallest WL values not only after autoclaving but also at all the three NaOH 
concentrations tested. These results demonstrate the excellent chemical resistance of such 
materials to alkalis (Ehrenstein, 2001). 
 
Table 4.2 – Weight losses (WL) in the samples of HCW components subjected to autoclaving 
and alkaline hydrolysis tests at 135 °C. 
Material WL, %
(1)
 
Autoclaving 0.1 M NaOH 1 M NaOH 2 M NaOH 
Serum bottle N.D. 0.05 ± 0.01 0.03 ± 0.00 0.01 ± 0.00 
Syringe N.D. 0.07 ± 0.00 0.10 ± 0.00 0.10 ± 0.00 
Transfusion tube 0.06 ± 0.01 0.60 ± 0.08 0.75 ± 0.18 1.12 ± 0.07 
Bag collector for urine 0.18 ± 0.04 0.48 ± 0.07 1.35 ± 0.10 4.85 ± 0.45 
Examination glove 1.41 ± 0.15 1.60 ± 0.08 5.73 ± 0.80 9.16 ± 1.20 
Surgical glove 2.33 ± 0.17 2.42 ± 0.08 2.90 ± 0.00 3.58 ± 0.41 
Cotton 1.59 ± 0.10 2.80 ± 0.29 5.36 ± 1.70 9.37 ± 0.96 
Surgical mask N.D. 1.82 ± 0.17 6.24 ± 0.84 8.14 ± 0.94 
Diaper 9.40 ± 0,82 11.90 ± 0.73 21.70 ± 1.33 32.10 ± 0.00 
Adhesive 0.28 ± 0.05 6.03 ± 0.60 45.87 ± 9.91 53.79 ± 8.50 
(1) Mean of three experiments ± SD; N.D. – Not detected. 
 
The surgical mask samples, composed of several materials (not exclusively PP), had non 
detectable WL under autoclaving but were degraded through alkaline hydrolysis. These 
treatments degraded the adhesives and diapers significantly, mainly when the 1 M and 2 M 
NaOH solutions were used. The WL obtained for diapers and adhesives with these two 
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solutions were above 20 %, being similar to or higher than the range of 20–35 % reported for 
autoclaving after HCW size reduction (Prüss et al., 1999). The assayed adhesive samples shrank 
drastically during the alkaline treatments, being kept agglomerated with part of its glue or any 
other binding agent. Most polyester present in composition was probably lost into the solution 
(Bendak, 1991).  
Table 4.3 reports the CL values of the tested components after both treatments, calculated as 
the percentage of their initial carbon content, shown in Table 4.1. The values of CL followed 
the trend seen for the WL values (Table 4.2) i. e., the highest and lowest CL were observed on 
the components that had the highest and the lowest WL, respectively. CL is a relevant part of 
the WL and contributed significantly to the high organic load of the effluents resultant from 
alkaline hydrolysis treatment, particularly for adhesives and diapers (Tables 4.4 and 4.5). 
 
Table 4.3 – Carbon losses (CL) in the samples of HCW components subjected to autoclaving 
and alkaline hydrolysis tests at 135 °C. 
Material CL, % 
Autoclaving 0.1 M NaOH 1 M NaOH 2 M NaOH 
Serum bottle 0.01 0.14 0.21 0.28 
Syringe 0.01 0.16 0.21 0.22 
Transfusion tube 0.04 1.05 1.07 1.13 
Bag collector for urine 0.11  0.93 2.52 3.31 
Examination glove 0.71 1.73 2.14 4.17 
Surgical glove 0.35  1.05 1.77 1.65 
Cotton 0.38  3.03 7.15 8.57 
Surgical mask 0.04  1.61 6.42 6.47 
Diaper 
(1)
 15.25 24.98 43.86 
Adhesive 0.09  5.15 49.27 59.79 
(1) CL was not determined because the diaper sample absorbed all the solution. 
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Table 4.4 – TOC, in mg C/L, and pH in the effluents resulting from autoclaving and alkaline 
hydrolysis of individual samples of HCW components. 
Material Autoclaving 0.1 M NaOH 1 M NaOH 2 M NaOH 
TOC pH TOC pH TOC pH TOC pH 
Serum bottle 6 5.5 [21 – 46]
(2)
 12.8 [37 – 52]
(2)
 13.4 [33 – 73]
(2)
 13.4 
Syringe 13 7.7 40 12.7 45 13.1 78 13.9 
Transfusion tube 23 7.6 124 12.7 339 13.3 473 13.7 
Bag collector for 
urine 
54 7.4 232 12.6 475 13.3 1517 13.8 
Examination glove 380 7.3 814 12.8 1061 13.4 2129 13.8 
Surgical glove 265 7.2 798 12.8 1071 13.4 [513 – 750]
(2)
 13.9 
Cotton 171 6.1 1051 12.7 2782 13.3 3649 13.8 
Surgical mask 37 6.0 1487 12.7 4940 13.4 5311 13.9 
Diaper 
(1)
 
(1)
 6381 12.6 7943 13.3 17325 13.7 
Adhesive 68 5.5 3895 12.1 38133 13.0 45951 13.8 
(1) Not determined because the diaper sample absorbed all the solution; (2)
 
Due to the variability of the 
results, values are presented as its range. 
 
As expected, all the effluents resultant from the alkaline hydrolysis assays showed high pH 
values, being approximately 12.7, 13.3 and 13.8 when 0.1 M, 1 M or 2 M NaOH were used, 
respectively. On the contrary, those from the autoclaving tests were close to neutrality. The 
alkaline effluents showed higher organic load than the autoclaved ones. In general, a positive 
correlation between the TOC and COD values and the NaOH concentration used was observed. 
TOC of the effluents resulting from the treatment of serum bottles and syringes were below 
100 mg C/L under all the conditions tested. This result is overall agreement with the small WL 
obtained for such components. On the contrary, the effluents resulting from the treatment of 
diapers and adhesives showed the highest TOC and COD, which is also in agreement with the 
WL verified in both treatments. Chloride concentrations in the effluents from treatments of 
components made with PVC (such as the transfusion tubes, the examination gloves and the 
urine bag collectors) were below 10 mg/L (limit of detection for the method of analysis used). 
This fact confirms that there was a very slight PVC decomposition under the studied 
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conditions. Therefore, chlorides will not become a problem in the treatment of the respective 
effluents when these technologies are to be applied to treat HCW. 
Table 4.5 – COD in the effluents from autoclaving and alkaline hydrolysis tests of samples of 
individual components. 
Material COD, mg O2/L 
Autoclaving 0.1 M NaOH 1 M NaOH 2 M NaOH 
Serum bottle 90 [101 – 151]
(2)
 [156 – 214]
(2)
 [154 – 480]
(2)
 
Syringe 109 146 207 247 
Transfusion tube 181 269 1242 1859 
Bag collector for urine 423 553 1210 2437 
Examination glove 563 3790 4909 11440 
Surgical glove 1956 3827 5383 7357 
Cotton 828 2943 8875 15107 
Surgical mask 235 2517 16778 21850 
Diaper 
(1)
 30646 34147 41971 
Adhesive  337 14192 88192 143756 
(1) Not determined because the diaper sample absorbed all the solution; (2)
 
Due to the variability of the 
results values are presented as its range. 
 
Table 4.6 shows TOC, COD and BOD5 values of the effluents resultant from the treatments of a 
mixture of samples of all components. The estimates of TOC and COD values were calculated 
as a linear combination of the average values of these parameters in the effluents from 
individual tests of samples of each component. They were a reasonable first approximation to 
the TOC and COD values for the effluents resultant from the alkaline hydrolysis of a mixture of 
these components. Using the COD and BOD5 values for calculating BOD5/COD ratio, one obtains 
0.44, 0.53 and 0.50, respectively, for the alkaline hydrolysis effluents and 0.35 for the 
autoclaving effluent. Thus, despite the fact that the effluents obtained from alkaline hydrolysis 
had a much higher organic load, they were more biodegradable than the ones from 
autoclaving. Since all ratio values are above 0.4, the alkaline effluents, after neutralization, 
could be accepted in a common domestic wastewater treatment plant. 
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Table 4.6 – TOC, as mg C/L, and COD and BOD5, as mg O2/L, in the effluents from autoclaving 
and alkaline hydrolysis tests of mixtures with samples of the components
(1)
. 
 Autoclaving 0.1 M NaOH 1 M NaOH 2 M NaOH 
TOC 464 ± 42 1692 ± 245 5286 ± 900 6504 ± 83 
TOCestimate 
(*)
 1487 ± 7 5687 ± 30 7019 ± 21 
COD 958 ± 53 5050 ± 900 12967 ± 1991 29779 ± 1212 
CODestimate 
(*)
 5725 ± 30 16074 ± 72 24682 ± 64 
BOD5 333 ± 32 2237 ± 366 6906 ± 1407 14875 ± 883 
(1) Mean of four tests ± SD; (*)
 
diaper effluent was all absorbed, thus there was no values for using in 
computation. 
 
4.3.2 TG AND DSC ANALYSES 
 
The changes in weight and heat flow detected in the blank tests of TG and DSC analyses were 
negligible. The WL values of the three TG replicate tests of a given component at a given 
temperature showed very low scatter with variation coefficients of less than 0.7 % in all 
temperatures ranges up to 135 °C, thus confirming the very good reliability of the analytical 
method.  
All the average TG profiles of healthcare components after being subjected to autoclaving and 
alkaline hydrolysis were not differentiable from the original ones, except in case of diapers and 
cotton. These cellulose-containing components before the treatments had WL values of 
approximately 5.7 % and 6.2 %, respectively. In case of cotton (Figure 4.2), most of the WL is 
due to water evaporation (Deng et al., 2008). The diaper decomposed more in the alkaline 
hydrolysis treatment than in the TG analysis; alkaline hydrolysis increased the decomposition 
of part of the materials from diapers, mostly sodium polyacrylate from flocgel, keeping a 
residual material stable at least up to 135 °C. 
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Figure 4.2 – TG profile of HCW components; (─) original; (---) hydrolysed; (∙∙∙∙) autoclaved.  
 
All the other components had higher WL after alkaline hydrolysis compared to the TG analysis, 
which means that they were chemically attacked and increasingly degraded by such solutions. 
Evaluated in the same way, autoclaving significantly affected the examination gloves and the 
surgical gloves, slightly affected the urine bag collectors and did not affect all the remaining 
sample components. Syringes, transfusion tubes, surgical masks and adhesives presented 
slightly less WL after autoclaving than in TG. As consequence, effluents resultant from 
treatment of examination gloves, surgical gloves and urine bag collector were those with the 
highest COD among all the effluents resulting from autoclaving, as shown in Table 4.5. The 
LDPE serum bottle and the HDPE plus PP syringe samples, both before and after the 
treatments showed negligible WL under the temperature cycle imposed, as shown in the 
Figure 4.2. This pattern is characteristic of medical components with very good chemical and 
thermal resistance in the range of conditions tested. 
The TG profiles of the PVC components before the treatments were close to those observed in 
a previous study where similar conditions were used (Deng et al., 2008). Although being based 
in the same material (PVC), the urine bag collectors and the examination gloves had different 
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TG profiles and WL values after the alkaline hydrolysis when compared to the transfusion 
tubes. This behaviour is surely due to differences in its composition, namely the additives.  
The surgical mask TG profiles showed the same trend of the other reasonably stable 
components with similar WL before and after the alkaline hydrolysis. TG analyses of adhesives 
and surgical gloves showed WL of the same magnitude, both for treated and untreated 
samples. Nevertheless, adhesives visibly decomposed more than surgical gloves when held at 
135 °C for 3600 s. This behaviour was also found in the untreated diaper samples as shown in 
Figure 4.2. This instability was increased by the alkaline hydrolysis. Consequently, the effluents 
resulting from the adhesive and diaper treatment were the most contaminated of all. 
The DSC profiles, in Figure 4.3, indicate that both autoclaving and 1 M NaOH alkaline hydrolysis 
caused sensible modifications in all the components. Except for serum bottles, the comparison 
of the profiles show that after the autoclaved and alkaline hydrolysis treatments the 
components required more specific energy for softening and melting than the untreated ones.  
This was most probably due to the release of the less stable constituents during the 
treatments and to the resultant hydration that increases the amount water to be removed 
during the thermal cycle.  
The profiles of the PVC components, i.e., transfusion tubes, urine bag collectors and 
examination gloves were similar. This is particularly true for the last two untreated 
components, which showed exothermic reactions above 105 °C whereas for transfusion tube 
was above 120 °C. In case of the untreated diapers, the exothermic reactions started near  
50 °C and held up to the end of the thermal cycle, indicating the continuous degradation of 
this component. After alkaline hydrolysis treatment, the diaper substances responsible for the 
exothermic reactions were apparently eliminated. 
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Figure 4.3 – DSC profile of HCW components, (─) original; (---) hydrolysed; (∙∙∙∙) autoclaved. The 
DSC profiles of untreated and hydrolysed bag collector for urine coincide with DSC profiles of 
examination glove. 
 
The same happened with the PVC components and the surgical glove. Syringe and surgical 
mask profiles show well defined patterns of endothermic transformations with two peaks and 
the serum bottle showed only one endothermic peak. No significant differences between the 
peak temperatures in the untreated and treated components occurred. Differences in the DSC 
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profiles of these three components are probably related to their composition. While syringe 
and surgical masks are multi-material components, serum bottles are composed by LDPE 
alone. 
 
4.3.3 PRINCIPAL COMPONENTS ANALYSIS 
 
Through multivariate analysis it was possible to conclude that the treatments promoted the 
degradation of all components, as measured by their WL and CL with consequent increase of 
the TOC and COD of their liquid effluents. The first two axes of the PCA, which could explain 
99.4 % of the variation found among the components after the treatments. All the parameters 
used to characterize the components showed high eigenvalues and significant correlation 
values with axis 1, contributing to separate the samples with the highest WL, CL, TOC and COD 
values, i.e., those of diapers and adhesives treated with 1 M and 2 M NaOH solutions, from the 
others which clustered in group A in Figure 4.4 (a). These results indicate that among all the 
components and treatments tested, diapers and adhesives were the most prone to alkaline 
hydrolysis, and that the degree of their degradation correlated with the NaOH concentration 
used. 
In an analysis excluding the diaper and adhesive samples, the 2 first orthogonal axes from PCA 
explained 97.9 % of total variance (Figure 4.4 (b)), and the samples clustered in 3 groups. 
Among this sub-set of components, samples of surgical masks after treatment with 1 M or 2 M 
NaOH, which had the highest WL and CL values and produced effluents with highest load of 
TOC and COD, clustered together. Among the remaining sub-set of components, also cotton 
treated with 1 M or 2 M NaOH and examination glove treated 2 M NaOH (group C) could be 
distinguished from the others (group B). These results indicate that after diapers and 
adhesives, surgical masks followed by cotton and examination gloves are the components 
more susceptible to alkaline hydrolysis, if NaOH concentrations higher than 1 M are used. 
CHAPTER 4 – EFFECTS OF ALKALINE HYDROLYSIS AND AUTOCLAVING ON DISCARDED MEDICAL COMPONENTS PRESENT IN HCW 
108 
 
 
 
In order to assess the effect of the tested treatments on the less degradable components, 
multivariate analyses including the data of individual components were performed. Despite 
the small variation on the values of the analysed parameters after the different treatments, 
the PCA biplots obtained, herein exemplified with syringe data (Figure 4.4 (c)), indicated that 
the degree of degradation depended on the NaOH concentration. Therefore, autoclaving was 
the less aggressive treatment while 2 M NaOH promoted the highest deterioration of each 
individual component. 
 
Figure 4.4 – Principal components analysis of the HCW treatments results and spatial 
distribution of the samples; arrows refer the parameters considered in the analysis (i.e., WL 
and CL of the sample and TOC and COD in the effluent produced): 3(a) – all the samples;  
3(b) – all the samples except diaper and adhesive; 3(c) – syringe samples. 
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4.4 CONCLUSIONS 
 
Common discarded medical components from healthcare waste subjected to autoclaving or 
alkaline hydrolysis degraded in a higher or lower degree according to the thermal resistance of 
the materials in their composition. Thus, components with LDPE, HDPE or PP, that are very 
stable up to 135 °C, showed good resistance to both treatments. 
The components tested lost up to 10 % of their weight, which means that the treatments were 
not efficient in reducing the mass of waste, except in the case of diapers and adhesives where 
the reduction is appreciable as shown by a 30 to 50 % mass loss with the 2 M NaOH solution. 
The composition of effluents resulting from the treatment depends on the degradation degree 
of the components and also on the solutions used. Those from alkaline treatment were 
hazardous due to their very high pH (> 12.5). On the contrary, the pH of effluents from 
autoclaving was close to neutrality or slightly acid. Alkaline effluents showed higher organic 
loads than those effluents obtained from autoclaving. Also, TOC and COD values increased as 
NaOH concentration increased in the solution used, reaching a COD of 42 and 144 g O2/L for 
the 2 M NaOH solutions in the case of diapers and adhesives, respectively. Although with very 
high organic loads, the effluents produced in alkaline hydrolysis of a mixture of all the 
components were biodegradable after neutralization. Therefore, these effluents might be 
acceptable in a domestic wastewater treatment plant.  
Autoclaving degraded components much less than alkaline hydrolysis. Therefore, the resulting 
effluents presented non-negligible organic loads, mainly from materials such as natural rubber, 
cellulose and polyvinyl chloride. Nevertheless, when treated under the same conditions, the 
effluents resulting from autoclaving were less biodegradable than those resulting from alkaline 
hydrolysis treatment, but showed values close to the limit of biodegradability. 
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CHAPTER 5 – APPLICABILITY OF ALKALINE HYDROLYSIS TO DESTROY 
ANIMAL TISSUES PRESENT IN HEALTHCARE WASTE 
 
This chapter is based on Pinho S. C.; Almeida M. F.; Nunes O. C. Applicability of alkaline  
hydrolysis to destroy organic components present in healthcare waste. 
in 2nd International Conference WASTES: Solutions, treatments and opportunities. 
 
 
ABSTRACT 
 
In this study, the minimum conditions of temperature and NaOH concentration for the total 
destruction of animal tissues were evaluated, using pork or beef as surrogates. The alkaline 
hydrolysis trials were performed with 1 M and 2 M NaOH solutions at different temperatures and 
different hydrolysis times.  
The pork and beef showed a similar behavior when subjected to alkaline hydrolysis. The destruction 
of meat was faster than the bone. The meat was totally hydrolyzed above 95 °C in less than 60 
minutes. The effluents obtained after alkaline treatment are hazardous due to their very high pH. 
Although with very high organic load, the effluents produced in alkaline hydrolysis were 
biodegradable after neutralization. Therefore, it may be acceptable to discharge the neutralized 
effluents in a domestic wastewater treatment plant. 
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5.1 INTRODUCTION  
 
One of fundamental policies for waste management is based on the waste quantities 
reduction. For this purpose the Best Environmental Practices (BEP) include source reduction, 
segregation, resource recovery and recycling. Likewise, the selection of the treatment system 
takes into account the waste characteristics, the volume and mass reduction obtained in the 
treatment, among many others (Chartier et al., 2014). Animal by-products is a type of waste 
that have been increasing over the last years due mainly to the increasing consumption of 
meat. Animal by-products are animal carcasses, parts of animals, or other materials which 
come from animals but are not meant for humans to eat. Of the 47 million tonnes of animals 
slaughtered for meat production in Europe every year, 17 million tonnes of by-products, such 
as minus hides, skins and bones for gelatin production are handled by the animal by-products 
industry. However, considerable numbers of carcasses are also left to rot or are illegally 
dumped (BREF, 2005). This illegal disposal poses a potential risk to the public health and to the 
environment. 
In 2002, with the appearance of BSE emerged restrictions that have led to an increased 
proportion of solid material being disposed of to landfill and by incineration. The limits placed 
on the traditional uses for animal by-products have led to further alternative uses and to new 
methods for disposal.  
Indeed, animal proteins have a very high biological value which opens wide possibilities for 
their use for generating of energy. Disposal by incineration and co-incineration is an 
advantageous energetic valorization process however, due to its high organic matter content, 
there is a great potential for anaerobic digestion. Nevertheless, this technology requires long 
process time and large facilities due to slow anaerobic processes involved (Ro et al., 2007). 
Therefore, the alkaline hydrolysis emerges as a waste treatment option, mainly because it is 
able to significantly reduce the volume of animal wastes and produces sterile by-products 
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(Tracker, 2004) which can be used for soil fertilization (Kalambura et al., 2011). The efficacy of 
alkaline hydrolysis on the destruction of tissue wastes, including anatomical parts, organs, 
placenta, blood, body fluids, specimens, human cadavers and animal carcasses has been 
proven in some studies (Tracker, 2004). However, conditions for destruction are reported to 
be 150 °C with a time of contact between three and eight hours. In this work it is intended to 
study the minimal conditions for destruction of animal tissues. The behavior of animal tissues, 
such as pork and beef, was studied when treated by alkaline hydrolysis. The efficiency of the 
treatment was assessed by determination of weight losses on the materials and 
characterization of TOC, COD and BOD5 in the effluents resulting from the alkaline hydrolysis 
treatment. 
 
5.2 MATERIALS AND METHODS 
 
The treatments were carried out in a Parr batch (Figure 5.1), described in Chapter 4, section 
4.2, with a heating rate of 10 °C/min. The samples were heated at 80 °C, 90 °C, 95 °C, 100 °C 
and 110 °C, during 30 to 240 minutes. A liquid/solid ratio of 5:1 (w/w) was used in all the tests. 
The tests were made using samples of 20 to 30 g of pork meat including bones (5:1 or 4:1 of 
meat/bone). The alkaline solutions used were 1 M and 2 M NaOH. The selection of these 
concentrations was based on the results described in Chapter 4. To compare the behavior of 
pork and beef, both containing bone, tests were performed at 90 °C using 1 M or 2M NaOH 
solutions over 150 minutes.  
To compare the hydrolysis efficiency of meat versus bone, pork meat or bone samples were 
hydrolized at 90 °C, with 1 M or 2 M NaOH at different times. 
After cool down to ambient temperature, the resulting solid product was filtered, washed with 
distilled water in order to remove all of the sodium hydroxide, after which it was dried at room 
temperature, further held for 48 hours in a desiccator and finally weighted. The pH, TOC, COD 
and BOD5 were determined in the solutions resultant from the treatments, according the 
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methods described in Chapter 4, section 4.2.2. Also, the main chemical compounds, in 
hydrolyzate at 110 °C and 1 M of NaOH solution, were analysed by gas chromatography with 
mass detector (GCMS) using an Agilent HP 6890/MSD 5793N from HP, 30 m × 0.25 mm I.D.,  
0.5 µm P/N 19091S-133 column; and using as carrier gas He at constant flux of 1.2 mL/min. 
Tests were carried out in the following conditions: split-less injector at 280 °C; oven 1 minute 
at 50 °C, followed by heating at 10 °C/min till 300 °C; transference line at 290 °C; and MSD scan 
mode. The separated compounds were identified using NIST 1998 library match. 
 
 
 
 
 
 
Figure 5.1 – Reactor and temperature control. 
Additionally, TG and DSC analyses were performed on the samples before and after alkaline 
hydrolysis with 1 M NaOH solution. The method used in TG and DSC analyses is described on 
Chapter 4, section 4.2.2. Briefly, samples of 40 mg were heated at a rate of 10 °C/min up to 
135 °C and held 3600 s at this temperature; after they were heated up to 200 °C at the same 
rate. 
 
5.3 RESULTS AND DISCUSSION 
 
For the temperature and NaOH concentrations used in this work, it was verified that with 
temperature raise, the time required to hydrolyze pork and beef decreased. At 100 °C and 1 M 
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NaOH, 45 min was sufficient to destroy all the sample, however at 80 °C, 240 min was 
necessary. Accordingly, the percentage of solid residue decreased with the increase of the 
temperature (Table 5.1). 
The increase of NaOH concentration, under specific conditions, namely at 90 °C and 95 °C for 1 
M and 2 M NaOH, does not seem to influence the hydrolysis time. Indeed, small differences 
were found in all the analyzed parameters for tests carried out at 1 M and 2 M NaOH. 
Nevertheless, differences in TOC, COD and BOD5 were observed, which may be due to 
variation on the proportion of meat and bone in each tested sample. 
In the most aggressive conditions, temperature and NaOH concentration, the proteins were 
hydrolyzed and esterified as showed in chromatography analysis of hydrolyzate of 110 °C and  
1 M NaOH solution. The molecular ions more frequently detected and with higher relative 
abundance had molecular mass of 28, 44, 72, 86 and 117. The main chemical structures 
identified include alkyl group and chains, amides and esters. NIST 1998 data base proposes the 
presence of propanamide, 4-methyl phenol, 4-methyl pentanamide, ethyl ester L-Isoleucine, 
indole, and triethyl phosphate.  
 
Table 5.1 – Alkaline hydrolysis conditions of samples composed by pork meat including bones 
versus hydrolysis time, residue amount, TOC, COD and BOD5 of the effluent produced.  
Experimental 
conditions 
Time 
(min) 
Residue 
(w/w %) 
Effluent 
TOC (g/kg) COD (g/kg) BOD5 (g/kg) 
80 °C, 1 M NaOH 240 25.0 97.5 n.d. n.d. 
90 °C, 1 M NaOH 90 12.3 101.0 345.8 316.6 
90 °C, 2 M NaOH 90 17.5 100.0 307.0 220.8 
95 °C, 1 M NaOH 50 15.0 122.5 360.2 319.2 
95 °C, 2 M NaOH 50 4.9 101.6 312.0 271.2 
100 °C, 1 M NaOH 45 3.2 110.6 351.5 302.2 
100 °C, 2 M NaOH 40 3.6 83.0 287.4 204.7 
110 °C, 1 M 35 3.8 115.7 356.9 260.9 
110 °C, 2 M 35 3.1 116.1 345.6 230.3 
     n.d.- not determined 
CHAPTER 5 – APPLICABILITY OF ALKALINE HYDROLYSIS TO DESTROY ANIMAL TISSUES PRESENT IN HCW 
 
118 
 
 
 
 
When bovine and pork were compared, both containing meat and bone, it was observed small 
differences only for short times of contact (up to 60 min). For higher times of hydrolysis, the 
TOC values obtained for both type of samples were similar, independently of the NaOH 
concentration (1 M or 2 M) as shown in Figure 5.2.  
 
 
 
 
 
 
Figure 5.2 – Alkaline hydrolysis of pork ((□) 1 M NaOH; (■) 2 M NaOH) and bovine ((○) 1 M (●); 
2 M NaOH) meat at 90 °C over time. 
 
When meat and bone were hydrolyzed separately at 90 °C, it was observed that meat requires 
less time of contact than bone, as expected due to their composition. The meat is composed 
mainly by water followed by proteins and lipids, which are easily hydrolyzed. The bone is 
composed predominantly by mineral component (carbonated hydroxyapatite), organic 
component (mainly type I collagen, 22 % by weight and 36 % by volume) and water (Collins et 
al., 2002; Figueiredo et al., 2012). 
For the same temperature and NaOH concentration, higher TOC values and lower solid residue 
values increased with time of hydrolysis, i.e., the treatment efficiency increased for both type 
of samples (Table 5.2). As expected, for the same time of contact and temperature, treatment 
with 2 M NaOH showed a better efficiency, for both type of samples (Table 5.2).  
0
20
40
60
80
100
120
0 20 40 60 80 100 120 140 160
T
O
C
 i
n
 h
y
d
ro
ly
za
te
 (
g/
kg
)
Time (min)
CHAPTER 5 – APPLICABILITY OF ALKALINE HYDROLYSIS TO DESTROY ANIMAL TISSUES PRESENT IN HCW 
 
119 
 
 
 
Even with under the harsher conditions tested (90 °C, 2 M NaOH and 60 minutes), it was not 
possible to completely destroy the bone samples, since solid residues constituted 20 % of the 
initial weight. This resultant solid residue could be crushed with reduced pressure to a powder 
sized fragments, probably because hydrolysis promotes the digestion of the structural 
collagen, which is needed to strengthen the bone structure (Collins et al., 2002) but not the 
mineral fraction, mainly constituted by calcium phosphate (Kaye et al., 1998) (Fig.5.3). In 
contrast, 90 °C, 1 M NaOH and 45 minutes were sufficient to achieve complete meat hydrolysis 
as shown in Table 5.2.  
 
 
 
 
 
Figure 5.3 – Hydrolyzed bone and hydrolyzate. 
 
Table 5.2 – Alkaline hydrolysis conditions versus hydrolysis time and residue amount of the 
meat and bone. 
Experimental 
conditions 
Time  
(min) 
Residue 
(%) 
TOC (in hydrolyzate)  
(g/kg) 
Meat 90 °C, 1 M NaOH 30 
60 
6.7 
0.0 
90.2 
94.0 
90 °C, 2 M NaOH 30 
45 
1.0 
0.0 
89.1 
92.0 
Bone  90 °C, 1 M NaOH 30 
45 
60 
66.5 
38.2 
18.2 
77.9 
85.6 
104.4 
90 °C, 2 M NaOH 30 
45 
52.7 
23.4 
90.0 
92.0 
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The analysis of the TG profiles of bone showed that the highest weight loss occurred during 
the first heating step, up to 135 °C (Figure 5.4). Untreated bone showed a weight loss of 5 % 
due, essentially, to water loss. In opposition, TG profiles of hydrolyzed bone at 80 °C, 90 °C and 
100 °C with 1 M NaOH showed weight losses of 10 %. Most probably, these weight losses were 
due to the increased amount of water absorbed by the matrix during the treatment. The fact 
that hydrolyzed bone showed similar TG profiles independently of the temperature, suggest 
that this parameter does not seem to influence the hydrolysis of the bone inorganic matrix.  
Similar conclusions were obtained through the analysis of the DSC profiles. These profiles 
showed an endothermic peak corresponding to the evaporation of water for both untreated 
and hydrolyzed bone, which occurred at a lower temperature for the hydrolyzed ones. 
 
The TG analysis of untreated meat showed a high weight loss of 74 % due essentially due to 
water evaporation, the main component of meat (data not shown). As expected, it was not 
possible to obtain TG profiles of treated meat, since no residues were obtained. 
 
 
 
 
 
 
 
 
 
Figure 5.4 – TG (a) and DSC (b) profiles of bone; (─) untreated; (─∙∙─) alkaline treated at 100 °C  
(---) alkaline treated at 90 °C; (∙∙∙∙) alkaline treated at 80 °C.  
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The effluents obtained from alkaline hydrolysis of animal tissues showed a brownish color and 
gelatinous, suggesting that the collagen was solubilized (Collins et al., 2002). The effluents 
showed also a higher value of TOC, COD and BOD5 with average values of about 20 000 mg/L, 
70 000 mg/L and 50 000 mg/L, respectively. Although with very high pH, approximately 13, and 
organic load, the effluents produced in alkaline hydrolysis are, presumably, biodegradable, 
since a BOD5/COD ratio above 0.70 was obtained after neutralization. Therefore, these 
effluents might be discharged and treated in a wastewater treatment plant. 
 
5.4  CONCLUSIONS 
 
Higher NaOH concentration and longer times of contact favored the hydrolysis of animal 
tissues. When tested separately, the meat was hydrolyzed faster than the bone when 
subjected at same treatment conditions. Meat hydrolysis was complete while bone generated 
a solid residue, which was easily crushed into a powder. Temperature at which hydrolysis was 
carried out influenced considerably the time required to destroy animal tissues as well as the 
solid residue obtained. 
Effluents resultant from alkaline hydrolysis of animal tissues, although with very high pH and 
organic load, were, presumably, biodegradable after neutralization.  
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CHAPTER 6 – INACTIVATION OF Geobacillus stearothermophilus SPORES 
BY ALKALINE TREATMENT  
 
This chapter is based on Pinho S. C., Nunes O. C., Lobo-da-Cunha A., Almeida M. F. 
Inactivation of Geobacillus stearothermophilus spores by alkaline treatment.  
Submitted for publication at Journal of Hospital Infection. 
 
 
ABSTRACT 
This study reports alkaline treatment as an alternative disinfection/sterilization method for 
healthcare waste. The effects of this treatment on the resistance of Geobacillus stearothermophilus 
spores were investigated and the influence of temperature and NaOH concentration was evaluated.  
The alkaline conditions were performed using 0.1 M, 0.25 M, 0.5 M, 0.75 M or 1 M NaOH at 80 °C, 
100 °C and 110 °C. In addition, spore inactivation in the presence of animal tissues and discarded 
medical components, used as surrogate of healthcare waste, was also assessed. The effectiveness of 
the alkaline treatment was carried out by determination of survival curves and D–values.  
No significant differences were seen between D–values obtained at 80 °C and 100 °C. The D–values 
obtained at 110 °C (2.3 – 0.5 min) were approximately 3 times lower than those at 100 °C  
(8.8 – 1.6 min). The alkaline treatment may be used in future as a disinfection or sterilization 
alternative method for contaminated waste. 
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6.1  INTRODUCTION  
 
A large number of methods are available to inactivate microorganisms. Most of them use the 
same fundamental principle of heat, chemicals, irradiation or combinations of these. Several 
methods are currently used for the sterilization, defined as a process that destroys all forms of 
life including dormant. These methods include plasma, vapour-phase hydrogen peroxide, 
ozone, chloride dioxide, autoclaving, ethylene oxide and radiation. The selection of the 
method depends on the type of material being treated as well as the intended purpose. For 
instance, the last three methods are the most widely used for the sterilization of medical 
instruments. Each of these methods has advantages and disadvantages. Autoclaving is usually 
employed to kill bacteria, viable spores including endospores and virus in heat resistant 
materials. At 121 °C or higher, sterilization is achieved. When temperature below 121 °C is 
used a disinfection process occurs, which may kill vegetative forms of microorganisms, such as 
pathogens or other harmful organisms but do not inactivate bacterial endospores (Russell, 
2001). 
Autoclaving is extremely time-consuming and is not adequate to treat heat sensitive materials. 
Exposure to ethylene oxide is highly efficient due to its penetrative properties. Therefore, it is 
considered one of the most suitable sterilization processes for thermo sensitive materials. 
However, ethylene oxide is extremely toxic and presents risks associated with handling a 
flammable (Mendes et al., 2007). Radiation by gamma rays or electron beam are also very 
effective sterilization methods, but can affect product integrity and can degrade polymers and 
rubbers. Additionally, their utilization requires high capital investment (Haji-Saeid et al., 2007). 
Plasma technology has been studied as an alternative to conventional sterilization methods 
(Kylián et al., 2006; Yardimci and Setlow, 2010). This method has some advantages over 
others, such as low energy consumption, absence of residuals and toxic emissions, safety and 
low capital and operational costs (Yardimci and Setlow, 2010). Nevertheless, it has a particular 
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limitation, namely its incompatibility with some polymeric materials (Lerouge et al., 2002). 
Sterilization processes are not only necessary for high added-value materials. Indeed, tonnes 
of HCW are produced per year (Lee and Huffman, 1996; Diaz et al., 2008) and must be treated 
to eliminate the infectious potential prior to disposal. Autoclaving and incineration are the 
main processes used for treating HCW (Lee and Huffman 1996, Sukandar et al., 2006). 
However, these processes demand high investment and exploration costs and it is not 
appropriate to treat small quantities of HCW. In this context, it is essential to develop effective 
low cost alternative sterilization processes.  
Various microorganisms, including pathogens, produce dormant forms, which permit their 
survival under stress conditions, such as high temperature, irradiation or chemical damage. 
Amongst these structures, the endospores, herein further designated as spores, produced by 
some low G+C Gram-positive bacteria, are the most resistant to harsh conditions. Several 
spore traits have been described to be involved on resistance against physical and chemical 
antimicrobial agents. The low water content in the spore core seems to be the most important 
factor of a spore wet heat resistance. Indeed, the wet heat resistance correlates negatively 
with the core water content (Setlow, 2006). The high core mineralization also confers wet heat 
resistance; ions such as Ca2+ ensure a higher wet heat protection than Mg2+, Mn2+, Na+ and K+. 
Another essential factor to the spore resistance is the high quantity of small acid-soluble spore 
proteins (SASPs) that protect the spore DNA by its saturation with α/β–type SASP and DNA 
repair systems (Setlow, 2006; Leggett et al., 2012).  
Geobacillus stearothermophilus comprise low G+C Gram-positive, thermophilic non-
pathogenic organisms, and their spores are one of the most heat and chemical agents 
resistant. Indeed, the low water content in the core and the intrinsic thermostability of 
proteins confers to spores of thermophilic species a higher resistant to wet heat than to those 
of mesophiles (Guizelini et al., 2012). Therefore, the spores of this organism are often used as 
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a biological indicator to assess the effectiveness of sterilization methods (López et al., 1997; 
Watanabe et al., 2003; Wood et al., 2010). 
This study reports the alkaline treatment as disinfection and sterilization alternative methods 
for waste contaminated with infectious agents. The successful inactivation of a Creutzfeldt–
Jajob disease (CDJ) agent by a sequential process involving exposure to 1 M NaOH, followed 
autoclaving at 121 °C for 30 min (Taguchi et al., 1991), the inactivation of 22A strain of scrapie 
agent by autoclaving at 121 °C for 30 min in the presence of 2 M NaOH (Taylor et al., 1997) and 
the inactivation of prions by 0.1 M NaOH after pre-treatment with detergent (Bauman et al., 
2006) has been proven. More recently, the prion decontamination using 0.15 M NaOH at 25 °C 
for 1 h was shown to be partly effective with a prion reduction of 4 log10 (McDonnell at al., 
2013). 
In the present study the effect of alkaline treatment on the degree of G. stearothermophilus 
spores inactivation, in terms of decimal reduction times (D–value), at three temperatures  
(80 °C, 100 °C and 110 °C) and different sodium hydroxide concentrations was assessed. In 
addition, dipicolinic acid (DPA) released from endospores after the alkaline treatment was 
detected by the terbium dipicolinate fluorescence method. 
 
6.2  MATERIALS AND METHODS 
 
6.2.1 PREPARATION OF Geobacillus stearothermophilus  SPORES  
 
Strain G. stearothermophilus 22T was obtained from the German Collection of Microorganisms 
and Cell Cultures (DSMZ). G. stearothermophilus was grown in Nutrient Agar (Liofilchem) at  
55 °C for 4 days. After incubation, the biomass was scraped from the agar surface and washed 
with sterile distilled water. The resulting suspension was incubated at 80 °C for 15 min. After 
cooling down, the suspension was centrifuged at 1000×g for 30 min at 5 °C. The supernatant 
was decanted, and the biomass was washed in chilled sterile distilled water and re-
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centrifuged. This step was repeated twice. After re-suspension in water, the suspension was 
incubated at 37 °C for 60 min in the presence of lysozyme (100 µg/mL) for peptidoglycan 
breakdown. After washing with sterile distilled water for three times, and centrifugation at 
1000×g for 20 min at 5 °C, the suspension was incubated with sodium dodecyl sulphate (SDS) 
at 2.5 % and incubated at 60 °C for 15 min, to increase the membrane fragmentation. After, 
the spores were washed with sterile distilled water for three times. Confirmation of the 
integrity of cells and spores after each step was carried out through transmission electron 
microscopy analysis (Figure 6.1A). The final suspension of spores was serially diluted with 
sterile distilled water to obtain approximately 107 colony-forming units per ml (CFU/mL) and 
stored at 4 °C. 
 
6.2.2 ALKALINE TREATMENT 
 
The experiments were carried out in a Parr batch reactor with a titanium vessel of 450 mL 
capacity under temperature control and with pressure reading. Five milliliters of spore 
suspension at 107 CFU/mL was mixed with 45 mL of NaOH solution at different concentrations 
(0.1 M, 0.25 M, 0.5 M, 0.75 M or 1 M). The batch reactor was heated at temperatures of 80 °C, 
100 °C or 110 °C with heating rates of 5 °C/min. When the temperature stabilized, samples of 
1.5 to 2 mL were taken, at regular time intervals up to 30 min. A control was made by heating 
the spore suspension at 100 °C without NaOH.  
To evaluate the behaviour of spores in the presence of materials usually present in HCW, 
experiments with animal tissues (pork meat and pork bone) and a mix of discarded medical 
components (cotton, diapers, tubes for transfusion, surgical gloves, examination gloves, 
adhesives, surgical masks, bag collectors for urine, serum bottles and syringes) were 
performed. Except for cotton, the discarded medical components were cut in fragments of 
approximately 1 cm2 and all the assays were carried out using samples with 1 g of each 
CHAPTER 6 – INACTIVATION OF Geobacillus stearothermophilus SPORES BY ALKALINE TREATMENT 
 
128 
 
 
 
component. The experiments performed with those components were carried out at the same 
conditions that performed in their absence. Approximately 10 g of material (animal tissues or 
discarded medical components) was added to the spore suspension (107 CFU/mL) with 50 mL 
of 0.5 M NaOH solution. All experiments were carried out in triplicate. 
 
6.2.3 INCUBATION AND SURVIVAL COUNTS 
 
The number of surviving spores was determined by the viable plate count method. Samples of 
heated spore suspensions (1.5 – 2 mL) were cooled in ice-water and neutralized with an HCl 
solution to pH 7. Samples were serially diluted in saline solution (0.85 % NaCl, w:v) and 0.1 mL 
were spread on triplicate nutrient agar plates and incubated at 55 °C for 24 h, 48 h, 72 h, 96 h 
and 120 h. It was verified an increase in the cell counts over time, stabilizing the cell growth at 
96 h. Thus, the D–values were calculated using data obtained after 96 h of incubation. A 
positive control consisting on the enumeration of the total cell counts (CFU/mL) of the spore 
suspension used in each assay was performed in parallel.  
 
6.2.4 FLUORIMETRIC DETECTION OF DPA 
 
The DPA released by a 106 CFU/mL spore suspension after autoclaving at 121 °C for 30 min and 
after the hydrolysis at 110 °C, with 1 M NaOH was determined through a fluorimetric method, 
as previously described (Navarro et al., 2008; Rosen et al., 1997). Briefly, a 1 000 µL aliquot of 
suspension was added into 1 cm quartz cuvette with 40 µL of 10 nM TbCl3 and 800 µL water 
distilled. The photoluminescence was measured at 270 nm excitation and 546 nm emission 
wavelengths in a spectrofluorometer. A calibration curve was prepared with DPA  
(2,6 pyridinedicarboxylic by Sigma-Aldrich) concentrations ranging from 0 up to 10 nM. As 
control, a standard DPA solution at 10 nM was quantified after the aforementioned 
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autoclaving and alkaline treatments. Five independent replicates were carried out for each 
condition. 
 
6.2.5 TRANSMISSION ELECTRON MICROSCOPY 
 
Bacterial and spore suspensions were fixed for 4 h with 2.5 % glutaraldehyde and 4 % 
formaldehyde (obtained from hydrolysis of paraformaldehyde) diluted in 0.1 M cacodylate 
buffer (pH 7.2), post-fixed overnight with 2 % OsO4 in cacodylate buffer, stained in bloc with  
1 % uranyl acetate, dehydrated with ethanol and embedded in Epon. Ultrathin sections were 
stained with uranyl acetate and lead citrate before being observed in a JEOL 100CXII 
transmission electron microscope. 
 
6.3  RESULTS AND DISCUSSION  
 
Preliminary assays with vegetative cells of G. stearothermophilus demonstrated that they were 
very sensitive to alkaline solutions, since 0.1 M NaOH at 100 °C killed 99.9999% of the initial 
106 cells/mL after 30 min of contact (data not shown). On the other hand, under the same 
conditions, only 99.9 % of the G. stearothermophilus spores were inactivated. In opposition, 
the spores were not inactivated at 100 °C in the absence of NaOH (Figure 6.2). Spore 
morphology was not affected by treatment with lysozyme (Figure 6.1B) or SDS (Figure 6.1C).  
The survival curves, obtained when the G. stearothermophilus spores were exposed to alkaline 
conditions, exhibited biphasic curves with a slope tailing, as shown in the Figure 6.2 and Figure 
6.3. There are several models that describe the inactivation of microorganisms (Chick, 1908; 
Kamau et al., 1990; Cole et al., 1993). Cerf (1977) proposed a model for populations 
constituted by two-fraction with a constant inactivation rate for each fraction. In this model it 
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is assumed that inactivation of both fractions is independent and irreversible, each following 
first order kinetics:  
 
 
 
where N(t)/No is the proportion of surviving spores, t is the exposition time (min), k1 and k2 
(k1>k2≥0) are the death rate constants for first fraction and second fraction, respectively, f and 
(1-f) are the initial proportion in first fraction and second fraction, respectively, and e is the 
Naperian base. The first and second fractions describe the death of the less and the more 
resistant spores, respectively (Xiong et al., 1999). 
 
 
Figure 6.1 – TEM images of Geobacillus stearothermophilus. Vegetative cells suspension (A), 
spores suspension after addition of lysozyme (B), after addition of SDS (C) and spore debris 
after alkaline treatment (D). sc, spore coat; co, cortex; cr, core. 
 
Given the biphasic behaviour of the survival curves of the G. stearothermophilus spores, the  
D–values, at specified conditions, were determined by estimating the parameter values of the 
Cerf`s model. Table 6.1 reports the D–values, 6 log10, f, k1, and k2.  
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The differences between the D–values at 80 °C and 100 °C were not significant for NaOH 
concentrations of 0.5 M and 0.75 M; the 6 log10 reduction times also were similar. Given that 
both incubation at 80 °C and 100 °C are currently used to isolate spores of low G+C content 
Gram positive bacteria (Gerhardt, 1994), at these two temperatures spore inactivation was 
solely due to the presence of the alkaline solution. Indeed, no spore inactivation was observed 
in the controls performed at 100 °C in the absence of NaOH, as shown in Figure 6.2. At 100 °C, 
6 log10 reductions varied between 66.1 and 19.7 min in the presence of 0.1 and 0.75 M NaOH, 
respectively (Table 6.1).  
As expected, for each temperature tested, the calculated D–values decreased with the 
increase of the NaOH concentration. At 100 °C, the lowest D–value (0.9 min), obtained with 
0.75 M, was about ten times lower than that obtained with 0.1 M NaOH (8.8 min).  
 
Table 6.1 – Decimal time reduction (D–value), 6 log10, estimates of the model parameters and 
standard derivation values for the Cerf model. Data presented are the mean of three 
independent experiences with standard deviation. 
Conditions D–value
 
(min) 
6 log10
 
(min) 
f k1 (min
-1
) k2 (min
-1
) 
80 °C, 0.5 M 1.9 ± 0.2 28.4± 2.7 0.9919±0.0219 1.2168±0.0777 0.3176±0.1179 
80 °C, 0.75 M 1.0 ± 0.0 20.2±0.0 0.9993±0.0000 2.3189±0.2117 0.3909±0.0280 
100 °C, 0.1 M 8.8 ± 0.8 66.1± 1.5 0.4144±0.0866 3.0538±0.0000 0.2010±0.0029 
100 °C, 0.25 M 2.5 ± 0.2 29.8± 3.6 0.7170±0.0577 5.9338±0.1111 0.4218±0.0531 
100 °C, 0.5 M 1.6 ± 0.2 24.3±.3.2 0.9967±0.0026 1.5322±0.2923 0.3296±0.1792 
100 °C, 0.75 M 0.9 ± 0.0 19.7± 1.1 0.9977±0.0008 2.4692±0.0604 0.3940±0.0343 
100 °C, 1 M 0.8 ± 0.0 10.8± 0.1 0.9691±0.0369 3.1831±0.1160 0.9500±0.0168 
110 °C, 0.1 M 2.3 ± 0.1 40.8± 6.0 0.9990±0.0029 1.0075±0.0752 0.0872±0.0806 
110 °C, 0.25 M 1.8 ± 0.3 29.0± 2.2 0.9993±0.0005 1.1392±0.0287 0.2148±0.0197 
110 °C, 0.5 M 0.5 ± 0.0 24.0± 0.1 0.9998±0.0004 5.2480±0.1350 0.2274±0.0523 
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On the other hand, for each NaOH concentration tested, the calculated D–values decreased 
with the increase of temperature. For NaOH concentrations of 0.1 M, 0.25 M and 0.5 M, the 
D–values obtained at 110 °C (2.3 – 0.5 min) were approximately 3 times lower than those at  
100 °C (8.8 – 1.6 min). The combined effect of high temperature (110 °C) and NaOH (1 M) led 
to the complete inactivation of spores (6 log10 reduction) after 5 min.  
 
 
 
 
 
 
Figure 6.2 – Survival curves for the Geobacillus stearothermophilus exposed to alkaline 
treatment at 100 °C with various NaOH concentrations; 0 M NaOH (□); 0.1 M NaOH (■);  
0.25 M NaOH (∆); 0.5 M NaOH (●); 0.75 M NaOH (○); 1 M NaOH (▲) and predicted by the Cerf 
model (―). Vertical bars represent standard deviations of the means. 
 
To confirm spores inactivation, DPA released after alkaline treatment (110 °C, 1 M  NaOH, 30 
min) was quantified, and compared to that released after autoclaving (121 °C, 30 min). The 
concentration of DPA after autoclaving (1.8 nM) was approximately 3.5 times higher than that 
quantified after the alkaline treatment (0.5 nM) (Table 6.2). Given this unexpected result, the 
effect of temperature and NaOH on the DPA determination was carried out, using a 10 nM 
standard solution of this compound. It was verified that the presence of NaOH interfere with 
the DPA quantification, since after the alkaline treatment the concentration of this organic acid 
was about 3 times lower than that after heating at 110 °C for 30 min (Table 6.2). Confirmation 
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of spores destruction after the alkaline treatment was given by TEM analysis. No spores were 
observed after the alkaline treatment (Figure 6.1D). 
 
Table 6.2 – Concentration of 10 nM standard DPA, and DPA released from endospores after 
autoclaving and alkaline treatment. 
Conditions DPA released 
(nM) 
DPA standard (110 °C, 30 min) 9.8±0.0 
DPA standard (110 °C, 1 M NaOH, 30 min) 3.3±0.2 
Autoclaving (121 °C, 30 min) 1.8±0.1 
Alkaline treatment (110 °C, 1 M NaOH, 30 min) 0.5±0.1 
 
 
Given the importance of medical waste sterilization, the behaviour of spores in the presence of 
components usually present in medical waste was assessed at 110 °C and 0.5 M NaOH. In first 
minutes (1 – 2 min), the rate of spores inactivation in the presence of discarded medical 
components and animal tissues was similar to that in the absence of materials, as shown in the 
Figure 6.3. However, after that period, there was a greater heat and alkaline resistance of 
those spores comparably to the ones solely in NaOH solution. Such differences can be 
explained by diffusion mechanism that occurred with sodium hydroxide and materials. In 
addition, NaOH consumption in hydrolysis of the materials occurred. Indeed, under the 
conditions tested, the animal tissues were almost destroyed. Nevertheless, the time required 
for the complete inactivation of spores in the presence of discarded medical components and 
animal tissues (6 log10 of 25 min and 26 min, respectively) was not much longer than that 
needed in their absence (6 log10 of 24 min). 
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Figure 6.3 – Survival curves for the Geobacillus stearothermophilus exposed to alkaline 
treatment at 110 °C with various NaOH concentrations; 0.1 M NaOH (■); 0.25 M NaOH (∆);  
0.5 M NaOH (●); and predicted data by the Cerf model in the absence of components (―); 
discarded medical components (‒‒‒) and animal tissues (---). Vertical bars represent standard 
deviations of the means.  
 
The survival curves of G. stearothermophilus spores after being subjected to alkaline treatment 
are typical of a mixture of two fractions or sub-populations with different resistance to 
stressful conditions, such as heat (Abraham et al., 1990). This difference in heat resistance has 
been attributed to different physiological states in the spore population (Iciek et al., 2006). A 
dormant spore transits to a vegetative cell by activation, germination and outgrowth. The 
activation is a reversible process; only when the germination phase starts the spore can no 
longer return to its dormant state (Leggett et al., 2012). Hence, spore suspensions may contain 
sub-populations of activated and dormant ones. Spores in the activated state are described as 
more sensitive to stressful conditions than in the dormant state. Thus, in the present study the 
spores were inactivated in two stages: the first corresponds, most probably, to the inactivation 
of the less resistant spores and the second of the more resistant ones. 
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The decline observed at 110 °C in spore heat resistance can be explained by an increase in the 
core water content. Although the mechanism of spore inactivation by wet heat is not entirely 
clear yet, it is partially due to the rupture of the spore inner membrane permeability barrier, 
which causes an increase in the core water content (Setlow, 2006). The spores inactivation by 
alkaline treatment seems to involve the removal of alkali-soluble coat proteins with 
consequent inactivation of the lytic enzymes essential for cortex hydrolysis and spore 
germination (Duncan et al., 1972). Treatment efficiency was proved by the release of DPA to 
the suspension after the alkaline treatment and TEM observations. 
It has been previously reported that inactivation of G. stearothermophilus at low temperatures 
(< 100 °C) can be achieved using chemicals agents (Mazzola el al., 2003; Rogers et al., 2007; 
Unger-Bimczok et al., 2008), high–pressure carbon dioxide (Watanabe el al., 2003) and 
supercritical carbon dioxide with added hydrogen peroxide (Hemmer et al., 2006) but the time 
required to inactivate spores is high. As shown in Table 6.3, the D–values found in literature for 
inactivation assays carried out at temperature ≤100 ºC were higher than those obtained in this 
work, except when using high pressure treatments. The D–values herein obtained at 100 °C 
were even lower than those found in studies using thermal inactivation at temperatures above 
100 °C. Except in the experiments carried out with 0.1 M NaOH, the highest D–value obtained 
was 2.3 min (Table 6.1), In contrast, at 120 °C, López et al. (1997) reported D–values ranging 
from 1.32 to 2.84 min and at 121 °C, Feeherry et al. (1987) and Guizelini et al. (2012) reported 
D–values from 1.3 to 5.4 min. Nevertheless, the time required to complete inactivation of G. 
stearothermophilus spores in the present study was probably, different from those obtained in 
abovementioned studies. Indeed, at 121 °C the thermal inactivation of spores generally follows 
a first order linear kinetics while under alkaline treatment, as described above, inactivation 
curves were non-linear. 
 
CHAPTER 6 – INACTIVATION OF Geobacillus stearothermophilus SPORES BY ALKALINE TREATMENT 
 
136 
 
 
 
Table 6.3 – Decimal time reduction (D–value) described in literature for G.stearothermophilus 
spores under different treatments. 
Treatments D–value(min) Reference 
Rapid decompression  
200 MPa, 95 °C 
200 MPa , 85 °C 
 
6 
11 
Hayakawa et al. (1998) 
High – Pressure Carbon Dioxide  
30 MPa, 95 °C 
30 MPa, 85 °C 
30 MPa, 75 °C 
 
29.9 
130 
179 
Watanabe el al. (2003) 
High – Pressure 
700 MPa, 100 °C 
500 MPa, 100 °C 
700 MPa, 92 °C 
500 MPa, 92 °C 
 
0.29 
1.3 
0.49 
1.81 
             Patazca et al. (2006) 
Chemical agents (25 °C) 
Sodium hypochlorite, 0.05% 
Sodium hypochlorite, 0.1% 
Glutaraldehyde, 2.0% 
Formaldehyde, 0.5% 
Chlorhexidine, 2.0% 
 
9.4 
3.5 
25 
10.9 
9.1 
Mazzola et al. (2003) 
 
6.4 CONCLUSIONS 
 
Given the low temperature values needed to achieve sterilization, the results herein obtained 
suggest that alkaline treatment may be implemented in the future as a disinfection or 
sterilization alternative method for contaminated HCW. The time required for total 
inactivation of spores in the presence of the tested animal tissues and discarded medical 
components, identical to those commonly found in HCW, was similar to that obtained in their 
absence.  
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The major disadvantage of this treatment is the production of an effluent with high alkalinity, 
which adds to the process one additional neutralization step before discharge. Nevertheless, 
the low cost of alkali and acid solutions when compared with the energy required to achieve 
sterilization when wet heat is the only antimicrobial agent, may be a stimulus for the 
implementation of this kind of waste treatment in future.  
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CHAPTER 7 – CHARACTERIZATION OF EFFLUENTS RESULTANT FROM 
ALKALINE HYDROLYSIS TREATMENT 
 
 
ABSTRACT 
This work aims to characterize the effluents from alkaline hydrolysis tests with samples of 
components usually present in healthcare waste, such as cotton, diapers, transfusion tubes, surgical 
gloves, examination gloves, adhesives, surgical masks, urine bag collectors, serum bottles and 
syringes, animal tissues when subjected to a temperature of  110 °C and 1 M NaOH solution. Some of 
the parameters imposed by the Portuguese legislation with regard to discharge of effluents were 
determined; also, tests for aerobic or anaerobic biodegradation of those effluents were carried out. 
The effluents from alkaline hydrolysis tests showed values lower than discharge limit values for 
almost all the parameters except pH, total nitrogen, TOC, COD and BOD5. Due to organic load the last 
three parameters showed very high values.  
Despite these effluents presented high total nitrogen, TOC, COD and BOD5 they showed a coefficient 
of total aerobic biological degradation of 50.5 % ± 2.5 % and 52.9 % ± 3.7 %, for the alkaline 
hydrolysis tests with discarded medical components and animal tissues, respectively. The toxicity of 
these effluents was 2 % and 22 % to discarded medical components and animal tissues, respectively. 
The anaerobic biodegradability obtained for effluents from alkaline hydrolysis tests with discarded 
medical components were 22.3 % ± 4.2 and 42.2 % ± 6.5 %, for animal tissues. 
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7.1  INTRODUCTION  
 
The autoclaving and incineration are the main processes for treating HCW (Sukandar et al., 
2006). These technologies have advantages and disadvantages vis-à-vis other alternatives of 
treatment, some of them not well clarified, yet. So, autoclaving and incineration may be 
advantageously substituted by alkaline hydrolysis to treat some types of HCW offering an 
interesting basis of decentralised treatment for reducing the risks of infection from handling 
and transporting HCW. The choice of HCW treatment is a task that involves not only treatment 
efficiency, itself, but also environmental factors. For this reason the aim of this work was to 
characterize the effluents from alkaline hydrolysis of some components usually present in 
HCW and, also, evaluate their biodegradability under aerobic or anaerobic conditions.  
In aerobic biodegradation occurs the breakdown of organic compounds by microorganisms in 
the presence of oxygen. In anaerobic processes, the microorganisms convert organic matter 
into biogas in the absence of oxygen. The biogas consists, essentially, of methane (CH4) and 
carbon dioxide (CO2) (Angelidaki and Sanders, 2004). The ratio between CH4 and CO2 depends 
on the oxidation state of the carbon present in the organic material, i.e. the more reduced the 
organic carbon content is, the more CH4 will be produced (Angelidaki and Sanders, 2004). 
There are several factors that affect biodegradation of organic compounds such as: 
temperature; pH; oxygen concentration; moisture; salinity. Temperature is a major factor in 
the biodegradation process. In case of anaerobic digestion the optimum temperature may vary 
depending on feedstock composition and type of digester, but in most anaerobic digestion 
processes it should be maintained relatively constant to sustain the gas production rate. 
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7.2  MATERIALS AND METHODS 
 
7.2.1 MATERIALS  
 
The samples studied were from representative components commonly present in HCW, 
including cotton, diapers, tubes for transfusion, surgical gloves, examination gloves, adhesives, 
surgical masks, bag collectors for urine, serum bottles and syringes. These components are 
described in chapter 4, section 4.2.1. Pork meat was also used in the tests to simulate the 
pathological waste content of HCW. For simplicity, the first components are herein referred to 
as discarded medical components and the second ones (pathological wastes) as animal tissues. 
 
7.2.2 ALKALINE HYDROLYSIS TESTS 
  
The preparation of discarded medical components was carried out according to the procedure 
described in Chapter 4, section 4.2.1. The reactor with the sample tested, described in the 
previous Chapter 4, was heated at the heating rate of 10 °C/min up to 110 °C and held for 35 
minutes. The selection of temperature, time and alkaline solution concentration was based in 
the results presented in Chapter 5 and Chapter 6. The temperature of 110 °C and the 
concentration of 1 M for the NaOH solution were chosen because they have been the 
conditions under which the complete inactivation of Geobacillus stearothermophillus was 
achieved in less time. The time selected was that needed for the complete destruction of the 
animal tissues in the conditions of temperature and concentration above referred.  
A liquid/solid ratio of 5:1 (w/w) was used in the discarded medical components hydrolysis tests 
and 10:1 (w/w) for the animal tissues ones. In the tests, 20 g of the sample (2 g of each 
component in case of the mixture of discarded medical components) were mixed with either 
100 mL or 200 mL of 1 M NaOH aqueous solution.  
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After cooling to room temperature, the obtained mixture was filtered through glass funnels 
using Whatman n. 1 filter paper, by gravity or under vacuum conditions. The solid fraction was 
washed with distilled water in order to remove all of the adherent sodium hydroxide. 
Following, it was dried and finally weighted. The liquid fraction – the effluent – was 
immediately characterized or frozen for analysis. 
All the experiments were repeated three times and the results showed in the tables are the 
mean values of the 3 tests carried out under the same conditions. 
 
7.2.3  EFFLUENTS CHARACTERIZATION  METHODS 
 
The effluent was characterized according the methods described in Chapter 4, section 4.2.2, 
namely TOC, COD and BOD5; the remaining parameters were determined following the 
methods listed in Table 7.1. Metals were determined by Atomic Absorption Spectroscopy 
(AAS), with an Unicam model 969 equipment, the cyanides with Merck spectroquart, model 
NOVA 60, nitrates and sulfates with Dionex Ion Chromatograph, model ICS-2100, and total 
nitrogen was measured in Shimadzu TC analyser model TOC-VCSH. 
 
7.1 – Chemical methods to characterize effluents 
Parameter Methods 
pH 4500 B – Electrometric Method (a) 
Ammonia 4500 D – Selective Electrode Method (a) 
Cyanides EPA 335.2; ISO 6703 
Nitrate and sulfate 4110 B – Ion Chromatography (a) 
Phosphorous  4500 P – Ascorbic Acid Method (a) 
Total metal: Al, As, Cd, Cr, Cu, Fe, Hg, Mn, Ni, Pb US EPA 7000B:2007 and AAS 
Oil and Grease  5520 D – Soxhlet Extraction Method (a) 
(a) Standard Methods for Examination of Waters and Waste Water 
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7.2.4 AEROBIC BIODEGRADATION TESTS OF EFFLUENTS 
 
The liquid fractions from alkaline hydrolysis of discarded medical components and animal 
tissues were subjected to aerobic biodegradation tests using the respirometry method in a 
BM-Advance Respirometer, according to the method described in Annex 2. The sludge needed 
in the method were collected from the aerobic waste water treatment plants of Freixo or 
Ponte de Moreira, about 3 km or 10 km of laboratory. In the tests, 700 mL of sludge with 5 mL 
of effluent or acetate with the same COD of the effluent were used. They were carried out at 
least in triplicate at the controlled temperature of 20 °C using a range of 2.6 % to 2.8 % of total 
solid sludge.  
 
7.2.5 ANAEROBIC BIODEGRADATION TESTS OF EFFLUENTS 
 
The liquid fractions from hydrolysis tests with the discarded medical components and animal 
tissues were subjected to anaerobic biodegradation tests based on the ISO11734:1995 
standard, according to the method described in Annex 3. The inoculum was collected from the 
anaerobic waste water treatment plant of the Freixo. The tests were carried out in vessels of 
125 mL, with 60 mL of medium, using approximately 2 g/L total solid of inoculum sludge and 5 
mL of effluent. In the control tests, cellulose and gelatine was used. The vessels were 
incubated at 35 °C during 60 days. All the tests were done at least in triplicate. The generated 
methane was measured by gas chromatography (GC) using Shimadzu GC, model GC – 2014. 
 
7.3  RESULTS AND DISCUSSION  
7.3.1  EFFLUENTS CHARACTERIZATION  
 
The parameters characterized were those recommended by Portuguese regulation, Decree 
Law No 236/98, which establishes their maximum admissible values for effluent discharge. 
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Table 7.2 reports the parameters, respective values and threshold values for the effluents from 
alkaline hydrolysis of discarded medical components. Almost all the determined parameters 
are below the threshold values, except pH, total nitrogen, TOC, COD and BOD5. The last three 
were much above the threshold values, and total nitrogen, mostly as nitrate, is four times the 
allowable value for effluent discharge. To these values of parameters determined in the 
effluents corresponds a significant degradation of components during the hydrolysis tests, 
since there was a loss of approximately 10 % of their initial weight. 
 
Table 7.2 – Characterization of effluent from alkaline hydrolysis of discarded medical 
components. 
Parameter Effluent Emission limit value 
pH 13.2 ± 0.3 6.0 – 9.0 
Total nitrogen, mg N/L 62 ± 2 15 
Ammonia, mg NH4/L 4.0 ± 1.2 10 
Nitrate, mg NO3/L 49 ± 7 50 
Sulfate, mg SO4/L 5.9 ± 2.1 2000 
Total phosphorus, mg P/L 4.1 ± 1.8 10 
Cyanides, mg/L <0.01 0.5 
Al, mg/L 1.6 ± 0.0 10 
Cu, mg/L <0.04 1.0 
Fe, mg/L <0.06 2.0 
Cd, mg/L <0.03 0.2 
Mn, mg/L <0.03 2.0 
Pb, mg/L 0.2 ± 0.0 1.0 
Ni, mg/L 0.1 ± 0.0 2.0 
Cr, mg/L <0.1 2.0 
As, mg/L <0.001 1.0 
Hg, mg/L <0.001 0.05 
TOC, mg C/L 6073 ± 182 (*) 
COD, mg O2/L 19117 ± 476 150 
BOD5, mg O2/L 8616 ± 927 40 
(*) parameter not considered in Decree Law No. 236/98 
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The effluents from alkaline hydrolysis tests with animal tissues showed low values for all the 
metals analysed as well as for sulfate and cyanides. The remaining parameters were above the 
threshold values, as shown in Table 7.3. These effluents present very high organic loads, with 
TOC, COD and BOD5 values of approximately 14 g/L, 51 g/L and 25 g/L, respectively. Also, the 
obtained values for total nitrogen and ammonia are 200 and 20, respectively, times higher 
than the allowed by current Portuguese regulation. Nitrogen released corresponds to organic 
nitrogen, mainly in the form of proteins and amino acids, and its values as well as TOC, COD 
and BOD5 are the result of the total destruction of the biological material. 
 
Table 7.3 – Characterization of effluent from alkaline hydrolysis of animal tissues. 
Parameter Effluent Emission limit value 
pH 12 6.0 – 9.0 
Total nitrogen, mg N/L 3030 ± 200 15 
Ammonia, mg NH4/L 274 ± 32 10 
Nitrate, mg NO3/L 63 ± 7 50 
Sulfate, mg SO4/L 4.0 ± 0.1 2000 
Total phosphorous, mg P/L 58 ± 4 10 
Cyanides, mg/L <0.01 0.5 
Al, mg/L 3.1 ± 0.2 10 
Cu, mg/L <0.04 1.0 
Fe, mg/L 0.7 ± 0.1 2.0 
Cd, mg/L <0.03 0.2 
Mn, mg/L <0.03 2.0 
Pb, mg/L 0.2 ± 0.0 1.0 
Ni, mg/L 0.6 ± 0.0 2.0 
Cr, mg/L <0.1 2.0 
As, mg/L <0.001 1.0 
Hg, mg/L <0.001 0.05 
Oil and Grease, mg/L 760 ± 310 15 
TOC, mg C/L 14378 ± 1100 (*) 
COD, mg O2/L 51467 ± 4856 150 
BOD5, mg O2/L 25269 ± 3350 40 
(*) parameter not considered in Decree Law No. 236/98 
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7.3.2  AEROBIC BIODEGRADATION OF EFFLUENTS 
 
Under the test conditions used, the effluent resultant from the alkaline hydrolysis tests with 
discarded medical components showed a coefficient of total aerobic biological degradation of 
50.5 % ± 2.5 % and a toxicity value of 2 %. The value for coefficient of total aerobic biological 
degradation of animal tissues was 52.9 % ± 3.7 % and the toxicity was 22 %.  
Based on these results, the aerobic biological process can be a good option of treatment for 
these effluents. 
 
7.3.3  ANAEROBIC BIODEGRADATION OF EFFLUENTS 
 
In the test conditions studied, the effluents from alkaline hydrolysis of discarded medical 
components showed a coefficient of total anaerobic biological degradation of 22.3 % ± 4.2 %. 
The same coefficient for animal tissues was 42.2 % ± 6.5 %, value close to the limit of 
biodegradability, thus it may be advantageous to treat these effluents by an anaerobic 
process. Therefore, they may be utilized as an energy source for biogas production, for 
example, adding them to an anaerobic co-digestion plant. 
 
7.4  CONCLUSIONS 
 
Although effluents from alkaline hydrolysis tests of both discarded medical components and 
animal tissues do not comply the admissible maximum values for all parameters considered by 
Portuguese regulation, namely total nitrogen, TOC, COD and BOD5, they gave aerobic 
biodegradability values above 50 %. It means that these effluents can be treated by an aerobic 
biological process, as those common in the domestic wastewater treatment plants, after 
neutralization. The effluents from the alkaline hydrolysis tests with animal tissues can also be 
treated by an anaerobic biological process, therefore being a source of biogas and working as a 
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feedstock of anaerobic digesters. On contrary, the discarded medical components subjected to 
alkaline hydrolysis generated effluents with low anaerobic biodegradability. 
The effluents from alkaline hydrolysis of animal tissues showed a very high organic load and 
were rich in nitrogen, which leads to opening some interest for applications such as liquid 
fertilizer. 
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ABSTRACT 
This work aims to present some results related to a scaled up test of alkaline hydrolysis treatment 
using a real sample of infectious HCW, namely the characteristics of the effluents obtained when 
using a 1 M NaOH aqueous solution and temperature of 110 °C during 35 min. Some of the 
parameters imposed by the Portuguese legislation with regard to discharge of effluents were 
determined and the disinfection effectiveness was assessed. The effluents from alkaline hydrolysis 
treatment showed higher values than discharge limits for all the parameters analysed: pH, total 
nitrogen, ammonia, TOC, COD and BOD5. The disinfection efficiency obtained with this alkaline 
treatment was confirmed. 
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8.1  INTRODUCTION  
 
In the alkaline treatment tests described in the previous chapters, small amounts of synthetic 
samples of HCW and laboratory conditions were always used. However, since the real HCW is a 
heterogeneous mixture of components with coarser sizes, just by increasing the sample size 
it’ll be possible to have a better representativeness of the HCW produced and respective 
results from alkaline treatments. Therefore, in order to gain additional confidence in the 
effectiveness of the alkaline treatment, it will be desirable to test it under the previous 
identified suitable conditions with higher amounts of HCW. Thus, first of all a new reactor 
having 70 L of useful volume was conceived and designed with the purpose of complying with 
the requirements of treatment from infectious HCW generated in many of the small and 
medium services in the private and public healthcare Portuguese system. Second, a real 
sample of infectious waste from Group III, according Portuguese classification, was obtained in 
a public hospital following the sound practice of infectious waste collection, storage and 
transport. Third, this sample was characterized and after being sub-sampled it was the basis of 
the scale up experiments here described. With this study, the effluents from two scale-up 
alkaline tests using the conditions of treatment defined in the laboratorial trials were 
characterized. Also, the disinfection effectiveness of the alkaline treatment was assessed. 
 
8.2  MATERIALS AND METHODS 
 
8.2.1 PILOT SCALE REACTOR 
 
A reactor with an internal volume of 70 L was built in 316 AISI stainless steel. It was designed 
to work at least under a pressure of water vapour in equilibrium at 200 °C. It has controlling 
devices to guarantee safety operation, namely temperature controller and discharge vapour 
safety valve regulated to release vapour at 130 °C. In addition, in order to increase operation 
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efficiency, it was designed to have an oscillating movement around its horizontal axis for 
mixing the solid and liquid feed, as well as to facilitate discharge and cleaning steps, in these 
cases assuming appropriate static positions. The pilot scale reactor is shown in Figure 8.1. 
 
Figure 8.1– Pilot reactor and real infectious HCW used in the alkaline hydrolysis tests. 
 
8.2.2 MATERIALS 
 
The infectious HCW was kindly provided by Hospital S. João, in Porto. It was a heterogeneous 
mixture of different components, which, in the perspective of characterisation, were 
separated in four types, respectively, paper, plastics, absorbents and liquids. The plastic 
fraction contained: syringes, gloves, tubes, serum bottles and bag collectors for urine. The 
absorbents fraction contained: adhesives, gauzes, compresses and diapers. Table 8.1 shows 
the composition of infectious HCW sample obtained for the experimental work. 
 
Table 8.1 – Composition of infectious HCW sample used in the tests. 
Fraction % (w/w) 
Paper 3.2 
Plastic 30.4 
Absorbents 9.4 
Liquids 57.0 
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8.2.3 ALKALINE HYDROLYSIS TESTS 
 
The selection of temperature, time and alkaline solution concentration was based in the 
results presented in Chapter 5 and Chapter 6. A liquid/solid ratio of 30:4 (w/w) was used; 4 kg 
of HCW sample was mixed with 30 L of 1 M NaOH aqueous solution. The sample was heated 
up to 110 °C and held 35 minutes at this temperature.  
After cooling, the liquid fraction (the effluent) was immediately characterized, or frozen for 
further analysis, following the methods described in Chapter 4, section 4.2.2 and Chapter 7, 
section 7.2.2. Two independent assays were performed. 
 
8.2.4 ASSESSMENT OF DISINFECTION EFFICIENCY  
 
The total number of heterotrophic mesophilic bacteria in HCW (CFU/kg) was determined by 
the viable plate count method. To assess the microbial load, 100 g of solid fraction infectious 
HCW sample was mixed with 750 mL of sterile saline solution (0.85 % NaCl, w:v) during 30 min. 
The resultant suspension was further serially diluted with saline solution up to 10
-7
, and 0.1 mL 
of each dilution were spread on triplicate PCA plates and incubated at 30 °C for 48 h. To assess 
the disinfection efficiency, samples of effluent (10 mL) were cooled down and neutralized with 
a highly concentrated HCl solution to pH 7 to avoid sample dilution; 0.1 mL of the neutralized 
effluent were spread on triplicate PCA plates and incubated at 30 °C for 48 h.  
 
8.3  RESULTS AND DISCUSSION  
 
Due to aggressiveness of caustic soda, alkaline hydrolysis enhances the degradation of some 
the components typically present in HCW of group III. The effluent resultant from the alkaline 
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hydrolysis treatment of real infectious HCW showed a brownish color and ammonia odor 
(Figure 8.2).  
 
Figure 8.2 – Effluent from the scaled-up alkaline hydrolysis treatment of real infectious HCW. 
 
The parameters determined on the effluent were those referred in Chapter 7 as having higher 
values than the threshold values for effluent discharge established by Portuguese regulation, 
Decree Law No. 236/98. Table 8.2 reports those parameters, the respective average values 
obtained from two independent tests of alkaline hydrolysis with infectious HCW samples and 
the respective threshold values for the effluents discharge. 
 
Table 8.2 – Characterization of the effluent from the scaled up alkaline hydrolysis treatment  
of real infectious HCW. 
Parameter Effluent Emission limit value 
pH 12.9 6.0 – 9.0 
Total nitrogen, mg/L 308 15 
Ammonia, mg/L 138 10 
TOC, mg C/L 1422 (*) 
COD, mg O2/L 4862 150 
BOD5, mg O2/L 1797 40 
                 (*) parameter not considered in Decree Law No. 236/98 
 
As expected, all the determined parameters (pH, total nitrogen, ammonia, TOC, COD and 
BOD5) were higher than the threshold values. These effluents presented high organic loads, 
with TOC, COD and BOD5 values of approximately 1.4 g/L, 4.9 g/L and 1.8 g/L, respectively.  
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These high values are, most probably, the result of the partial destruction of the some 
material, such as absorbents, paper and the hydrolysis of the liquid fraction. In visual 
evaluation it was possible to see that the bag collectors for urine burst, the serum bottles were 
shrunken and paper and absorbers were partially destroyed, which led to a volume decrease, 
estimated of about 30 %. The infectious HCW after alkaline hydrolysis treatment is shown in 
Figure 8.3. 
The total nitrogen and ammonia were, respectively, 20 and 10 times higher than the levels 
allowed by the current Portuguese regulation. The nitrogen present in effluent was essentially 
composes by ammonia (about 45 %). This high value of ammonia is, probably, due to the 
hydrolysis of the liquid fraction of HCW, in particular from bursting of the bag collectors for 
urine. 
 
 
Figure 8.3 – Real infectious HCW after alkaline hydrolysis treatment. 
 
Concerning to the microbial load, the real infectious HCW contained 8 – 9 × 10
6
 CFU/kg of total 
heterotrophic mesophilic bacteria. This value may be under-evaluated because it was only the 
solid fraction and not the whole of the real infectious HCW sample that was analyzed as a 
precaution to avoid possible contamination of the operator. The results obtained to assess 
disinfection efficiency, confirmed that the alkaline hydrolysis treatment was effective in 
bacteria inactivation. Indeed, none of the three suspensions of neutralized effluent tested 
formed any CFU/kg on the plates corresponding to microbial load in effluent of  
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<7.5 × 10
4
 CFU/kg. In future work would be useful to study the application of other methods to 
assess disinfection in order to reduce the detection limit of the method used. 
 
8.4  CONCLUSIONS 
 
The results obtained with a real sample of infectious HCW at pilot scale corroborate those 
obtained in the tests carried out in the laboratorial study. 
The alkaline effluents from infectious HCW treatment showed high organic loads, high 
nitrogen values and a strong alkaline pH. The alkaline hydrolysis allowed a reduction of the 
total heterotrophs of at least 2 log. Therefore, alkaline hydrolysis may be used as an 
alternative process to treat infectious HCW reducing its volume; thus, it can be further 
disposed of as municipal waste. 
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CHAPTER 9 – CONCLUSIONS AND FUTURE WORK  
 
 
9.1 CONCLUSIONS 
 
Degradation of the components usually present in healthcare waste, when subjected to 
autoclaving or alkaline hydrolysis at the same conditions, occur at a higher or lower degree 
according to the thermal resistance of the materials in their composition. Despite autoclaving 
degrade materials much less than alkaline hydrolysis, the effluents generated have an 
appreciable organic load and showed values of biodegradability close to the limit. Alkaline 
hydrolysis degrades significantly almost of the components, particularly adhesive and diaper; 
on contrary, components constituted by LDPE, HDPE or PP show good resistance to the 
treatment. The alkaline hydrolysis is not efficient in reducing the mass of waste because the 
materials tested have lost only up to 10 % of their weight, except in case of diapers and 
adhesives for which the reduction is 30 % to 50 %, respectively. The effluents resultant from 
alkaline treatment show higher organic loads than autoclaving and are biodegradable after 
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neutralization. Under conditions commonly used in autoclaving, the application of alkaline 
hydrolysis treatment to a HCW essentially constituted by polymers does not present any 
relevant advantage. 
However, the application of alkaline hydrolysis treatment in milder conditions may be a 
valuable option of treatment to HCW because it proved to be able to sterilize and destroy 
animal tissues at temperatures lower than those used in common processes of heat 
sterilization. 
The results obtained showed that the inactivation of Geobacillus stearothermophilus was 
achieved under milder conditions than those described in the literature, due to the 
combination of alkaline conditions and heat. 
Although this treatment has the disadvantage of generating alkaline effluents with very high 
organic load, they can be treated by an aerobic biological process, as those commonly found in 
the domestic wastewater treatment plants, after neutralization. The effluents from the 
alkaline hydrolysis of animal tissues with very high organic loads can also be treated by an 
anaerobic biological process, being, therefore, a source of biogas and working as a feedstock of 
anaerobic digesters.  
The results obtained with a real sample of infectious HCW of group III at pilot scale 
corroborate those obtained in laboratorial tests. The resultant effluents showed high organic 
loads, high nitrogen values, high pH and disinfection effectiveness was verified. 
 
9.2 FUTURE WORK 
 
The perspective is to address the treatment in a more comprehensive way, i.e. from the 
components behavior, gaseous emissions and resultant effluents, including answers to all the 
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environmental effects in a life cycle point of view. Thus, the main subjects that are considered 
important to be developed in the future are: 
• study the transformations that may occur in alkaline hydrolysis of other components 
which have not been studied at this work and may be present in HCW; 
• look into the gaseous emissions resulting from the alkaline hydrolysis of HCW in the 
tested conditions, particularly to the presence of organic halogen compounds; 
• better characterize the hydrolyzate from alkaline hydrolysis in order to define 
alternatives of its application, for example the possibility of treating animal tissues, which 
by having a high protein content, would be further used in agriculture, as organic 
fertilizer; 
• assess autoclaving followed by sanitary landfilling as well as alkaline hydrolysis with 
landfilling from a life cycle perspective of HCW management. 
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ANNEX 1 – CHEMICAL TEST METHODS DESCRIPTION 
 
A.1.1 TOTAL ORGANIC CARBON (TOC) 
 
Total organic carbon was determined according EN 13137:2001 and EN 1484:1997 which 
proposed two methods. In the indirect method, TOC is obtained by the difference between the 
results of the measurements of total carbon (TC) and total inorganic carbon (TIC). TC is 
converted to carbon dioxide by combustion (at approximately 700 °C) in an oxygen-containing 
gas flow. The amount of carbon dioxide released is measured by infrared spectrometry. TIC is 
determined separately from another subsample by means of acidification (with 
ortophosphoric acid at 200 °C). 
In the direct method, the carbonates present in the sample are previously removed by 
acidification. The carbon dioxide released is measured by infrared spectrometry and it 
indicates the amount of TOC directly. 
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In the present study, the indirect method was used and TC and TOC in solutions were 
determined with a Shimadzu TC analyser model TOC-VCSH (Figure A.1.1), according to EN 1484 
(1997). TC in the materials was determined with the same equipment using its solids module, 
according to EN 13137 (2001). 
  
Figure A.1.1 – TC analyser used in TOC and TC determination. 
 
A.1.2 CHEMICAL OXYGEN DEMAND (COD) 
  
The chemical oxygen demand (COD) method determines the amount of oxygen required to 
oxidize the organic matter in a sample, under specific conditions of oxidizing agent, 
temperature and time. COD was determined following the 5220 D: Closed Reflux - Colorimetric 
Method by the Standard Methods for Examination of Water and Wastewater (1998). 
In this method, the sample was refluxed in a strongly sulphuric acid solution with a known 
excess of potassium dichromate (K2Cr2O7). The sample (of 2.5 mL) and reagents (Table A.1.1) 
were added in the digestion vessel (culture tubes of 16 × 100 mm). After digestion (2 hours of 
reflux time at 150 °C), the consumed oxygen was measured against standards at 600 nm using 
a Shimadzu spectrophotometer, model UVmini-1240 (Figure A.1.2). 
Five standards of potassium hydrogen phthalate with COD from 100 to 900 mg O2/L were 
prepared. 
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Table A.1.1 – Reagents used in COD determination.  
Reagents/volume  
Digestion solution/1.5 mL 10.216 g of K2Cr2O7 
167 mL of conc. H2SO4 
33.3 g of HgSO4 
in 1000 mL of distilled water 
Sulphuric acid reagent/3.5 mL 5.5 g of AgSO4/kg H2SO4 
Potassium hydrogen phthalate standard (KHP) 425 mg of KHP in 500 mL distilled water 
 
 
 
Figure A.1.2 – Digester and spectrophotometer used in COD determination. 
 
A.1.3 BIOCHEMICAL OXYGEN DEMAND (BOD) 
 
The biochemical oxygen demand (BOD) method measures the quantity of oxygen required for 
the biochemical degradation of organic matter plus the oxygen used to oxidize inorganic 
matter, such as sulphides and ferrous iron. It also may measure the oxygen used to oxidize 
reduced forms of nitrogen, unless their oxidation is prevented by an inhibitor.  
The BOD after five days was determined following the 5210 B: 5-Day BOD Method as described 
by the Standard Methods for Examination of Water and Wastewater (1998). 
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The method consists of filling with diluted sample, to overflowing, an airtight bottle and 
incubating the bottle at 20 °C for five days. The dilution water contains the inoculum and the 
following reagents (Table A.1.3).  
 
Table A.1.3. – Reagents used in dilution water of BOD determination. 
Reagents  
Phosphate buffer solution  8.5 g of KH2PO4 
21.75 g of K2HPO4 
33.4 g of Na2HPO4.7H2O 
1.7 g of NH4Cl 
in 1000 mL of distilled water 
Magnesium sulphate solution  22.5 g of MgSO4.7H2O 
in 1000 mL of distilled water 
Calcium chloride solution  27.5 g of CaCl2 
in 1000 mL of distilled water 
Ferric  chloride solution  0.25 g of FeCl3.6H2O 
in 1000 mL of distilled water 
 
The dissolved oxygen (DO) was measured initially and after incubation, using an Orion DO 
meter, model 850. The BOD was computed from the difference between the initial and final 
DO. The BOD5 in the sample (in mg/L) is given by the equation: 
 
 =
 − 	
 −  − 	
 × 

 
 
Where: D1 – DO of diluted sample before incubation (mg/L); D2 – DO of diluted sample after 
incubation at 20 °C for five days (mg/L); B1 – DO of seed control before incubation (mg/L); B2 – 
DO of seed control after incubation (mg/L); f – ratio of seed in sample to seed in control; P – 
decimal volumetric fraction of sample used. 
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Figure A.1.3 – DO meter used in BOD5 determination. 
 
A.1.4 TOTAL NITROGEN AND AMMONIA  
Total nitrogen was measured using the principles of oxidative combustion chemiluminescence. 
The sample was injected into the high temperature furnace where it was catalytically 
combusted at 720 °C in a carrier/oxygen atmosphere. The nitrogen oxide formed was 
measured in a Shimadzu TC analyser model TOC-VCSH (Figure A1). The calibration curve was 
obtained using five standards from 20 to 100 mg/L. 
In this work the ammonia was determined according to 4500 F: Ammonia-Selective Electrode 
Method, as described by the Standard Methods for Examination of Water and Wastewater 
(1998).  
The ammonia-selective electrode uses a hydrophobic gas-permeable membrane to separate 
the sample solution from an electrode internal solution of ammonium chloride. During the 
test, dissolved ammonia (NH3(aq) and NH4
+
) is converted to NH3(aq) by raising pH to above 11 
with NaOH. NH3(aq) diffuses through the membrane and changes the internal solution pH that 
is sensed by a pH electrode. The fixed level of chloride in the internal solution is sensed by a 
chloride ion-selective electrode that serves as the reference electrode. Potentiometric 
measurements were made with a pH meter having an expanded millivolt scale. The method is 
applicable to the measurement of 0.03 to 1400 mg NH3-N/L.  
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For calibration curve the standards used were 1000, 100, 10, 1, 0.1 mg NH3-N/L. The standard 
solutions were prepared with NH4Cl in 1000 mL of distilled water. The standard solutions or 
the samples were stirred (magnetic bar), the electrode introduced and the NaOH added to 
raise the pH above 11. After 5 minutes readings of millivolt for standards and samples were 
performed. A tenfold change of NH3-N concentration produces a potential change of about 59 
mV. 
The standard curve was done using semi logarithmic graph paper, plotting ammonia 
concentration in mg NH3-N/L on the log axis versus potential in millivolts on the linear axis. 
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ANNEX 2 – AEROBIC RESPIROMETRIC TEST  
A.2.1 INTRODUCTION 
The aerobic respirometric test is used to estimate the biodegradability of the waste/water. It is 
performed under aerobic conditions and measured the oxygen consumption and/ or the 
amount of CO2 released. This oxygen consumption, or respiration, is proportional to the COD 
biodegradable fraction where more substrate available to the bacteria, more oxygen is 
consumed. Deviations in oxygen uptake can occur in the presence of a toxicant or any 
inhibitory condition that specially affects the biomass. 
These tests can be performed in a few days, hours or even minutes. The measurements can be 
carried out in “closed bottles”, where no aerobic takes place, or “dynamic”, where oxygen is 
allowed to flow during the test. 
The activated sludge is the “reagent” and, for that reason, its preparation and condition 
deserves special care so, after collecting the sludge must leaving aerated along 24 hours from 
the day before; but in case of extended aeration process type with long hydraulic retention 
time and efficient performance, normally it is only necessary a couple of hours of aeration. 
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The final sludge volume that the analyzer normally need is 1 liter. For that, it is convenient to 
get at least 2 liters at the time of collecting the sample. 
 
A.2.2 PRINCIPLE 
 
The aerobic test was based on the oxygen uptake by the microorganisms contained in the 
activated sludge from biological reactor in one wastewater treatment plant.  
The tests were carried out in a closed circuit batch reactor glass, by means of continuous 
dissolved oxygen measurements from the activated sludge, mixed liquor and mixing formed 
with sludge and sample to be analyzed. The measured dissolved oxygen is resultant effect of 
the microorganisms respiration in the activated sludge, from the biological oxidation of 
substrate (organic matter or ammonium) and from its own survival consumption (endogenous 
respiration). 
 
 
 
 
 
 
 
 
Figure A.2.1 – Respirometer used in the aerobic tests. 
 
A.2.3 DETERMINATION OF AEROBIC BIODEGRADATION 
 
The determination of aerobic biodegradation is given by the ratio of the curves slopes of 
oxygen consumption during the sample and acetate tests. 
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The Figure A.2.2 shows the results obtained with one of the three tests performed with 
effluents resultant from alkaline hydrolysis of discarded medical components. 
 
 
 
 
 
 
Figure A.2.2 – Dissolved oxygen versus time for sample and acetate. 
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ANNEX 3 – ANAEROBIC BIODEGRADABILITY TEST  
A.3.1 INTRODUCTION 
 
The anaerobic biodegradation is a naturally occurring process of decomposition and decay, by 
which organic matter is broken down in the absence of oxygen. 
The anaerobic digestion involves a complex processes of degradation, which are described by 
the following steps: Hydrolysis; Acidogenesis; Acetogenesis ; Methanogenesis. 
In hydrolysis large polymers such as lipids, polysaccharides and proteins, are broken down into 
soluble monomers, such as, fatty acids, sugars and amino acids (Angelidaki et al., 2009). 
Hydrolysis of different compounds occurs in different time frames. For instance, the hydrolysis 
of carbohydrates lasts within a few hours, of lipids and proteins is done in a few days and 
cellulose and lignin are broken down only at a slow rate and incompletely. 
In acidogenesis, the monomers from hydrolysis are fermented by acidogenic bacteria into 
carbon dioxide, hydrogen, ammonia, and organic acids. 
Acetogenesis is the breakdown of organic acids (volatile fatty acids) to acetate, carbon dioxide 
and hydrogen. 
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Methanogenesis converts acetate, formaldehyde, hydrogen and carbon dioxide into methane 
and water. The methane is formed in strictly anaerobic conditions. 
Many factors affect the rate of methane generation such as, temperature, pH, moisture 
content, nutrient content and concentration of toxic substances. 
Temperature is the most important variable in controlling the rate of microbial metabolism in 
anaerobic conditions. Higher temperatures increase microbial activity, with activity roughly 
doubling for every 10 °C increase within the optimal range. Anaerobic process can be designed 
for temperatures appropriate for mesophilic bacteria (25 – 40 °C) or thermophilic bacteria  
(45 – 60 °C). The effect of temperature on anaerobic process only influences the degradation 
rates and not the ultimate biodegradability of a compound (Angelidaki and Sanders, 2004). 
 
The optimal pH values for the acidogenesis and methanogenesis steps are different. Low pH 
can inhibit acidogenesis while high pH leads to an increase in free ammonia, which is toxic for 
the methanogenic population (Lesteur et al., 2009). An optimal pH range for all the metabolic 
processes is between 6.4 and 7.2. 
The relationship between the amount of carbon and nitrogen present in organic materials is 
represented by the C:N ratio. Optimum C:N ratios in anaerobic digesters are between 20 and 
30. A high C:N ration is an indication of a rapid consumption of nitrogen by the methanogens 
and results in low gas production. On the other hand, a lower C: N ratio causes ammonia ion 
accumulation with consequent pH values exceeding 8.5, which is toxic to methanogens. 
Optimum C:N ratio of the feedstock materials can be achieved by mixing waste of low and high 
C:N ratio, such as organic solid waste mixed with sewage or animal manure. 
High levels of ammonia, soluble sulfides, soluble salts of metals, and alkali and alkaline-earth 
metal salts in solution (e.g. those of sodium, potassium, calcium, or magnesium) can be toxic 
to methanogens. 
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The anaerobic biodegradability tests are based on the measurement of one or more products 
involved in the biological reaction or measurement of substrate depletion. The methods to 
characterize the anaerobic process based on product formation consist in the determination of 
the biogas (end product) or intermediates products. Since the biogas is the fundamental end 
product of anaerobic process, most methods are based on monitoring the biogas production. 
The biogas production can be measured using volumetric methods, manometric methods or 
measurement of methane and carbon dioxide by gas chromatography. Volumetric and 
manometric methods can use manual or automated devices. In gas chromatography methods 
the determination of biogas may be by: thermal conductivity detector where both methane 
and carbon dioxide are measured; flame ionization detector, where only methane is measured 
(Angelidaki and Sanders, 2004).  
Methods based on substrate depletion, determine some parameters such as TOC, COD, 
dissolved organic carbon, volatile solids, etc., or direct analysis of the compound that is being 
used as substrate (Angelidaki and Sanders, 2004). 
Methane potential can be expressed specifically per amount of waste (L CH4/kg-waste), per 
volume of waste (L CH4/L-waste), per mass volatile solids added (L CH4/kg-VS) or COD added  
(L CH4/kg-COD). The volume is usually expressed in standard pressure (1 atm) and temperature 
(0 °C) conditions (STP conditions) (Angelidaki et al., 2009). 
  
A.3.2 PRINCIPLE 
 
To verify the anaerobic biodegradability of effluents resultants from alkaline hydrolysis of 
organic and inorganic wastes a laboratory method based in ISO 11734: Water quality – 
Evaluation of the “ultimate” anaerobic biodegradability of organic compound in digested 
sludge – Method by measurement of the biogas production was used. 
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This method consists in an aqueous biodegradation test at a mesophilic temperature  
(35 °C ± 2 °C) in sealed vessels with a synthetic growth medium with a mixed microbial 
population derived normally from a waste water treatment facility. The sludge is diluted with a 
mineral salts medium. The increase in headspace pressure in the test vessels resulting from 
the production of CO2 and CH4 is measured. The dissolved CO2 (inorganic carbon) is measured 
at the end of the test. The method uses as inoculum washed of domestic sewage or laboratory 
grown. To ensure the anaerobic conditions pure N2 is used as purge gas. Incubation takes 
normally up to 60 days or till a plateau phase is reached, in the dark, with stirring or shaking.  
 
A.3.3 REAGENTS 
 
Medium  
The medium contains the constituents below referred and, in order to remove oxygen, it must 
be purged with nitrogen for about 20 min immediately before use. 
 
Inoculum sludge 
The sludge was collected from a digester at a sewage treatment plant. The sludge was 
incubated at 35 °C ± 2 °C for up to 7 days. After digestion the sludge was wash to reduce the 
inorganic carbon. The final concentration of total solids in the test vessels was in the range of  
1 g/L to 3 g/L. 
 
Reference substances  
Cellulose or gelatin were the substances used in control vessels and prepared solutions were 
expected to have a degradation degree higher than 60 %. 
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Medium   
Anhydrous potassium dihydrogenphosphate (KH2PO4) 0.27 g 
Disodium hydrogenphosphate dodecahydrate (Na2HPO4.12H2O) 1.12 g 
Ammonium chloride (NH4Cl) 0.53 g 
Calcium chloride dihydrate (CaCl2.2H2O) 0.075 g 
Magnesium chloride hexahydrate (MgCl2.6 H2O) 0.10 g 
Iron(II) chloride tetrahydrate (FeCl2.4H2O) 
Resazurin (oxygen indicator) 
0.02 g 
0.001 g 
Sodium sulfide nonahydrate (Na2S.9H2O) 0.1 g 
Stock solution of trace elements 10 mL 
De-oxygenated water to 1 L 
  
Stock solution of trace elements  
Manganese chloride tetrahydrate (MnCl2.4H2O) 0.05 g 
Boric acid (H3BO3) 0.005 g 
Zinc chloride (ZnCl2) 0.005 g 
Copper(II) chloride (CuCl2) 0.003 g 
Disodium molybdate dihydrate (Na2MoO4.2H2O) 0.001 g 
Cobalt chloride hexahydrate (CoCl2.6H2O) 0.1 g 
Nickel chloride hexahydrate (NiCl2.6H2O) 0.01 g 
Disodium selenite (Na2SeO3) 0.005 g 
Water to 1 L 
 
A.3.4 TEST PROCEDURE  
 
To ensure the anoxic conditions the tests were carried out in plastic bags fitted with gloves. 
The samples, blank and controls were prepared at least in triplicate, in 125 mL vessels (Figure 
A.3.1). The same volume of inoculum and medium was added to the vessels with samples, 
blanks and controls. Following, the pH was measured and adjusted. The prepared vessels were 
incubated at 35 °C ± 2 °C for up to 60 days, in the dark, ensuring that all vessels were 
maintained at the digestion temperature.  
In this work, the biogas production (methane) was measured by gas chromatography with a 
flame ionization detector using the gas conditions described in Table A.3.1. The gas 
chromatograph used was a Shimadzu, model GC-2014. 
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The measurement was compared with five standard with known methane content. For the 
calibration curve methane was added to the vessels with same headspace volume used in 
sample, blank and control vessels. The methane production from inoculum was subtracted 
from the methane production of the samples. 
 
 
 
 
Figure A.3.1 – The samples, blank and controls vessels used in anaerobic tests. 
 
A.3.5 DETERMINATION OF ANAEROBIC BIODEGRADATION 
 
The coefficient of total degradation was calculated using the equation: 
 
 =	
/350 ×	
 × 100
    (Eq. A.2.1) 
Where:  
 is the total biodegradation, expressed as a percentage; 
CH4  is the volume of methane produced, in mL, expressed in the Standard Temperature and 
Pressure (STP), respectively 0 °C and 1 atm. 
CODSample is the chemical oxygen demand of sample (g). 
 
It is admitted that 1 g of COD produces about 350 mL of CH4.  Although, bacterial growth uses 
part of the organic matter that is consumed during methane production, in biodegradability 
determination this value was not accounted.   
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The Figure A.3.2 shows the results obtained with one of the three tests performed with 
effluents resultant from alkaline hydrolysis of discarded medical components and animal 
tissues. 
 
Figure A.3.2 – Cumulative methane production (at 0 °C and 1 atm) of samples and controls. 
 
Table A.3.1 – Gas chromatography conditions. 
Gas chromatography conditions  
Column temperature  175 °C 
Oven temperature 200 °C 
L column flow 30/30 (mL/min) 
R column flow 40/40 (mL/min) 
 
 
 
Figure A.3.3 – Gas chromatograph. 
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